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Abstract
Epigallocatechin-3-gallate (EGCG), the principal polyphenol isolated from green tea, was recently
shown to inhibit Hsp90, however structure-activity relationships for this natural product have not
yet been produced. Herein, we report the synthesis and biological evaluation of EGCG analogues
to establish structure-activity relationships between EGCG and Hsp90. All four rings as well as
the linker connecting the C- and the D-rings were systematically investigated, which led to the
discovery of compounds that inhibit Hs90 and display improvement in efficacy over EGCG. Anti-
proliferative activity of all the analogues was determined against MCF-7 and SKBr3 cell lines and
Hsp90 inhibitory activity of four most potent analogues was further evaluated by western blot
analyses and degradation of Hsp90-dependent client proteins. Prenyl substituted aryl ester of 3,5-
dihydroxychroman-3-ol ring system was identified as novel scaffold that exhibit Hsp90 inhibitory
activity.
INTRODUCTION
Heat shock protein 90 (Hsp90) is ubiquitously expressed and essential for the folding of
many nascent polypeptides.1–4 As a molecular chaperone, Hsp90 regulates the
conformational maturation of more than 200 client proteins, including steroid hormone
receptors, Akt, Raf-1 and the Src-family kinases.5 Many of these Hsp90-dependent client
proteins regulate signaling pathways associated with cell survival, cell proliferation, as well
as cellular transformation and oncogenesis.6, 7 Prior studies have shown that Hsp90 is
upregulated in malignant cells and that Hsp90 inhibitors accumulate more efficiently in
tumor cells than in the surrounding normal tissue.8 Consequently, Hsp90 inhibition
represents a multi-faceted approach toward the treatment of cancer. 9, 10
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Natural products represent a class of diverse structures that contribute to clinically relevant
therapeutics.11, 12 They serve as lead compounds and/or scaffolds upon which molecules
with improved efficacy and drugability can be pursued.13 Structure-activity relationships
studies on natural products have led to the identification of structurally less complex
molecules that are clinically used today. (−)-Epigallocatechin-3-gallate (EGCG (1)) is a
polyphenolic natural product that can be isolated from green tea leaves and has been shown
to inhibit Hsp90’s function and induce the degradation of client proteins; including
telomerase, multiple kinases and the aryl hydrocarbon receptor (AhR).14–16 Palermo and
coworkers demonstrated through affinity chromatography that (−)-EGCG binds to amino
acids 538-728 within the Hsp90 C-terminus and inhibits AhR-mediated transcription
through interactions with Hsp9017. Unfortunately, the exact mechanism by which EGCG
inhibits the Hsp90 protein folding machinery remains undetermined. Similar to EGCG,
novobiocin (2) also binds Hsp90 within amino acids 538-728 and represents another
naturally occurring C-terminal inhibitor (Figure 1).4, 18 The bioavailability and lipophilicity
exhibited by EGCG along with its metabolically susceptible functionalities and modest
efficacy against various cancer cell lines make EGCG a poor lead compound for
development.19 However, only two natural products are known to inhibit the Hsp90 C-
terminus, and therefore EGCG was pursued as a probe to further investigate the mechanism
by which C-terminal inhibitors modulate the Hsp90 protein folding machinery.
EGCG is well known for its antioxidant activity both in vitro and in vivo, which also leads
to epimerization and/or dimerization (Scheme 1) and contributes to its low efficacy and
metabolic instability.20, 21 Epimerization of the methine hydrogen leads to formation of the
thermodynamically more stable anti product, GCG (Figure 2), whose activity against Hsp90
has not been investigated. Studies by Suzuki and co-workers have shown that incorporation
of hydroxyl groups onto the B-ring can lead to epimerization at C-2, whereas O-methylated
derivatives at the 4–position prevent epimerization.22 Therefore, the design of new EGCG
analogues must take into account these prior studies in an effort to produce stable
derivatives that are not prone to oxidation/epimerization.23–28 To probe EGCG’s structure-
activity relationships with Hsp90, three series of analogues (Scheme 2) were pursued; (I) 3′,
4′,5′-trimethoxy groups were incorporated into the B-ring, (II) compounds omitting
substituents on the B-ring were prepared, and (III) compounds lacking the B-ring were also
constructed. Furthermore, the phenols on the A-ring were converted to methyl ethers for
biological evaluation and finally, the gallic acid moiety (D-ring) of EGCG was replaced
with various aryl acids for elucidation of additional SAR trends. These aryl acids were
chosen to probe the effect of substitution at the 3- and 4-position of the D-ring and to
incorporate optimized novobiocin appendages to evaluate their potential for overlapping
binding modes.29–31
RESULTS AND DISCUSSION
Synthesis of the A-, B- and D-ring modified compounds (10a–j & 11a–j) are described in
Scheme 3. Prior work by Li and coworkers provided rapid access towards preparation of the
flavon-3-ol core, enlisting the use of a silica/sulfuric acid catalyst to couple electron rich
phenols (4a–b) with substituted cinnamyl alcohols (5a–b), which worked surprisingly well
and led to various substituted A- and B-ring analogues (6a–d).32 Dihydroxylation of the
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resulting alkenes (6a–d) with catalytic osmium tetroxide and excess N-methylmorpholine-
N-oxide gave the corresponding diol’s, 7a–d.33 Various methods have been reported for
cyclization and construction of the benzopyran core, however, stereochemical control at the
2,3-ring junction is dependent upon substituents on the B-ring. Therefore, cylization of
diol’s 7a–d to furnish the 2,3-dihydrobenzopyran core in a stereoselective manner was
pursued via two steps. Treatment of 7a–d with trimethylorthoacetate in the presence of
catalytic pyridinium p-toluenesulfonate, led to formation of the corresponding orthoesters,
which upon the addition of 10% boron trifluoride diethyl etherate produced the desired
cyclic products. Without purification, the cyclized products were subjected to solvolysis
conditions to furnish alcohols 8a–d in high yields and with the anti configuration. 34 The
2,3-syn products, 9a–d, were established by Dess-Martin oxidation of the secondary
alcohols (8a–d) to the corresponding ketones, which underwent subsequent reduction with
L–selectride to give syn products, 9a–d, respectively.35 These flavon-3-ol moieties (9a–d)
served as late stage intermediates to incorporate additional substitutions onto the D-ring.
Aryl acids 12–16 (Scheme 2) were chosen as replacements for the metabolically susceptible
gallic ester moiety of EGCG and also represent optimized side chains identified from prior
studies with the other Hsp90 C-terminal inhibitor, novobiocin.36, 37 Coupling of the alcohols
(9a–d) with aromatic acids 12–16 enlisting 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
(EDCI) and 4-dimethylaminopyrine (DMAP) gave the corresponding esters, 10a–t.38
Hydrogenolysis of 10k–t with palladium/carbon and hydrogen gas gave 11a–j in high yield.
Upon preparation of the A-, B- and the D-ring modified EGCG analogues (10a–j and 11a–
j), these compounds were evaluated against MCF-7 and SKBr3 breast cancer cell lines for
determination of their anti-proliferative activities (Table 1). The SKBr3 (estrogen receptor
negative, Her2 overexpressing) and the MCF-7 (estrogen receptor positive) cell lines were
chosen due to the fact that both Her2 and the estrogen receptor are Hsp90-dependent client
proteins. Four of the D-ring analogues that contain two methoxy groups on the A-ring and
no substituents on the B-ring (10a–d) were inactive against both MCF-7 and SKBr3 cell
lines and only compound 10e manifested significant anti-proliferative activity with an IC50
value of 25.35 ± 5.25 μM against MCF-7 and 36.1 ± 2.51 μM against SKBr3 cell lines.
Similar trends were observed for compounds (10f–j) containing the 3,4,5-trimethoxy
substituents on the B-ring, as only 10j was found to be potent and exhibits an IC50 value of
19.48 ± 2.5 μM and 24.87 ± 3.29 μM against MCF-7 and SKBr-3 cell lines, respectively.
Analogues 11a–e that contain phenols on the A-ring were also evaluated and found to be
more potent when compared to EGCG and analogues 10a–j. Incorporation of a methoxy
group at the meta- and the para- positions of the D-ring (11b and 11c) did not alter activity
as compared to unsubstituted analogue, 11a. Compound 11e was found to be the most potent
of this series and displayed an IC50 value of 3.99 ± 1.4 μM against the MCF-7 cell line. In
contrast, compounds with 3-,4-,5-trimethoxy groups on the B-ring (11f–j) were less active
when compared to analogues without substitution on the B-ring (11a–e). This data suggests
that substitutions on the B-ring are detrimental to activity, whereas replacement of the
gallate ester moiety with prenyl benzoate enhances potency. In addition, the MCF-7 cell line
was found to be more sensitive than the SKBr3 cell line upon administration of these
analogues. Furthermore, the anti isomer of 11e was synthesized and evaluated and found to
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be less active (IC50 = 33.7 ± 1.8 against MCF-7 cell line), confirming that syn-
stereochemistry is important for inhibitory activity.
Simultaneous with the above studies, synthesis of analogues that lack the B-ring were
commenced by the treatment of 3,5-dibenzyloxyphenol (Scheme 4) with allyl bromide in the
presence of potassium carbonate to give allyl ether 18a.39 3,3-Rearrangement of the O-
allylated product (18a) gave 19a in high yield.40 Dihydroxylation of the resulting olefin
afforded diol 20a. Unfortunately, attempts to cyclize via the orthoester were unsuccessful as
only the 5-membered product was formed. Therefore, an alternative strategy for the
cyclization of 20a was pursued. Treatment of the primary alcohol present in 20a with p-
toluenesulfonyl chloride resulted in formation of the corresponding p-toluenesulfonic ester,
which underwent intramolecular cyclization upon exposure to potassium carbonate to give a
1:1 mixure of 5- and 6-membered rings that were separated by silica gel chromatography.
Subsequent coupling of 22a with various substituted benzoic acids produced the requisite
esters, which underwent hydrogenolysis to afford 23a–i, respectively.
Upon construction of analogues that lack the B-ring, each phenol on the A-ring was
systematically investigated. Therefore, derivatives 23i–s that contain only one hydroxyl at
either the 5- or the 7-position were pursued similar to that described above. Allylation of the
phenol (17) gave ally ether, 18b. 3,3-Rearrangement of the allyl ether (18b) gave a mixture
of two regioisomers, 19b and 19c, which upon dihydroxylation and subsequent ring closure
gave 22b and 22c, respectively.
Results from the anti-proliferative studies with compounds 23a–s are summarized in Table
2. In addition to previously investigated substituents, the effect of hydroxyl substitution on
the D-ring was also explored. Many of the compounds were found to be more efficacious
than EGCG itself. This data suggests that methoxy substitution on the D-ring is more
beneficial than the naturally occurring phenols, which corresponds to an overall pattern
represented by O-alkyl substitutions at the 3′-position are more active than those at the 4′-
position. Data also suggests that aryl and prenyl substitution on the D-ring produce
enhanced efficacy, as 23i manifested an IC50 value of 10.66 ± 1.09 μM against MCF-7 cells
and 23.15 ± 0.25μM against SKBr3 cells. The IC50 values of compounds containing only
one phenolic group at the 7-position on the A-ring resulted in decreased activity, except for
23n. Similarly, compounds with 5-hydroxyl substitution on the A-ring also resulted in
decreased activity with the exception of 23r, which manifested enhanced activity and an
IC50 value of 21.6 ± 2.55 against the MCF-7 cell line. Similar to the most active analogue
produced from the B-ring series, 11e, the most active analogue identified in this series was
23i (IC50 = 10 μM in MCF-7 cell line), which also incorporates the prenylated benzoate side
chain.
In an effort to further investigate the A-ring, the free phenols were replaced with methyl
ethers. 5,7-Dimethoxychroman-3-ol (26) was synthesized in two steps using a gold(III)-
mediated procedure as described by Zhangjie and coworkers (Scheme 5).41 Commencing
with commercially available 3,5-dimethoxyphenol and enlistment of epichlorohydrin and
sodium hydride, produced oxirane 25, which underwent 6-endo cyclization to yield 26 upon
treatment with a gold(III) chloride/silver trifluormethanesulfonate catalyst. Upon
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construction of the chroman-3-ol core (26), subsequent coupling with various substituted
aryl acids to furnish the corresponding esters, 27a–m. The final products 28a–e were
prepared via hydrogenolysis of 27i–m.
In addition, investigation of the linker connecting the B- and D-rings was pursued. The ester
linker was replaced with an amide functionality. These amide-based analogues were
prepared from previously synthesized alcohol 26, which was transformed into azide 29 via
Mitsunobu conditions with diisopropyl azodicarboxylate, triphenylphosphine and
diphenylphosphoryl azide, followed by Staudinger reduction with triphenylphosphine to
afford amine 30 (Scheme 6).42 Subsequent coupling of amine 30 with the optimal aryl acids
gave the corresponding amides, 31a–d. 37
Results from anti-proliferative studies for compounds lacking the B-ring are summarized in
Table 3. The 3-methoxy substituted compound 28b was found to be the most active
compound against the MCF-7 and the SKBr3 cell lines, and manifested IC50 values 0.775
± .02 μM and 0.88 ± 0.06 μM, respectively. Increasing the length of side chain resulted in
decreased activity for compound 27h. The hydroxyl group was found to be more beneficial
at the 4′-position in lieu of the 3′-position. Unfortunately, the combination of 3-methoxy and
4-hydroxyl substitutions on the D-ring (28e) did not improve anti-proliferative activity.
Once again, MCF-7 cells exhibited greater sensitivity to these compounds. The IC50 values
for 27d and 27e (Table 4) correlate directly with prior studies using novobiocin, suggesting
a beneficial effect for inclusion of aryl or prenyl group on the D-ring. The linker between the
B- and D-ring was also evaluated and replacement of the ester with an amide (31a–d) was
found detrimental.
After determination of anti-proliferative activity for EGCG analogues, four representative
examples were chosen for subsequent western blot analyses to confirm Hsp90 inhibition,
based on each class of scaffold investigated. Since Hsp90 inhibition results in the induction
of client protein degradation via the ubiquitin-proteasome pathway, immunoblots are used to
confirm Hsp90 inhibitory activity. As shown in Figure 2, 11e, 27e and 10e induced the
degradation of Hsp90 client proteins Her2, Raf and pAkt at concentrations that mirror the
concentration needed to exhibit anti-proliferative activity, thereby linking Hsp90 inhibition
to cell viability. Analog 27b failed to induce client protein degradation, demonstrating that
this compound manifests anti-proliferative activity through a mechanism independent of
Hsp90 inhibition. However a related compound containing the prenylated benzoate side
chain, 27e, was shown to exhibit Hsp90 inhibitory activity. Further investigation of 11e at
increasing concentrations demonstrated client protein degradation in a dose-dependent
manner, while actin levels remained the same. Actin is not an Hsp90-dependent protein and
is therefore unaffected by Hsp90 inhibition. Similar to other Hsp90 C-terminal inhibitors,
the level of Hsp90 was unaffected.
CONCLUSIONS
In summary, we have synthesized and evaluated the first structure-activity relationships
between EGCG and Hsp90 (Figure 3). The results obtained suggest that phenolic groups on
the A-ring are beneficial for Hsp90 inhibition, while phenolic substituents on the D-ring are
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detrimental. The inclusion of a novobiocin-derived prenyl benzoate was found to be a
suitable replacement for the gallic acid moiety present on EGCG, and suggests that both
novobiocin and the EGCG may bind similarly to the Hsp90 C-terminus. Results from these
studies have led to the development of analogue 11e, which exhibits a 18-fold improvement
over EGCG and can serve as a probe for further biological investigations.
EXPERIMENTAL SECTION
All reactions were performed in oven-dried glassware under argon atmosphere unless
otherwise stated. Dichloromethane (DCM), tetrahydrofuran (THF), and toluene were passed
through a column of activated alumina prior to use. Anhydrous methanol, acetonitrile,
dimethylformamide (DMF), and dimethoxyethane (DME) were purchased and used without
further purification. (−)-EGCG (≥95%) was purchased from Sigma-Aldrich and used as
obtained. Flash column chromatography was performed using silica gel (40 – 63 μm particle
size). The 1H (500 MHz and 400 MHz) and 13C-NMR (proton 125 MHz and 100 MHz)
spectra were recorded on 500 MHz and 400 MHz spectrometer. Data are reported as p =
pentet, q = quartet, t = triplet, d = doublet, s = singlet, bs = broad singlet, m = multiplet;
coupling constant (s) in Hz. Infrared spectra were obtained using FT/IR spectrometer. High
resolution mass spectral data were obtained on a Electrospray Ionization spectra were
acquired on a LCT Premier, time of flight mass spectrometer. The purity of all compounds
was determined to be >95% by 1H and 13C NMR spectra, unless otherwise noted.
3,5-Bis(benzyloxy)phenol (4b) and (E)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-ol (5b) and
3-(benzyloxy)phenol (17) were prepared following literature procedures.32, 43–44 Reactions
of phenols (4a–b) with cinnamyl alcohols (5a–b) to yield compounds 6a–d were
accomplished via the protocol described by Li et. al. 32
2-Cinnamyl-3,5-dimethoxyphenol (6a)
A solution of 3,5-dimethoxy phenol (2.3 g, 14.91 mmol) and cinnamyl alcohol (2.0 g, 14.91
mmol) in a solvent mixture of dichloromethane (30 mL) and carbon disulfide (30 mL) was
treated with 25% H2SO4/SiO2 catalyst (2.4 g, 5.96 mmol) at rt. The resulting mixture was
stirred for 4 h and then filtered through a plug of SiO2 (40 – 63 μm particle size). Solvent
was removed and the residue purified by flash chromatography (SiO2, 1:9 EtOAc/Hexanes)
to give 6a (1.735 g, 43.15 %) as an amorphous light yellow solid: 1H NMR (500 MHz,
CDCl3) δ 7.37 – 7.26 (m, 2H), 7.30 (dd, J = 7.2, 1.7 Hz, 2H), 7.23 – 7.17 (m, 1H), 6.48 (dt,
J = 16.0, 1.7 Hz, 1H), 6.34 (dt, J = 15.9, 6.3 Hz, 1H), 6.15 (d, J = 2.3 Hz, 1H), 6.11 (d, J =
2.3 Hz, 1H), 5.06 (s, 1H), 3.82 (s, 3H), 3.80 (s, 3H), 3.56 (d, J = 1.6 Hz, 1H), 3.55 (d, J =
1.6 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 159.9, 159.0, 155.9, 137.4, 130.6, 128.6 (2),
128.6, 128.5, 127.3, 126.3, 106.1, 93.9, 91.8, 56.0, 55.5, 26.4; IR (KBr)νmax 3367, 1614,
1596, 1454, 1423, 1201, 1147, 1097, 1053, 811, 736, 692 cm−1; HRMS (ESI+) m/z [M+H+]
calcd for C17H19O3, 271.1334, found 271.1336.
3,5-Bis(benzyloxy)-2-cinnamylphenol (6b)
A solution of 3,5-bis(benzyloxy)phenol (3.3 g, 9.98 mmol) and cinnamyl alcohol (1.34 g,
9.98 mmol) in a solvent mixture of dichloromethane (20 mL) and carbon disulfide (20 mL)
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was treated with 25% H2SO4/SiO2 catalyst (1.59g, 3.99 mmol) at rt. The resulting mixture
was stirred for 4 h and then filtered through a plug of SiO2 (40 – 63 μm particle size).
Solvent was removed and the residue purified by flash chromatography (SiO2, 1:8 EtOAc/
Hexanes) to give 6b (1.425 g, 33.7 %) as amorphous light yellow solid: 1H NMR (400 MHz,
CDCl3) δ 7.48 – 7.29 (m, 15H), 6.53 – 6.44 (m, 1H), 6.39 – 6.30 (m, 1H), 6.29 (d, J = 2.2
Hz, 1H), 6.18 (d, J = 2.3 Hz, 1H), 5.03 (m, 5H), 3.60 (dd, J = 6.5, 1.6 Hz, 2H); 13C NMR
(125 MHz, CDCl3) δ 159.0, 158.1, 155.9, 137.5, 137.2, 137.0 (2), 128.8 (2), 128.7 (2), 128.6
(3), 128.5, 128.2, 128.0, 127.8, 127.5 (2), 127.3, 126.3 (2), 107.0, 95.3, 93.9, 70.5, 70.3,
26.7; IR (KBr)νmax 3419, 3028, 2925, 1618, 1596, 1452, 1436,1375, 1147, 1091, 734, 696
cm−1; HRMS (ESI+) m/z [M+H+] calcd for C29H27O3, 423.1960, found 423.1966.
(E)-3,5-Dimethoxy-2-(3-(3,4,5-trimethoxyphenyl)allyl)phenol (6c)
A solution of 3,5-dimethoxy phenol (2.06 g, 13.4 mmol) and (E)-3,4,5-trimethoxycinnamyl
(3.0 g, 13.4 mmol) in a solvent mixture of dichloromethane (26 mL) and carbon disulfide
(26 mL) was treated with 25% H2SO4/SiO2 catalyst (2.2g, 5.36 mmol) at rt. The resulting
mixture was stirred for 4 h and then filtered through a plug of SiO2 (40 – 63 μm particle
size). Solvent was removed and the residue purified by flash chromatography (SiO2, 1:2
EtOAc/Hexanes) to give 6c as an amorphous light yellow solid: (1.660 g, 39.4 %): 1H NMR
(500 MHz, CDCl3) δ 6.56 (s, 2H), 6.38 (dt, J = 15.8, 1.7 Hz, 1H), 6.23 (dt, J = 15.8, 6.2 Hz,
1H), 6.14 (d, J = 2.4 Hz, 1H), 6.10 (d, J = 2.3 Hz, 1H), 5.09 (s, 1H), 3.85 (s, 6H), 3.83 (s,
3H), 3.81 (s, 3H), 3.79 (s, 3H), 3.54 (dd, J = 6.2, 1.7 Hz, 2H); 13C NMR (125 MHz, CDCl3)
δ 159.9, 159.0, 155.9, 153.4 (2), 137.6, 133.2, 130.4, 128.1, 106.1, 103.3 (2), 93.9, 91.7,
61.1, 56.2 (2), 56.0, 55.5, 26.2; IR (KBr)νmax 3379, 3379, 2937, 1620, 1593, 1506, 1421,
1361, 1330, 1201, 1147, 1053, 817, 707 cm−1; HRMS (ESI+) m/z [M+H+] calcd for
C20H25O6, 361.1651, found 361.1657.
(E)-3,5-Bis(benzyloxy)-2-(3-(3,4,5-trimethoxyphenyl)allyl)phenol (6d)
A solution 3,5-bis(benzyloxy)phenol (5.2 g, 6.97 mmol) and (E)-3,4,5 trimethoxycinnamyl
alcohol (3.81 g, 16.97 mmol) in a solvent mixture of dichloromethane (33 mL) and carbon
disulfide (33 mL) was treated with 25% H2SO4/SiO2 catalyst (1.11 g, 2.8 mmol) at rt. The
resulting mixture was stirred for 4 h and then filtered through a plug of SiO2 (40 – 63 μm
particle size). Solvent was removed and the residue purified by flash chromatography (SiO2,
1:3 EtOAc/Hexanes) to give 6d (1.970 g, 22.6 %) as an amorphous light yellow solid: 1H
NMR (500 MHz, CDCl3) δ 7.47 – 7.28 (m, 10H), 6.54 (s, 2H), 6.39 (dt, J = 15.8, 1.7 Hz,
1H), 6.30 (d, J = 2.3 Hz, 1H), 6.24 (dt, J = 15.8, 6.3 Hz, 1H), 6.19 (d, J = 2.3 Hz, 1H), 5.05
(s, 2H), 5.03 (s, 1H), 5.02 (s, 2H), 3.90 – 3.80 (m, 9H), 3.65 – 3.56 (m, 2H). 13C NMR (125
MHz, CDCl3) δ 159.1, 158.2, 155.9, 153.5 (2), 137.6, 137.3, 137.1, 133.3, 130.7, 128.9 (2),
128.8 (2), 128.7, 128.3 (2), 128.1 (2), 127.8 (2), 127.5, 107.0, 103.4, 95.3, 93.9, 70.6, 70.4,
61.2, 56.3 (2), 26.6. IR (KBr)νmax 3400, 2937, 1614, 1585, 1454, 1328, 1238, 1126, 1001,
736, 696 cm−1. HRMS (ESI+) m/z [M+Na+] calcd for C32H32NaO6, 535.2097, found
535.2100.
Khandelwal et al. Page 7























N-methylmorpholine-N-oxide (1.26g, 10.76 mmol) was added to a solution of 6a (1.7g, 6.33
mmol) in a solvent mixture of tetrahydrofuran (18 mL) and H2O (12 mL). The resulting
solution was stirred for 15 min at rt before the addition osmium tetraoxide (0.1 mmol, 4%
solution in water). The mixture was stirred for 14 h at rt before quenching with 20% of
sodium metabisulphite (15 mL). The aqueous layer was extracted with ethyl acetate (3 × 25
mL) and the combined organic layers were washed with saturated sodium chloride solution
(50 mL), dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified
by flash chromatography (SiO2, 1:2 EtOAc/Hexanes) to afford 7a (1.55 g, 81 %) as a
colorless oil: 1H NMR: (500 MHz, CDCl3) δ 7.98 (brs, 1H), 7.43 – 7.37 (m, 2H), 7.37 –
7.32 (m, 3H), 6.17 (d, J = 2.4 Hz, 1H), 6.03 (d, J = 2.4 Hz, 1H), 4.55 (d, J = 6.6 Hz, 1H),
4.04 (ddd, J = 7.4, 6.5, 3.8 Hz, 1H), 3.77 (s, 3H), 3.59 (s, 3H), 3.23 (brs, 1H), 2.84 (dd, J =
14.8, 3.8 Hz, 1H), 2.74 (dd, J = 14.8, 7.4 Hz, 1H), 2.46 (brs, 1H); 13C NMR (125 MHz,
CDCl3) δ 160.2, 158.9, 157.5, 140.6, 128.7 (2), 128.5 (2), 127.2, 105.5, 76.9, 76.5, 94.6,
91.5, 55.5 (2), 26.2; IR (KBr)νmax 3348, 2837, 1622, 1593, 1496, 1456, 1338, 1199, 1147,
1105, cm−1; HRMS (ESI−) m/z [M−H−] calcd for C17H19O5, 303.1233, found 303.1227.
3-(2,4-Bis(benzyloxy)-6-hydroxyphenyl)-1-phenylpropane-1,2-diol (7b)
N-methylmorpholine-N-oxide (393 mg, 3.36 mmol) was added to a solution of 6a (0.9g, 2.1
mmol) in a solvent mixture of tetrahydrofuran (9 mL) and H2O (6 mL). The resulting
solution was stirred for 15 min at rt before the addition osmium tetraoxide (0.02 mmol, 4%
solution in water). The mixture was stirred for 14 h at rt before quenching with 20% of
sodium metabisulphite (10 mL). The aqueous layer was extracted with ethyl acetate (3 × 20
mL) and the combined organic layers were washed with saturated sodium chloride solution
(40 mL), dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified
by flash chromatography (SiO2, 1:3 EtOAc/Hexanes) to afford 7b (0.78g, 80.1 %) as a
colorless oil: 1H NMR (500 MHz, CDCl3) δ 8.03 (s, 1H), 7.46 – 7.36 (m, 5H), 7.36 – 7.29
(m, 6H), 7.27 – 7.25 (m, 2H), 7.19 – 7.06 (m, 2H), 6.29 (d, J = 2.3 Hz, 1H), 6.21 (d, J = 2.4
Hz, 1H), 5.01 (s, 2H), 4.90 – 4.82 (m, 2H), 4.56 (d, J = 6.8 Hz, 1H), 4.04 (ddd, J = 8.5, 6.7,
3.5 Hz, 1H), 3.32 (s, 1H), 2.93 (dd, J = 14.7, 3.5 Hz, 1H), 2.75 (dd, J = 14.6, 8.4 Hz, 1H),
2.46 (s, 1H); 13C NMR (125 MHz, CDCl3) δ 159.3, 158.0, 157.7, 140.4, 137.1, 137.0, 128.8
(5), 128.7 (2), 128.6, 128.2, 127.8 (4), 127.2 (2), 127.0 (2), 106.3, 96.1, 93.6, 70.3 (2), 26.6;
IR (KBr)νmax 3363, 3330 3087, 3031, 1701, 1620, 1598, 1452, 1375, 1147, 1099, 815, 698
cm−1; HRMS (ESI+) m/z [M+H+] calcd for C29H29O5, 457.2015, found 457.2028.
3-(2-Hydroxy-4,6-dimethoxyphenyl)-1-(3,4,5-trimethoxyphenyl)propane-1,2-diol (7c)
N-methylmorpholine-N-oxide (702 mg, 6 mmol) was added to a solution of 6c (1.350 g,
3.75 mmol) in a solvent mixture of tetrahydrofuran (12 mL) and H2O (8 mL). The resulting
solution was stirred for 15 min at rt before the addition osmium tetraoxide (0.04 mmol, 4%
solution in water). The mixture was stirred for 14 h at rt before quenching with 20% of
sodium metabisulphite (12 mL). The aqueous layer was extracted with EtOAc (3 × 25 mL)
and the combined organic layers were washed with saturated sodium chloride solution (50
mL), dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by
flash chromatography (SiO2, 1:10 Acetone/Dichloromethane) to afford 7c (1.33 g, 90.4 %)
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as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 8.08 (s, 1H), 6.54 (s, 2H), 6.14 (d, J = 2.4
Hz, 1H), 6.03 (d, J = 2.4 Hz, 1H), 4.47 (d, J = 6.0 Hz, 1H), 3.98 (ddd, J = 8.0, 6.1, 3.8 Hz,
1H), 3.84 (s, 6H), 3.82 (s, 3H), 3.75 (s, 3H), 3.62 (s, 3H), 3.44 (brs, 1H), 3.10 – 2.92 (m,
1H), 2.85 (dd, J = 14.7, 3.8 Hz, 1H), 2.73 (dd, J = 14.7, 7.8 Hz, 1H); 13C NMR (125 MHz,
CDCl3) δ 160.1, 159.0, 157.3, 153.4 (2), 137.6, 136.5, 105.6, 103.9 (2), 94.6, 91.4, 76.9,
76.7, 61.0, 56.3 (2), 55.7, 55.5, 26.5; IR (KBr)νmax 3405, 2932, 1620, 1591, 1498, 1439,
1379, 1218, 1146, 1029, 817 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C20H27O8,
395.1706, found 395.1719.
3-(2,4-Bis(benzyloxy)-6-hydroxyphenyl)-1-(3,4,5-trimethoxyphenyl)propane-1,2-diol (7d)
N-methylmorpholine-N-oxide (444 mg, 3.79 mmol) was added to a solution of 6c (1.0 g,
2.36 mmol) in a solvent mixture of tetrahydrofuran (7.5 mL) and H2O (5 mL). The resulting
solution was stirred for 15 min at rt before the addition osmium tetraoxide (0.02 mmol, 4%
solution in water). The mixture was stirred for 14 h at rt before quenching with 20% of
sodium metabisulphite (10 mL). The aqueous layer was extracted with ethyl acetate (3 × 20
mL) and the combined organic layers were washed with saturated sodium chloride solution
(40 mL), dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified
by flash chromatography (SiO2, 1:10 Acetone/Dichloromethane) to afford 7d (595 g, 56.7
%) as an amorphous light yellow solid: 1H NMR (500 MHz, CDCl3) δ 8.00 (brs, 1H), 7.47 –
7.28 (m, 10H), 6.54 (s, 2H), 6.28 (d, J = 2.3 Hz, 1H), 6.22 (d, J = 2.3 Hz, 1H), 5.06 – 4.95
(m, 4H), 4.91 (d, J = 3.0 Hz, 1H), 4.52 (d, J = 6.0 Hz, 1H), 3.77 (d, J = 10.2 Hz, 9H), 3.25
(brs, 1H), 3.01 – 2.95 (m, 1H), 2.83 (dd, J = 14.6, 8.3 Hz, 1H), 2.74 (brs, 1H); 13C NMR
(125 MHz, CDCl3) δ 159.4, 158.1, 157.6, 153.5 (2), 137.1, 137.0, 136.4, 129.0, 128.8,
128.7, 128.5, 128.4, 128.3 (2), 128.1, 127.8, 127.5, 127.4, 127.3, 126.9, 106.3, 103.8 (2),
96.2, 93.7, 70.3 (2), 61.0, 56.3, 56.3, 27.0; IR (KBr)νmax 3446, 2935, 2837, 1591, 1498,
1456, 1328, 1232, 1126, 1004, 736 cm−1; HRMS (ESI−) m/z [M−H−] calcd for C32H33O8,
547.2332, found 547.2347.
5,7-Dimethoxy-2-phenylchroman-3-ol (8a)
Trimethyl orthoacetate (2.50 mmol, 300 μl) and pyridinium p-toluenesulfonate (9 mg, 0.036
mmol) were added to a solution of 7a (600 mg, 1.92 mmol) in dichloromethane (36 mL) at
rt. The resulting mixture was stirred for 30 min at rt and then cooled to 0 °C before the
dropwise addition of borontrifluoride diethyletherate (25 μl, 0.192 mmol). The reaction
mixture was warmed to rt and stirred for another 15 min before quenching with aqueous
acetone (4 mL). Solvent was removed and the residue was dissolved methanol (32 mL).
Potassium carbonate (225 mg, 1.84 mmol) was added and mixture stirred for 6 h at rt.
Methanol was removed, water (25 mL) was added and the products extracted with ethyl
acetate (2 × 30 mL). Organic layers were combined and washed with saturated sodium
chloride solution (60 mL). The organic phase was dried over anhydrous Na2SO4 and
filtered. Solvent was removed and residue was purified via flash chromatography (SiO2, 1:4
EtOAc/Hexanes) to yield compound 8a (422 mg, 77.7 %) as a colorless oil: 1H NMR (500
MHz, CDCl3) δ 7.47 – 7.34 (m, 5H), 6.16 (d, J = 2.3 Hz, 1H), 6.12 (d, J = 2.3 Hz, 1H), 4.79
(d, J = 7.8 Hz, 1H), 4.11 (td, J = 8.1, 5.5 Hz, 1H), 3.81 (s, 3H), 3.77 (s, 3H), 3.00 (dd, J =
16.4, 5.5 Hz, 1H), 2.63 (dd, J = 16.4, 8.4 Hz, 1H), 1.71 (s, 1H); 13C NMR (125 MHz,
CDCl3) δ 159.7, 158.8, 155.1, 138.1, 128.8, 128.6, 127.1, 101.4, 93.0, 91.9, 81.7, 68.2, 55.5,
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55.4, 27.2; IR (KBr)νmax 3446, 2937, 2839, 1618, 1593, 1496, 1213, 1143, 1120, 1051,
1022, 813, 761, 689 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C17H19O4, 287.1283, found
287.1270.
5,7-Bis(benzyloxy)-2-phenylchroman-3-ol (8b)
Trimethyl orthoacetate (1.48 mmol, 188 μl) and pyridinium p-toluenesulfonate (6 mg, .012
mmol) were added to a solution of 7b (560 mg, 1.22 mmol) in dichloromethane (24 mL) at
rt. The resulting mixture was stirred for 30 min and cooled to 0 °C before the addition of
borontrifluoride diethyletherate (18 μl, 0.24 mmol) dropwise. The reaction mixture was
warmed to rt and stirred for another 15 min before quenching with aqueous acetone (4 mL).
Solvent was removed and the residue was dissolved methanol (18 mL). Potassium carbonate
(185 mg, 1.34 mmol) was added and mixture stirred for 6 h at rt. Methanol was removed,
water (20 mL) was added and the products extracted with ethyl acetate (2 × 25 mL). The
combined organic layers and washed with saturated sodium chloride solution (60 mL). The
organic phase was dried over anhydrous Na2SO4 and filtered. Solvent was removed and the
residue was purified via flash chromatography (SiO2, 1:4 EtOAc/Hexanes) to yield
compound 8b (420 mg, 78.2 %) as a pale yellow oil: 1H NMR (400 MHz, CDCl3) δ 7.61 –
7.23 (m, 15H), 6.28 – 6.09 (m, 2H), 5.09 – 4.76 (m, 4H), 4.73 (d, J = 7.9 Hz, 1H), 4.07 (td, J
= 8.4, 5.6 Hz, 1H), 3.05 (dd, J = 16.5, 5.5 Hz, 1H), 2.65 (dd, J = 16.4, 8.6 Hz, 1H); IR
(KBr)νmax 3460, 2912, 1617, 1592, 1375, 1145, 1126, 1076, 973, 813, 696 cm−1; HRMS
(ESI+) m/z [M+H+] calcd for C29H27O4, 439.1909, found 439.1897.
5,7-Dimethoxy-2-(3,4,5-trimethoxyphenyl)chroman-3-ol (8c)
Trimethyl orthoacetate (1.92 mmol, 250 μl) and pyridinium p-toluenesulfonate (10 mg,
0.032 mmol) were added to a solution of 7c (620 mg, 1.6 mmol) in dichloromethane (32
mL) at rt. The resulting mixture was stirred for 30 min at rt and then cooled to 0 °C before
the dropwise addition of borontrifluoride diethyletherate (20 μl, 0.16 mmol). The reaction
mixture was warmed to rt and stirred for another 15 min before quenching with aqueous
acetone (4 mL). Solvent was removed and the residue dissolved in methanol (32 mL).
Potassium carbonate (240 mg, 1.76 mmol) was added and mixture stirred for 6 h at rt.
Methanol was removed, water (25 mL) was added and the products extracted with ethyl
acetate (2 × 30 mL). The combined organic layers were washed with saturated sodium
chloride solution (50 mL). The organic phase was dried over anhydrous Na2SO4 and
filtered. Solvent was removed and the residue was purified via flash chromatography (SiO2,
1:4 EtOAc/Hexanes) to yield compound 8c (460 mg, 77.8) as a colorless oil: 1H NMR (500
MHz, CDCl3) δ 6.68 (s, 2H), 6.15 (d, J = 2.3 Hz, 1H), 6.12 (d, J = 2.3 Hz, 1H), 4.63 (d, J =
8.5 Hz, 1H), 4.07 (ddd, J = 9.3, 8.5, 5.8 Hz, 1H), 3.87 (s, 6H), 3.85 (s, 3H), 3.82 (s, 3H),
3.76 (s, 3H), 3.11 (dd, J = 16.3, 5.8 Hz, 1H), 2.60 (dd, J = 16.3, 9.3 Hz, 1H); 13C NMR (125
MHz, CDCl3) δ 159.9, 158.9, 155.4, 153.7 (2), 138.2, 133.6, 104.3 (2), 101.9, 93.2, 92.2,
82.4, 68.5, 61.0, 56.3 (2), 55.7, 55.6, 28.0; IR (KBr)νmax 3438, 3001, 2916, 2848, 1622,
1593, 1496, 1622, 2593, 1456, 1361, 1215, 1145, 1120, 810, 667 cm−1; HRMS (ESI+) m/z
[M+Na+] calcd for C20H24NaO7, 399.1420, found 399.1414.
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Trimethyl orthoacetate (0.94 mmol, 120 μl) and pyridinium p-toluene sulfonate (4 mg, 0.016
mmol) were added to a solution of 7d (425 mg, 0.78 mmol) in dichloromethane (16 mL) at
rt. The resulting mixture was stirred for 30 min at rt and then cooled to 0 °C before the
dropwise addition of borontrifluoride diethyletherate (11 μl, 0.08 mmol) dropwise. The
reaction mixture was warmed to rt and stirred for another 15 min before quenching with
aqueous acetone (3 mL). Solvent was removed and the residue dissolved in methanol (16
mL). Potassium carbonate (118 mg, 0.85 mmol) was added and mixture stirred for 6 h at rt.
Methanol was removed, water (20 mL) was added and the products extracted with ethyl
acetate (2 × 25 mL). The combined organic layers were washed with saturated sodium
chloride solution (30 mL). The organic phase was dried over anhydrous Na2SO4 and
filtered. Solvent was removed and the residue was purified via flash chromatography (SiO2,
1:4 EtOAc/Hexanes) to afford 8d (265 mg, 63.3 %) as a pale yellow oil: 1H NMR (500
MHz, CDCl3) δ 7.49 – 7.37 (m, 8H), 7.37 – 7.30 (m, 2H), 6.69 (s, 2H), 6.30 (d, J = 2.3 Hz,
1H), 6.26 (d, J = 2.3 Hz, 1H), 5.11 – 4.96 (m, 4H), 4.65 (d, J = 8.5 Hz, 1H), 4.10 (td, J =
8.9, 5.8 Hz, 1H), 3.88 (s, 6H), 3.86 (s, 3H), 3.22 (dd, J = 16.3, 5.8 Hz, 1H), 2.69 (dd, J =
16.4, 9.3 Hz, 1H), 1.82 (s, 1H); 13C NMR (125 MHz, CDCl3) δ 159.0, 157.9, 155.4, 153.7
(2), 137.1, 137.0 (2), 133.5, 128.8 (2), 128.7 (2), 128.2, 128.1, 127.7, 127.3 (3), 104.3 (2),
102.6, 94.5, 94.1, 82.4, 70.3, 70.1, 68.5, 61.0, 56.3 (2), 28.2; IR (KBr)νmax 3481, 2935,
1618, 1593, 1498, 1460, 1421, 1346, 1145, 1128, 1022, 829, 752, 734 cm−1; HRMS (ESI+)
m/z [M+H+] calcd for C32H33O7, 529.2226, found 529.2234.
Transformations of anti-alcohols to syn-alcohols was accomplished via following the
procedure described by Tuckmantel et. al.26
5,7-Dimethoxy-2-phenylchroman-3-ol (9a)
Obtained as a colorless oil (232 mg, 55%): 1H NMR (400 MHz, CDCl3) δ 7.58 – 7.52 (m,
2H), 7.45 (dd, J = 8.4, 6.7 Hz, 2H), 7.43 – 7.33 (m, 1H), 6.23 (d, J = 2.3 Hz, 1H), 6.15 (d, J
= 2.3 Hz, 1H), 5.05 (s, 1H), 4.34 (s, 1H), 3.82 (s, 3H), 3.80 (d, J = 0.7 Hz, 3H), 3.04 – 2.82
(m, 2H), 1.73 (brs, 1H). 13C NMR (125 MHz, CDCl3) δ 159.9, 159.5, 155.4, 138.4, 129.0,
128.8, 128.3, 126.5, 126.4, 100.4, 93.5, 92.4, 78.8, 66.6, 55.7, 55.6, 28.3. IR (KBr)νmax
3451, 1952, 2923, 2854, 1618, 1593, 1203, 1145, 1118, 1058, 968, 811, 746, 700 cm−1.
HRMS (ESI+) m/z [M+H+] C17H19O4, 287.1283, found 287.1277.
5,7-Bis(benzyloxy)-2-phenylchroman-3-ol (9b)
Obtained as a pale yellow oil (198 mg, 47%). 1H NMR (400 MHz, CDCl3) δ 7.91 (s, 1H),
7.65 – 7.31 (m, 15H), 6.23 (d, J = 2.3 Hz, 1H), 6.16 (d, J = 2.3 Hz, 1H), 5.62 (dt, J = 7.6, 4.9
Hz, 1H), 5.13 (d, J = 5.3 Hz, 1H), 4.99 (d, J = 1.9 Hz, 4H), 3.25 (dd, J = 14.6, 4.9 Hz, 1H),
2.89 (dd, J = 14.6, 8.0 Hz, 1H); IR (KBr)νmax 3449, 2954, 2842, 1618, 1593, 1498, 1458,
1198, 1145, 1120, 1080, 729 cm−1; HRMS (ESI+) m/z [M+Na+] calcd for C29H26NaO4,
461.1729, found 461.1724.
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Obtained as a colorless oil (175 mg, 43%). 1H NMR (500 MHz, CDCl3) δ 6.75 (s, 2H), 6.21
(d, J = 2.3 Hz, 1H), 6.12 (d, J = 2.4 Hz, 1H), 4.93 (s, 1H), 4.44 – 4.23 (m, 1H), 3.89 (s, 6H),
3.85 (s, 3H), 3.80 (s, 3H), 3.78 (s, 3H), 3.00 – 2.93 (m, 1H), 2.89 (dd, J = 17.3, 4.4 Hz, 1H),
1.88 (brs, 1H); 13C NMR (125 MHz, CDCl3) δ 159.8, 159.4, 155.2, 153.6 (2), 137.5, 134.2,
103.4 (2), 100.4, 93.5, 92.4, 78.8, 66.6, 61.0, 56.3 (2), 55.6, 55.5, 28.2; IR (KBr)νmax 3460,
2997, 2939, 2839, 1620, 1593, 1498, 1456, 1419, 1357, 1330, 1317, 1236, 1197, 1145,
1120, 1081, 939, 815, 729 cm−; HRMS (ESI+) m/z [M+H+] calcd for C20H25O7, 377.1600,
found 377.1593.
5,7-Bis(benzyloxy)-2-(3,4,5-trimethoxyphenyl)chroman-3-ol (9d)
Obtained as an amorphous pale yellow solid (72 mg, 68 %): 1H NMR (500 MHz, CDCl3) δ
7.44 – 7.34 (m, 10H), 6.75 (s, 2H), 6.32 (d, J = 2.3 Hz, 1H), 6.30 (d, J = 2.3 Hz, 1H), 5.06 –
5.00 (m, 4H), 4.97 (s, 1H), 4.30 (d, J = 4.3 Hz, 1H), 3.91 (s, 6H), 3.87 (s, 3H), 3.07 (dd, J =
17.4, 2.5 Hz, 1H), 2.98 (dd, J = 17.3, 4.5 Hz, 1H), 1.78 (brs, 1H); 13C NMR (125 MHz,
CDCl3) δ 159.0, 158.5, 155.3, 153.7 (2), 137.2 (2), 137.1, 134.1, 128.8 (2), 128.7 (2), 128.2,
128.1, 127.8 (2), 127.4 (2), 103.4 (2), 101.1, 94.9, 94.4, 78.9, 70.4, 70.2, 66.8, 61.1, 56.4 (2),
28.5; IR (KBr)νmax 3461, 2925, 2834, 1593, 1458, 1375, 1236, 1145, 1126, 1078, 1010,
813, 738, 696 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C32H33O7, 529.2226, found
529.2234.
5,7-Dimethoxy-2-phenylchroman-3-yl benzoate (10a)
Benzoyl chloride (8 μl, 0.07 mmol) in dichloromethane (0.5 mL) was added to a solution of
9a (10 mg, 0.035 mmol) and 4-dimethylaminopyridine (11 mg, 0.08 mmol) in
dichloromethane (1mL) at 0 °C. The resulting mixture was stirred for 6 h at rt. Solvent was
removed and the residue purified via flash chromatography (SiO2, 1:8 EtOAc/Hexanes) to
give the desired ester, 10a, as an amorphous white solid: (11 mg, 88.8%): 1H NMR (500
MHz, CDCl3) δ 7.95 – 7.87 (m, 2H), 7.56 – 7.47 (m, 3H), 7.41 – 7.28 (m, 5H), 6.27 (d, J =
2.3 Hz, 1H), 6.12 (d, J = 2.3 Hz, 1H), 5.69 (ddd, J = 4.1, 3.2, 1.4 Hz, 1H), 5.21 (m, 1H),
3.82 (s, 3H), 3.78 (s, 3H), 3.15 – 3.02 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 165.9, 159.9,
159.1, 155.7, 138.0, 133.1, 130.2, 129.9 (2), 128.5 (3), 128.3 (2), 126.7, 100.4, 93.5, 92.1,
78.0, 68.8, 55.6 (2), 26.1; IR (KBr)νmax 2956, 1935, 2839, 1714, 1593, 1458, 1419, 1361,
1257, 1147, 1124, 1101, 1029, 1006, 846, 813, 769 cm−1; HRMS (ESI+) m/z [M+H+] calcd
for C24H23O5, 391.1545, found 391.1538.
5,7-Dimethoxy-2-phenylchroman-3-yl 3-methoxybenzoate (10b)
A solution of 9a (8 mg, 0.027 mmol) in dichloromethane (0.5 mL) was added to a solution
of 3-methoxybenzoic acid (8 mg, 0.05 mmol), N-(3-dimethylamino-propyl)-N′-
ethylcarbodiimide hydrochloride (9.5 mg, 0.05 mmol) and 4-dimethylaminopyridine (6 mg,
0.05 mmol) in dichloromethane (1 mL) at 0 °C. The resulting mixture was stirred for 6 h at
rt and then diluted with dichloromethane (5 mL). The organic phase was washed with
saturated sodium bicarbonate solution (2 × 4 mL). The organic layer was dried over
anhydrous sodium sulfate, filtered and solvent removed. The residue was purified via flash
chromatography (SiO2, 1:8 EtOAc/Hexanes) to give the desired ester, 10a (9 mg, 76.9%), as
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a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.56 – 7.46 (m, 3H), 7.42 (dd, J = 2.7, 1.5 Hz,
1H), 7.38 – 7.30 (m, 2H), 7.29 (t, J = 2.6 Hz, 1H), 7.27-7.21 (m, 1H), 7.04 (ddd, J = 8.3, 2.7,
1.0 Hz, 1H), 6.26 (d, J = 2.3 Hz, 1H), 6.12 (d, J = 2.3 Hz, 1H), 5.67 (ddd, J = 4.1, 3.2, 1.4
Hz, 1H), 5.21 (s, 1H), 3.81 (s, 3H), 3.80 (s, 3H), 3.78 (s, 3H), 3.10 – 3.04 (m, 2H). 13C
NMR (125 MHz, CDCl3) δ 165.8, 159.9, 159.6, 159.1, 155.7, 138.0, 131.5, 129.5 (2), 128.5
(2), 128.3, 126.7, 122.3, 119.6, 114.4, 100.3, 93.5, 92.1, 77.9, 69.0, 55.6 (3), 26.0. IR
(KBr)νmax 2925, 2837, 1718, 1618, 1593, 1319, 1274, 1220, 1147, 1105, 1041, 958, 910,
811, 752, 696 cm−1. HRMS (ESI+) m/z [M+H+] calcd for C25H25O6, 421.1651, found
421.1642
5,7-Dimethoxy-2-phenylchroman-3-yl 4-methoxybenzoate (10c)
A solution of 9a (10 mg, 0.035 mmol) in dichloromethane (0.5 mL) was added to a solution
4-methoxybenzoic acid (18 mg, 0.07 mmol), N-(3-Dimethylamino-propyl)-N′-
ethylcarbodiimide hydrochloride (13.5 mg, 0.07 mmol) and 4-dimethylaminopyridine (9 mg,
0.07 mmol) in dichloromethane (1 mL) at 0 °C. The resulting mixture was stirred for 6 h at
rt and then diluted with dichloromethane (5 mL). The organic phase was washed saturated
sodium bicarbonate solution (2 × 4 mL). The organic layer was dried over anhydrous
sodium sulfate, filtered and the solvent removed. The residue was purified via flash
chromatography (SiO2, 1:8 EtOAc/Hexanes) to give the desired ester, 10c, as a colorless oil
(9.5 mg, 81.1%): 1H NMR (500 MHz, CDCl3) δ 7.93 – 7.83 (m, 2H), 7.57 – 7.49 (m, 2H),
7.36 – 7.30 (m, 2H), 7.28 (d, J = 7.0 Hz, 1H), 6.87 – 6.82 (m, 2H), 6.26 (d, J = 2.3 Hz, 1H),
6.12 (d, J = 2.3 Hz, 1H), 5.66 (td, J = 3.7, 1.5 Hz, 1H), 5.20 (s, 1H), 3.82 (s, 3H), 3.81 (s,
3H), 3.78 (s, 3H), 3.08 – 3.04 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 165.6, 163.5, 159.8,
159.1, 155.7, 138.1, 131.9 (2), 128.5 (2), 128.2 (2), 126.7, 122.6, 113.7 (2), 100.5, 93.5,
92.1, 78.0, 68.4, 55.6 (3), 26.1; IR (KBr)νmax 2958, 2935, 2839, 1716, 1618, 1255, 1203,
1147, 1101, 1029, 906, 846, 700 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C25H25O6,
421.1651, found 421.1644.
(5,7-Dimethoxy-2-phenylchroman-3-yl 3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxylate (10d)
A solution of 9a (10 mg, 0.035 mmol) in dichloromethane (0.5 mL) was added to a solution
of 3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxylic acid (18 mg, 0.07 mmol), N-(3-
dimethylamino-propyl)-N′-ethylcarbodiimide hydrochloride (13.5 mg, 0.07 mmol) and 4-
dimethylaminopyridine (9 mg, 0.07 mmol) in dichloromethane (1 mL) at 0 °C. The resulting
mixture was stirred for 6 h at rt and then diluted with dichloromethane (5 mL). The organic
phase was washed with saturated sodium bicarbonate solution (2 × 4mL), dried over
anhydrous sodium sulfate, filtered and concentrated. The residue was purified via flash
chromatography (SiO2, 1:7 EtOAc/Hexanes) to give desired ester, 10d (14 mg, 76%), as a
colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.94 – 7.84 (m, 2H), 7.58 – 7.48 (m, 2H), 7.38
– 7.31 (m, 3H), 7.31 – 7.28 (m, 1H), 7.05 (ddd, J = 7.6, 1.6, 1.0 Hz, 1H), 7.01 (dd, J = 2.6,
1.6 Hz, 1H), 6.96 – 6.87 (m, 2H), 6.24 (d, J = 2.3 Hz, 1H), 6.11 (d, J = 2.3 Hz, 1H), 5.65 (td,
J = 3.7, 1.5 Hz, 1H), 5.21 (s, 1H), 3.84 (d, J = 0.7 Hz, 6H), 3.80 (s, 3H), 3.78 (s, 3H), 3.11 –
3.04 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 165.5, 160.2, 159.6, 159.3, 158.9, 155.5,
138.8, 137.9, 132.5, 131.0, 130.2, 129.0 (2), 128.3, 128.1 (2), 126.5, 122.5, 122.0, 115.2,
112.9, 110.5, 100.2, 93.3, 91.9, 77.8, 68.5, 55.8, 55.4 (2), 55.3, 25.8; IR (KBr)νmax 2933,
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1716, 1616, 1595, 1298, 1245, 1205, 1147, 1108, 1027, 918, 813, 696, 649 cm−1; HRMS
(ESI+) m/z [M+Na+] calcd for C32H30NaO7, 549.1889, found 549.1863.
5,7-Dimethoxy-2-phenylchroman-3-yl 4-acetoxy-3-(3-methylbut-2-en-1-yl)benzoate (10e)
A solution of 9a (20 mg, 0.07 mmol) in dichloromethane (0.5 mL) was added to a solution
of 4-acetoxy-3-(3-methylbut-2-en-1-yl)benzoic acid (35 mg, 0.14 mmol), N-(3-
dimethylamino-propyl)-N′-ethylcarbodiimide hydrochloride (27 mg, 0.14 mmol) and 4-
dimethylaminopyridine (25 mg, 0.21 mmol) in dichloromethane (1 mL) at 0 °C. The
resulting mixture was stirred for 6 h at rt, diluted with dichloromethane (5 mL) and washed
saturated sodium bicarbonate solution (2 × 4 mL). The organic layer was dried over
anhydrous sodium sulfate, filtered and the solvent removed. The residue was purified via
flash chromatography (SiO2, 1:7 EtOAc/Hexanes) to give desired ester, 10e (20 mg, 55.5
%), as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 7.80 (d, J = 2.1 Hz, 1H), 7.76 (dd, J =
8.4, 2.1 Hz, 1H), 7.50 (dd, J = 7.9, 1.4 Hz, 2H), 7.34 (m, 3H), 7.01 (d, J = 8.4 Hz, 1H), 6.25
(d, J = 2.3 Hz, 1H), 6.11 (d, J = 2.3 Hz, 1H), 5.68 – 5.57 (m, 1H), 5.22 – 5.15 (m, 2H), 3.81
(s, 3H), 3.78 (s, 3H), 3.21 (d, J = 7.3 Hz, 2H), 3.05 (d, J = 3.5 Hz, 2H), 2.31 (s, 3H), 1.75 (d,
J = 1.5 Hz, 3H), 1.71 – 1.62 (m, 3H); 13C NMR (125 MHz, CDCl3) δ 170.10, 155.48,
154.11, 151.35, (2), 136.7 (2), 128.39 (5), 128.30(5), 126.14, 111.17 (2), 104.62, 102.86,
78.23, 66.5, 60.7, 60.4 (2), 31.0, 29.7, 26.8, 20.7; IR (KBr)νmax 2925, 1760, 1716, 1593,
1369, 1201, 1147, 1108, 813 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C31H33O7,
517.2226, found 517.2215.
(2R,3R)-5,7-Dimethoxy-2-(3,4,5-trimethoxyphenyl)chroman-3-yl benzoate (10f)
Benzoyl chloride (14 μl, 0.12 mmol) in dichloromethane (0.5 mL) was added to a solution of
9c (15 mg, 0.04 mmol) and 4-dimethylaminopyridine (24 mg, 0.2 mmol) in dichloromethane
1 (mL) at 0 °C and stirred for 6 h at rt. The solvent was removed and the residue purified via
flash chromatography (SiO2, 1:4 EtOAc/Hexanes) to give desired ester, 10f (17 mg, 89.4%),
as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 8.02 – 7.89 (m, 2H), 7.59 – 7.47 (m, 1H),
7.42 – 7.33 (m, 2H), 6.72 (s, 2H), 6.27 (d, J = 2.3 Hz, 1H), 6.14 (d, J = 2.3 Hz, 1H), 5.69 (td,
J = 3.5, 1.3 Hz, 1H), 5.09 (t, J = 1.0 Hz, 1H), 3.82 (s, 3H), 3.80 (d, J = 1.7 Hz, 6H), 3.71 (s,
6H), 3.10 – 3.05 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 165.5, 159.6, 158.9, 155.5, 153.1
(2), 137.7, 133.3, 133.1, 130.0, 129.7 (3), 128.3 (2), 103.8 (2), 100.2, 93.4, 92.0, 78.0, 68.5,
60.8, 55.9, 55.4 (2), 26.1; IR (KBr)νmax 2910, 2848, 1718, 1595, 1461, 1271, 1118 cm−1;
HRMS (ESI+) m/z [M+H+] calcd for C27H29O8, 481.1862 found 481.1863.
5,7-Dimethoxy-2-(3,4,5-trimethoxyphenyl)chroman-3-yl 3-methoxybenzoate (10g)
A solution of 9c (12 mg, 0.03mmol) in dichloromethane (0.5 mL) was added to a solution of
3-methoxybenzoic acid (10 mg, 0.06 mmol), N-(3-dimethylamino-propyl)-N′-
ethylcarbodiimide hydrochloride (13 mg, 0.06 mmol) and 4-dimethylaminopyridine (8 mg, .
06 mmol) in dichloromethane (1 mL) at 0 °C. The resulting mixture was stirred for 6 h at rt,
diluted with dichloromethane (5 mL) and washed with saturated NaHCO3 (2 × 4 mL)
solution. The organic layer was dried over anhydrous sodium sulfate, filtered and
concentrated. The residue was purified via flash chromatography (SiO2, 1:3 EtOAc/
Hexanes) to give desired ester product 10g as a colorless oil (13 mg, 80.4%): 1H NMR (500
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MHz, CDCl3) δ 7.56 (dt, J = 7.7, 1.2 Hz, 1H), 7.48 (dd, J = 2.7, 1.5 Hz, 1H), 7.30 – 7.26 (m,
1H) 7.05 (ddd, J = 8.3, 2.7, 1.0 Hz, 1H), 6.72 (s, 2H), 6.26 (d, J = 2.3 Hz, 1H), 6.13 (d, J =
2.4 Hz, 1H), 5.67 (td, J = 3.6, 1.3 Hz, 1H), 5.08 (s, 1H), 3.81 (s, 3H), 3.81 – 3.78 (m, 9H),
3.73 (s, 6H), 3.07 (d, J = 3.5 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 165.4, 159.6, 158.9,
155.5, 153.1 (2), 137.7, 133.3, 131.3, 129.3 (2), 122.0, 119.1, 114.7, 103.8 (2), 100.1, 93.4,
92.0, 78.0, 68.6, 60.8, 55.9 (2), 55.4 (3), 26.0; IR (KBr)νmax 2937, 1718, 1622, 1593, 1498,
1456, 1274, 1218, 1124, 1047, 754 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C28H31O9,
511.1968, found 511.1977.
5,7-Dimethoxy-2-(3,4,5-trimethoxyphenyl)chroman-3-yl 4-methoxybenzoate (10h)
4-methoxybenzoyl chloride (10 μl, 0.07 mmol) in dichloromethane (0.5 mL) was added to a
solution of 9c (13 mg, 0.035 mmol) and 4-dimethylaminopyridine (13 mg, 0.1 mmol) in
dichloromethane 0.7 (mL)-pyridine (0.3 mL) at 0 °C. The resulting mixture was stirred for 6
h at rt, solvent was removed and the residue purified via flash chromatography (SiO2, 1:3
EtOAc/Hexanes) to give desired ester, 10h, (15 mg, 87.4 %) as a colorless oil: 1H NMR
(500 MHz, CDCl3) δ 7.77 – 7.55 (m, 2H), 6.66 – 6.53 (m, 2H), 6.46 (s, 2H), 6.01 (d, J = 2.3
Hz, 1H), 5.88 (d, J = 2.3 Hz, 1H), 5.41 (td, J = 3.5, 1.3 Hz, 1H), 4.82 (s, 1H), 3.58 (s, 3H),
3.57 (s, 3H), 3.55 (s, 3H), 3.54 (s, 3H), 3.48 (s, 6H), 2.80 (d, J = 3.5 Hz, 2H); 13C NMR
(125 MHz, CDCl3) δ 165.2, 163.4, 159.6, 158.9, 155.5, 153.1 (2), 133.4, 131.8 (2), 122.4,
113.5 (2), 103.9 (2), 100.3, 93.4, 91.9, 78.1, 68.0, 60.8, 55.9 (2), 55.4 (4), 26.1; IR
(KBr)νmax 2927, 1731, 1604, 1591, 1508, 1458, 1458, 1419, 1373, 1326, 1255, 1234, 1126,




A solution of 9c (15 mg, 0.04 mmol) in dichloromethane (0.5 mL) was added to a solution
of 3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxylic acid (21 mg, 0.08 mmol), N-(3-
dimethylamino-propyl)-N′-ethylcarbodiimide hydrochloride (16 mg, 0.08 mmol) and 4-
dimethylaminopyridine (9.6 mg, .08 mmol) in dichloromethane (1 mL) at 0 °C. The
resulting mixture was stirred for 6 h at rt, diluted with dichloromethane (5 mL) and washed
saturated sodium bicarbonate (2 × 4 mL) solution. The organic layer was dried over
anhydrous sodium sulfate, filtered and concentrated. The residue was purified via flash
chromatography (SiO2, 1:3 EtOAc/Hexanes) to give desired ester, 10i (15 mg, 62.5 %), as a
colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.95 (dd, J = 8.6, 2.3 Hz, 1H), 7.92 (d, J = 2.2
Hz, 1H), 7.32 (t, J = 7.9 Hz, 1H), 7.02 (ddd, J = 7.6, 1.6, 1.0 Hz, 1H), 6.99 (dd, J = 2.6, 1.6
Hz, 1H), 6.93 (d, J = 8.7 Hz, 1H), 6.90 (ddd, J = 8.3, 2.6, 1.0 Hz, 1H), 6.75 (s, 2H), 6.25 (d,
J = 2.3 Hz, 1H), 6.13 (d, J = 2.3 Hz, 1H), 5.65 (ddd, J = 4.2, 2.9, 1.3 Hz, 1H), 5.16 – 5.02
(m, 1H), 3.84 (s, 3H), 3.83 (s, 3H), 3.81 (s, 3H), 3.80 (s, 3H), 3.79 (s, 3H), 3.69 (s, 6H), 3.07
(t, J = 3.3 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 165.3, 160.3, 159.6, 159.3, 158.9, 155.5,
153.1 (2), 138.7, 133.4, 132.4, 131.0, 130.4 (2), 129.1, 122.5, 121.9, 115.1, 113.0, 110.5,
103.8 (2), 100.3, 93.4, 92.0, 78.0, 68.4, 60.8, 55.9 (2), 55.8, 55.4 (2), 55.3, 26.1; IR
(KBr)νmax 2927,2848, 1716, 1593, 1496, 1456, 1361, 1238, 1126, 771 cm−1; HRMS (ESI+)
m/z [M+H+] calcd for C35H37O10, 617.2387, found 617.2382.
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A solution of 9c (24 mg, 0.064 mmol) in dichloromethane (0.5 mL) was added to a solution
of 4-acetoxy-3-(3-methylbut-2-en-1-yl)benzoic acid (32 mg, 0.13 mmol), N-(3-
dimethylamino-propyl)-N′-ethylcarbodiimide hydrochloride (26 mg, 0.13 mmol) and 4-
dimethylaminopyridine (15 mg, 0.13 mmol) in dichloromethane (1 mL) at 0 °C. The
resulting mixture was stirred for 6 h at rt, diluted with dichloromethane (5 mL) and washed
saturated sodium bicarbonate solution (2 × 4 mL). The organic layer was dried over
anhydrous sodium sulfate, filtered and concentrated. The residue was purified via flash
chromatography (SiO2, 1:4 EtOAc/Hexanes) to give desired ester, 10j (28 mg, 72.5%), as a
colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 2.1 Hz, 1H), 7.81 (dd, J = 8.3, 2.2
Hz, 1H), 7.02 (d, J = 8.3 Hz, 1H), 6.69 (s, 2H), 6.26 (d, J = 2.3 Hz, 1H), 6.13 (d, J = 2.4 Hz,
1H), 5.67 (td, J = 3.4, 1.2 Hz, 1H), 5.14 (dddd, J = 7.3, 5.8, 2.9, 1.4 Hz, 1H), 5.08 (brs, 1H),
3.81 (s, 3H), 3.80 (s, 3H), 3.79 (s, 3H), 3.71 (s, 6H), 3.21 (d, J = 7.2 Hz, 2H), 3.05 (d, J =
3.3 Hz, 2H), 2.30 (s, 3H), 1.72 (s, 3H), 1.66 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 168.8,
164.9, 159.6, 158.9, 155.4, 153.1 (2), 152.7, 137.8, 134.0, 133.9, 133.3, 131.8, 128.6, 127.8,
122.4, 120.7, 103.8 (2), 100.0, 93.3, 92.0, 77.9, 68.4, 60.8, 56.0, 55.4 (3), 28.6, 25.7 (2),
20.9, 17.8; IR (KBr)νmax 2921, 2850, 1716, 1593, 1458, 1282, 1201, 1142, 1010, 948, 813
cm−1; HRMS (ESI+) m/z [M+H+] calcd for C34H39O10, 607.2543, found 607.2541.
5,7-Bis(benzyloxy)-2-phenylchroman-3-yl benzoate (10k)
A solution of 9b (20 mg, 0.046 mmol) in dichloromethane (0.5 mL) was added to a solution
of 3-methoxybenzoic acid (14 mg, 0.09 mmol), N-(3-dimethylamino-propyl)-N′-
ethylcarbodiimide hydrochloride (18 mg, 0.09 mmol) and 4-dimethylaminopyridine (12 mg,
0.09 mmol) in dichloromethane (1 mL) at 0 °C. The resulting mixture was stirred for 6 h at
rt, diluted with dichloromethane (5 mL) and washed with saturated sodium bicarbonate (2 ×
4 mL) solution. The organic layer was dried over anhydrous sodium sulfate, filtered and
concentrated. The residue was purified via flash chromatography (SiO2, 1:7 EtOAc/
Hexanes) to give the desired ester, 10k (23 mg, 93 %), as a colorless oil: 1H NMR (500
MHz, CDCl3) δ 7.97 – 7.91 (m, 2H), 7.55 – 7.51 (m, 3H), 7.50 – 7.44 (m, 2H), 7.42 – 7.30
(m, 13H), 6.38 (d, J = 2.3 Hz, 1H), 6.31 (d, J = 2.3 Hz, 1H), 5.72 (ddd, J = 4.4, 2.9, 1.4 Hz,
1H), 5.22 (s, 1H), 5.06 (d, J = 4.9 Hz, 2H), 5.02 (d, J = 2.6 Hz, 2H), 3.21 – 3.08 (m,
2H); 13C NMR (125 MHz, CDCl3) δ 165.7, 158.8, 158.0, 155.6, 137.7, 136.9, 136.8, 133.0,
129.9 (2), 129.7 (2), 128.6 (2), 128.5 (2), 128.3 (4), 128.1, 128.0, 127.9, 127.6 (2), 127.2 (2),
126.5, 100.9, 94.7, 93.9, 77.8, 70.2, 70.0, 68.6, 26.1; IR (KBr)νmax 2952, 2923, 2852, 1716,
1616, 1269, 1147, 1107, 1027, 1002, 906, 811, 739 cm−1; HRMS (ESI+) m/z [M+Na+] calcd
for C36H30NaO5, 565.1991, found 565.1998.
5,7-Bis(benzyloxy)-2-phenylchroman-3-yl 3-methoxybenzoate (10l)
A solution of 9b (20 mg, 0.046 mmol) in dichloromethane (0.5 mL) was added to a solution
of 3-methoxybenzoic acid (14 mg, 0.09 mmol), N-(3-dimethylamino-propyl)-N′-
ethylcarbodiimide hydrochloride (18 mg, 0.09 mmol) and 4-dimethylaminopyridine (12 mg,
0.09 mmol) in dichloromethane (1 mL) at 0 °C. The resulting mixture was stirred for 6 h at
rt, diluted with dichloromethane (5 mL) and washed with saturated sodium bicarbonate (2 ×
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4 mL) solution. The organic layer was dried over anhydrous sodium sulfate, filtered and
concentrated. The residue was purified via flash chromatography (SiO2, 1:7 EtOAc/
Hexanes) to give the desired ester, 10l (23.5 mg, 90 %), as a colorless oil: 1H NMR (500
MHz, CDCl3) δ 7.55 – 7.50 (m, 3H), 7.48 – 7.44 (m, 2H), 7.44 – 7.28 (m, 13H), 7.06 (ddd, J
= 8.3, 2.7, 1.0 Hz, 1H), 6.37 (d, J = 2.3 Hz, 1H), 6.30 (d, J = 2.3 Hz, 1H), 5.69 (ddd, J = 4.4,
2.8, 1.5 Hz, 1H), 5.22 (s, 1H), 5.05 (d, J = 4.2 Hz, 2H), 5.02 (d, J = 2.4 Hz, 2H), 3.80 (s,
3H), 3.20 – 3.09 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 165.6, 159.4, 158.8, 158.0, 155.6,
137.8, 136.9, 136.8, 131.3, 129.3, 128.6 (2), 128.5 (2), 128.4 (2), 128.3, 128.1 (2), 128.0,
127.9, 127.6, 127.2 (2), 126.5, 122.2, 119.4, 114.2, 100.9, 94.7, 93.9, 77.7, 70.2, 70.0, 68.8,
55.4, 26.0; IR (KBr)νmax 2960, 2927, 2854, 1716, 1652, 1496, 1436, 1205, 1153, 1095,
1068, 1024, 798, 754, 684 cm−1. HRMS (ESI+) m/z [M+H+] calcd for C37H33O6, 573.2277,
found 573.2263.
5,7-Bis(benzyloxy)-2-phenylchroman-3-yl 4-methoxybenzoate (10m)
A solution of 9b (20 mg, 0.046 mmol) in dichloromethane (0.5 mL) was added to a solution
of 4-methoxybenzoic acid (14 mg, 0.09 mmol), N-(3-dimethylamino-propyl)-N′-
ethylcarbodiimide hydrochloride (18 mg, 0.09 mmol) and 4-dimethylaminopyridine (12 mg,
0.09 mmol) in dichloromethane (1 mL) at 0 °C. The resulting mixture was stirred for 6 h at
rt and then diluted with dichloromethane (5 mL). The organic phase was washed with
saturated sodium bicarbonate solution (2 × 4 mL), dried over anhydrous sodium sulfate,
filtered and concentrated. The residue was purified via flash chromatography (SiO2, 1:7
EtOAc/Hexanes) to give desired ester, 10m (22 mg, 85%), as a colorless oil: 1H NMR (500
MHz, CDCl3) δ 7.89 (d, J = 2.0 Hz, 1H), 7.89 – 7.85 (m, 1H), 7.53 – 7.49 (m, 2H), 7.49 –
7.44 (m, 2H), 7.44 – 7.30 (m, 11H), 6.86 (d, J = 2.0 Hz, 1H), 6.85 (d, J = 2.1 Hz, 1H), 6.37
(d, J = 2.3 Hz, 1H), 6.30 (d, J = 2.3 Hz, 1H), 5.69 (ddd, J = 4.5, 2.9, 1.5 Hz, 1H), 5.21 (brs,
1H), 5.06 (d, J = 4.8 Hz, 2H), 5.04 – 5.00 (m, 2H), 3.83 (s, 3H), 3.19 – 3.05 (m, 2H); 13C
NMR (125 MHz, CDCl3) δ 165.4, 163.4, 158.8, 158.0, 155.6, 137.8, 136.9, 136.8, 131.8,
128.6, 128.5 (3), 128.3 (3), 128.1 (2), 128.0, 127.9 (2), 127.6 (2), 127.2, 126.5, 122.4, 113.5
(2), 101.0, 94.7, 93.8, 77.9, 70.2, 69.9, 68.2, 55.4, 26.1; IR (KBr)νmax 2925, 2852, 1716,




A solution of 9b (20 mg, 0.045 mmol) in dichloromethane (0.5 mL) was added to a solution
of 3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxylic acid (25 mg, 0.09 mmol), N-(3-
dimethylamino-propyl)-N′-ethylcarbodiimide hydrochloride (18 mg, 0.00 mmol) and 4-
dimethylaminopyridine (11 mg, 0.09mmol) in dichloromethane (1 mL) at 0 °C. The
resulting mixture was stirred for 6 h at rt and the diluted with dichloromethane (5 mL). The
organic phase was washed with saturated sodium bicarbonate solution. The organic layer
was dried over anhydrous sodium sulfate, filtered and concentrated. The residue was
purified via flash chromatography (SiO2, 1:4 EtOAc/Hexanes) to give desired ester, 10n (27
mg, 90 %), as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.94 – 7.89 (m, 2H), 7.55 –
7.52 (m, 2H), 7.48 – 7.44 (m, 2H), 7.42 – 7.29 (m, 12H), 7.09 – 7.04 (m, 1H), 7.03 (dd, J =
2.6, 1.5 Hz, 1H), 6.96 – 6.89 (m, 2H), 6.36 (d, J = 2.3 Hz, 1H), 6.30 (d, J = 2.3 Hz, 1H),
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5.68 (ddd, J = 4.3, 3.1, 1.5 Hz, 1H), 5.22 (brs, 1H), 5.04 (d, J = 3.5 Hz, 2H), 5.02 (d, J = 2.2
Hz, 2H), 3.85 (s, 3H), 3.84 (s, 3H), 3.20 – 3.11 (m, 2H); 13C NMR (125 MHz, CDCl3) δ
165.5, 160.2, 159.2, 158.7, 157.9, 155.6, 138.8, 137.9, 136.9, 136.8, 132.5, 131.0, 130.2,
129.0, 128.6 (3), 128.5 (2), 128.3, 128.1, 128.0, 127.9 (2), 127.6 (2), 127.2, 126.5, 122.4,
122.0, 115.2 (2), 112.9, 110.5, 101.0, 94.7, 93.8, 77.8, 70.2, 69.9, 68.5, 55.8, 55.3, 26.0; IR
(KBr)νmax 2952, 2923, 2852, 1716, 1558, 1456, 1245, 1145, 1101, 1026, 798 cm−1; HRMS
(ESI+) m/z [M+H+] calcd for C44H39O7, 679.2696, found 679.2682.
5,7-Bis(benzyloxy)-2-phenylchroman-3-yl 4-acetoxy-3-(3-methylbut-2-en-1-yl)benzoate
(10o)
A solution of 4-acetoxy-3-(3-methylbut-2-en-1-yl)benzoic acid (34 mg, 0.138 mmol) in
THF (5 mL) was treated with thionyl chloride (20 μl, 0.276 mmol). The resulting solution
was heated at 70 0 °C for 3 h, cooled to rt and concentrated. The residue was dissolved in
dichloromethane (0.5 mL) and added to a solution of 9b (20 mg, 0.046 mmol) and 4-
dimethylaminopyridine (22 mg, 0.184 mmol) in dichloromethane 1 (mL) at 0 °C. The
resulting mixture was stirred for 6 h at rt. The solvent was removed and the residue was
purified via flash chromatography (SiO2, 1:7 EtOAc/Hexanes) to give the ester 10o (22.5
mg, 83.5 %), as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.73 (d, J = 2.2 Hz, 1H), 7.69
(dd, J = 8.4, 2.2 Hz, 1H), 7.46 – 7.35 (m, 5H), 7.34 – 7.22 (m, 11H), 6.94 (d, J = 8.4 Hz,
1H), 6.28 (d, J = 2.3 Hz, 1H), 6.21 (d, J = 2.3 Hz, 1H), 5.58 (ddd, J = 4.3, 3.1, 1.5 Hz, 1H),
5.17 – 5.06 (m, 2H), 5.00 – 4.89 (m, 4H), 3.13 (d, J = 7.5 Hz, 2H), 3.04 (t, J = 2.6 Hz, 2H),
2.23 (s, 3H), 1.67 (q, J = 1.3 Hz, 3H), 1.60 (d, J = 1.3 Hz, 3H); 13C NMR (125 MHz,
CDCl3) δ 168.9, 165.1, 158.8, 158.0, 155.5, 152.5, 137.8, 136.9, 136.8, 134.0, 133.7, 131.9,
128.7, 128.6 (2), 128.5 (2), 128.4 (2), 128.1, 128.0, 127.9 (2), 127.8 (2), 127.6 (2), 127.2,
126.4, 122.3, 120.8, 100.8, 94.6, 93.8, 77.7, 70.2, 70.0, 68.7, 29.7, 28.5, 26.1, 20.9, 17.84;
IR (KBr)νmax 2921, 2852, 1760, 1716, 1616, 1373, 1257, 1201, 1149, 1114, 1027, 736
cm−1; HRMS (ESI+) m/z [M+Na+] calcd for C43H40NaO7, 691.2672, found 691.2682.
5,7-Bis(benzyloxy)-2-(3,4,5-trimethoxyphenyl)chroman-3-yl benzoate (10p)
Benzoyl chloride (8 μl, 0.064 mmol) in dichloromethane (0.5 mL) was added to a solution of
9d (17 mg, 0.032 mmol) and 4-dimethylaminopyridine (12 mg, 0.092 mmol) in
dichloromethane 0.7 (mL) with pyridine (0.3 mL) at 0 °C. The resulting mixture was stirred
for 6 h at rt. The resulting mixture was stirred for 6 h at rt. The solvent was removed and the
residue purified via flash chromatography (SiO2, 1:8 EtOAc/Hexanes) to give desired ester,
10p (16 mg, 83.5%), as an amorphous white solid: 1H NMR (500 MHz, CDCl3) δ 8.01 –
7.96 (m, 2H), 7.63 (d, J = 1.7 Hz, 1H), 7.53 – 7.34 (m, 12H), 6.72 (s, 2H), 6.38 (d, J = 2.3
Hz, 1H), 6.32 (d, J = 2.3 Hz, 1H), 5.71 (ddd, J = 4.1, 3.0, 1.3 Hz, 1H), 5.10 (d, J = 3.8 Hz,
1H), 5.08 – 5.01 (m, 4H), 3.80 (s, 3H), 3.71 (s, 6H), 3.18 – 3.10 (m, 2H); 13C NMR (125
MHz, CDCl3) δ 172.0, 165.5, 158.8, 158.0, 155.6, 153.1, 137.7, 136.9, 136.8, 133.8, 133.3,
133.2, 130.2, 130.0, 129.8 (2), 129.3, 128.6 (2), 128.6, 128.5, 128.3 (2), 128.0, 127.9 (2),
127.6, 127.2, 100.9, 94.8, 94.0, 78.1, 70.2, 70.0, 68.5, 60.8, 55.9 (2), 26.3; IR (KBr)νmax
2929, 2839, 1716, 1616, 1591, 1506, 1456, 1361, 1226, 1149, 1126, 1041, 811, 754 cm−1;
HRMS (ESI+) m/z [M+Na+] calcd for C39H36 NaO8, 655.2308, found 655.2307.
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3-methoxybenzoyl chloride (9 μl, 0.064 mmol) in dichloromethane (0.5 mL) was added to a
solution of 9d (17 mg, 0.032 mmol) and 4-dimethylaminopyridine (12 mg, 0.092 mmol) in
dichloromethane 0.7 (mL) with pyridine (0.3 mL) at 0 °C. The resulting mixture was stirred
for 6 h at rt. The resulting mixture was stirred for 6 h at rt. The solvent was removed and the
residue purified via flash chromatography (SiO2, 1:8 EtOAc/Hexanes) to give desired ester,
10q (16 mg, 85.1%), as an amorphous white solid: 1H NMR (500 MHz, CDCl3) δ 7.58 (dt, J
= 7.7, 1.2 Hz, 1H), 7.50 – 7.30 (m, 12H), 7.07 (ddd, J = 8.2, 2.7, 1.0 Hz, 1H), 6.72 (s, 2H),
6.37 (d, J = 2.3 Hz, 1H), 6.31 (d, J = 2.3 Hz, 1H), 5.68 (ddd, J = 4.2, 3.0, 1.3 Hz, 1H), 5.17 –
5.03 (m, 4H), 5.03 (s, 1H), 3.80 (s, 6H), 3.73 (s, 6H), 3.17 – 3.11 (m, 2H); 13C NMR (125
MHz, CDCl3) δ 165.4, 159.5, 158.8, 158.0, 155.6, 153.1 (2), 137.7, 136.9, 136.8, 133.3,
131.3, 129.3, 128.6 (3), 128.5, 128.0, 127.9 (3), 127.6, 127.2 (2), 122.1, 119.1, 114.7, 103.8
(2), 100.8, 94.8, 94.0, 78.0, 70.2, 70.0, 68.6, 60.8, 55.9, 55.4, 26.2; IR (KBr)νmax 2931,
2664, 1716, 1593, 1506, 1456, 1361, 1269, 1217, 1126, 1070. 1008 cm−1; HRMS (ESI+)
m/z [M+Na+] calcd for C40H38NaO9, 685.2414, found 685.2401.
5,7-Bis(benzyloxy)-2-(3,4,5-trimethoxyphenyl)chroman-3-yl 4-methoxybenzoate (10r)
4-methoxybenzoyl chloride (9 μl, 0.064 mmol) in dichloromethane (0.7 mL) was added to a
solution of 9d (17 mg, 0.032 mmol) and 4-dimethylaminopyridine (12 mg, 0.092 mmol) in
dichloromethane 0.7 (mL) with pyridine (0.3 mL) at 0 °C. The resulting mixture was stirred
for 6 h at rt. The solvent was removed and the residue purified via flash chromatography
(SiO2, 1:8 EtOAc/Hexanes) to give desired ester product 10r (17 mg, 87.4%) as an
amorphous white solid: 1H NMR (500 MHz, CDCl3) δ 7.98 – 7.89 (m, 2H), 7.49 – 7.44 (m,
2H), 7.44 – 7.31 (m, 8H), 6.88 – 6.84 (m, 2H), 6.71 (s, 2H), 6.37 (d, J = 2.3 Hz, 1H), 6.31
(d, J = 2.3 Hz, 1H), 5.68 (tt, J = 3.1, 1.2 Hz, 1H), 5.08 (s, 1H), 5.08 – 5.01 (m, 4H), 3.84 (s,
3H), 3.80 (s, 3H), 3.72 (s, 6H), 3.12 (t, J = 3.0 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ
165.2, 163.5, 158.7, 158.0, 155.6, 153.1, 137.7, 136.9, 136.8, 133.3 (2), 131.8, 128.6 (2),
128.5 (2), 128.0 (2), 127.9 (2), 127.6 (2), 127.2, 122.4, 113.5 (2), 103.9 (2), 101.0, 94.8,
93.9, 78.1, 70.2, 70.0, 68.0, 60.8, 60.0, 55.9, 55.5, 26.4; IR (KBr)νmax 3348, 2952, 2927,
1716, 1506, 1417, 1257, 1168, 1126, 1035, 821 cm−1; HRMS (ESI+) m/z [M+H+] calcd for
C40H39O9, 663.2594, found 663. 2608.
5,7-Bis(benzyloxy)-2-(3,4,5-trimethoxyphenyl)chroman-3-yl 3′,6-dimethoxy-[1,1′-
biphenyl]-3-carboxylate (10s)
A solution of 3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxylic acid (35 mg, 0.135 mmol) in
THF (5 mL) was treated with thionyl chloride (20 μl, 0.27 mmol). The resulting solution
was heated at reflux for 3 h, cooled to rt before the solvent was removed. The crude was
dissolved in dichloromethane (0.5 mL) and added to a solution of 9d (18 mg, 0.045 mmol)
and 4-dimethylaminopyridine (22 mg, 0.18 mmol) in dichloromethane (0.7 mL) with
pyridine (0.3 mL) at 0 °C. The resulting mixture was stirred for 6 h at rt, the solvent was
removed and the residue purified via flash chromatography (SiO2, 1:3 EtOAc/Hexanes) to
give desired ester, 10s (28 mg, 83%), as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.97
(dd, J = 8.6, 2.2 Hz, 1H), 7.93 (d, J = 2.2 Hz, 1H), 7.44 (d, J = 1.3 Hz, 1H), 7.43 – 7.29 (m,
10H), 7.03 (dt, J = 7.7, 1.2 Hz, 1H), 7.00 (dd, J = 2.6, 1.5 Hz, 1H), 6.94 (d, J = 8.7 Hz, 1H),
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6.91 (ddd, J = 8.3, 2.6, 1.0 Hz, 1H), 6.71 (s, 2H), 6.37 (d, J = 2.3 Hz, 1H), 6.30 (d, J = 2.3
Hz, 1H), 5.67 (td, J = 3.6, 1.4 Hz, 1H), 5.10 (s, 1H), 5.07 – 5.01 (m, 4H), 3.86 – 3.79 (m,
9H), 3.69 (s, 6H), 3.15 (d, J = 3.6 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 165.6, 160.6,
159.5, 159.0, 158.2, 155.8, 153.3 (2), 138.9, 137.1, 137.1, 133.6, 132.6, 131.3, 130.7, 129.3,
128.9, 128.8 (2), 128.3 (2), 128.2 (2), 127.8 (2), 127.4 (2), 122.7, 122.1, 115.4, 113.2, 110.7,
104.0 (2), 101.3, 95.0, 94.2, 78.3, 70.4, 70.2, 68.6, 61.1, 56.2, 56.1 (2), 55.5, 26.5; IR
(KBr)νmax 3434, 2929, 1712, 1616, 1593, 1500, 1456, 2440, 2303, 1238, 1149, 1126, 1027,




A solution of 4-acetoxy-3-(3-methylbut-2-en-1-yl)benzoic acid (33.5 mg, 0.135 mmol) in
THF (5 mL) was treated with thionyl chloride (20 μl, 0.27 mmol). The resulting solution
was heated at 70 0 °C for 3 h and cooled to rt and concentrated. The residue was dissolved
in dichloromethane (0.5 mL) and added to a solution of 9d (18 mg, 0.045 mmol) and 4-
dimethylaminopyridine (22 mg, 0.18 mmol) in dichloromethane (0.7 mL) with pyridine (0.3
mL) at 0 °C. The resulting mixture was stirred for 6 h at rt. The solvent was removed and the
residue purified via flash chromatography (SiO2, 1:3 EtOAc/Hexanes) to give desired ester,
10t (26.6 mg, 78%), as colorless a oil: 1H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 2.1 Hz,
1H), 7.74 (dd, J = 8.4, 2.2 Hz, 1H), 7.52 – 7.46 (m, 2H), 7.44 – 7.36 (m, 2H), 7.39 – 7.28
(m, 6H), 7.01 (d, J = 8.4 Hz, 1H), 6.79 (s, 2H), 6.29 – 6.37 (m, 2H), 5.76 (ddd, J = 4.3, 2.9,
1.4 Hz, 1H), 5.22 (m, 1H), 5.15 (m, 3H), 5.00 (s, 2H), 3.81 (s, 3H), 3.77 (s, 6H), 3.20 (d, J =
7.4 Hz, 2H), 3.19 – 3.06 (m, 2H), 2.31 (s, 3H), 1.71 (d, 1.6 Hz, 3H), 1.66 (d, J = 1.4 Hz,
3H); 13C NMR (125 MHz, CDCl3) δ 169.0, 165.1, 156.7, 155.1, 153.3, 152.9 (2), 152.1,
137.7, 136.9, 136.6, 134.3, 134.1, 133.0, 132.0, 128.9, 128.8 (2), 128.3 (2), 128.2 (2), 127.8
(2), 127.4 (2), 127.3 (2), 122.6, 120.8, 103.5 (2), 102.6, 93.0, 92.9, 78.2, 71.5, 70.5, 68.0,
61.0, 56.2 (2), 28.8, 26.5, 25.9, 21.0, 18.0; IR (KBr)νmax 2960, 2925, 1714, 1604, 1456,
1353, 1261, 1236, 1174, 1126, 1012, 819 cm−1; HRMS (ESI+) m/z [M+H+] calcd for
C46H47O10, 759.3169, found 759.3195.
5,7-Dihydroxy-2-phenylchroman-3-yl benzoate (11a)
10k (20 mg, 0.036 mmol) and palladium/carbon (10%) were suspended in tetrahydrofuran
(2 mL) and stirred for 18 h under a hydrogen atmosphere. The suspension was filtered
through plug of SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue
purified by flash chromatography (SiO2, Acetone/Dichloromethane 1:12) to give 11a (12
mg, 90 %) as a colorless oil: 1H NMR (500 MHz, CD3OD) δ 7.87 – 7.79 (m, 2H), 7.56 –
7.47 (m, 3H), 7.43 – 7.34 (m, 2H), 7.31 – 7.19 (m, 3H), 6.01 (d, J = 2.3 Hz, 1H), 5.98 (d, J =
2.3 Hz, 1H), 5.66 (ddd, J = 4.6, 2.4, 1.3 Hz, 1H), 5.23 (s, 1H), 3.08 (dd, J = 17.5, 4.6 Hz,
1H), 2.93 (ddd, J = 17.6, 2.5, 0.9 Hz, 1H); 13C NMR (125 MHz, CD3OD) δ 167.1, 158.0,
157.9, 157.1, 139.9, 134.2, 131.2, 130.5, 129.5 (2), 129.1 (2), 128.8 (2), 127.5 (2), 99.1,
96.7, 95.8, 78.6, 70.6, 26.7; IR (KBr)νmax 3427, 2921, 2848, 1701, 1560, 1473, 1271, 1097
cm−1; HRMS (ESI+) m/z [M+H+] calcd for C22H19O5, 363.1232, found 363.1241.
Khandelwal et al. Page 20























10l (20 mg, 0.034 mmol) and palladium/carbon (10%) were suspended in tetrahydrofuran (2
mL) and stirred for 18 h under a hydrogen atmosphere. The suspension was filtered through
plug of SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue purified
by flash chromatography (SiO2, Acetone/Dichloromethane 1:10) to give 11b (20 mg, 89%)
as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.50 (dt, J = 7.7, 1.2 Hz, 3H), 7.41 (dd, J =
2.7, 1.5 Hz, 1H), 7.38 – 7.30 (m, 2H), 7.31 – 7.27 (m, 2H), 7.05 (ddd, J = 8.3, 2.7, 1.0 Hz,
1H), 6.17 (d, J = 2.4 Hz, 1H), 5.99 (d, J = 2.4 Hz, 1H), 5.67 (ddd, J = 4.4, 2.9, 1.5 Hz, 1H),
5.21 (brs, 1H), 5.18 (brs, 1H), 5.05 (brs, 1H), 3.79 (s, 3H), 3.22 – 3.00 (m, 2H); 13C NMR
(125 MHz, CDCl3) δ 166.0, 159.6, 156.2, 155.5, 155.3, 137.8, 131.3, 129.6, 128.5, 128.4
(2), 126.6 (2), 122.3, 119.7, 114.4, 99.1, 96.5, 96.2, 77.8, 68.9, 55.6, 25.7; IR (KBr)νmax
3359, 2923, 2852, 1714, 1631, 1461, 1274, 1103, 754, cm−1; HRMS (ESI−) m/z [M−H−]
calcd for C23H19O6, 391.1182, found 391.1181.
5,7-Dihydroxy-2-phenylchroman-3-yl 4-methoxybenzoate (11c)
10m (16 mg, 0.027 mmol) and palladium/carbon (10%) were suspended in tetrahydrofuran
(2 mL) and stirred for 18 h under a hydrogen atmosphere. The suspension was filtered
through plug of SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue
purified by flash chromatography (SiO2, Acetone/Dichloromethane 1:10) to afford 11c (10
mg, 91%) as a colorless oil: 1H NMR (500 MHz, (CD3)2CO) δ 8.20 (d, J = 1.3 Hz, 1H),
8.00 (d, J = 1.2 Hz, 1H), 7.72 – 7.67 (m, 2H), 7.51 – 7.41 (m, 2H), 7.25 – 7.16 (m, 2H), 7.16
– 7.08 (m, 1H), 6.84 – 6.79 (m, 2H), 5.95 (s, 2H), 5.53 (ddd, J = 4.7, 2.4, 1.4 Hz, 1H), 5.21
(s, 1H), 3.71 (s, 3H), 2.99 (dd, J = 17.7, 4.4 Hz, 1H), 2.87 (ddd, J = 17.4, 2.4, 0.9 Hz,
1H); 13C NMR (125 MHz, (CD3)2CO) δ 165.7, 164.6, 158.0, 157.6, 156.9, 139.9, 132.3 (2),
129.0 (2), 128.6 (2), 127.5, 123.4, 114.7 (2), 98.9, 96.7, 95.9, 78.2, 69.6, 56.0, 26.6; IR
(KBr)νmax 3369, 2925, 2852, 1714, 1604, 1512, 1456, 1257, 1168, 1101, 1029, 667 cm−1;
HRMS (ESI−) m/z [M−H−] calcd for C23H19O6, 391.1182, found 391.1175.
5,7-Dihydroxy-2-phenylchroman-3-yl 3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxylate (11d)
10n (20 mg, 0.029 mmol) and palladium/carbon (10%) were suspended in tetrahydrofuran
(2 mL) and stirred for 18 h under hydrogen atmosphere. The suspension was filtered through
plug of SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue purified
by flash chromatography (SiO2, Acetone/Dichloromethane 1:9) to give 11d (13 mg, 89%) as
a colorless oil: (500 MHz, CDCl3) 1H NMR δ 7.83 – 7.78 (m, 2H), 7.45 – 7.39 (m, 2H),
7.31 – 7.22 (m, 3H), 7.23 – 7.20 (m, 1H), 6.98 (ddd, J = 7.6, 1.6, 1.0 Hz, 1H), 6.93 (dd, J =
2.6, 1.6 Hz, 1H), 6.88 – 6.80 (m, 2H), 6.08 (d, J = 2.2 Hz, 1H), 5.91 (d, J = 2.4 Hz, 1H),
5.57 (tt, J = 3.3, 1.5 Hz, 1H), 5.13 (s, 1H), 5.01 (s, 1H), 4.91 (s, 1H), 3.76 (d, J = 1.4 Hz,
6H), 3.08 – 2.95 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 165.8, 160.5, 159.4, 156.2, 155.5,
155.3, 138.9, 137.9, 132.7, 131.2, 130.5, 129.2, 128.5 (2), 128.3 (2), 126.7, 122.5, 122.2,
115.5, 113.1, 110.7, 99.2, 96.6, 96.2, 77.9, 68.6, 56.0, 55.5, 25.7; IR (KBr)νmax 3374, 2952,
2852, 1714, 1558, 1456, 1271, 1101, 1026 cm−1; HRMS (ESI+) m/z [M+H+] calcd for
C30H27O7, 499.1757, found 499.1744.
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A solution of palladium acetate (2 mg, 0.008 mmol), triethylamine (13μL, 0.09 mmol),
triethylsilane (64μL, 0.405) in dichloromethane (0.8 mL) was stirred for 15 min before the
addition of 10j (30 mg, 0.045 mmol) in dichloromethane (0.4 mL). The resulting mixture
was stirred for 15 h, quenched with saturated ammonium chloride (2 mL), and extracted
with diethyl ether (3 × 4 mL). The combined organic layers were washed with saturated
sodium chloride solution and dried over anhydrous Na2SO4. The solvent was removed and
residue purified via flash chromatography (SiO2, 5:95 MeOH/DCM) to give 11e (4 mg, 18.9
%) as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.71 – 7.63 (m, 2H), 7.51 – 7.45 (m,
2H), 7.33 – 7.25(m, 3H), 6.69 (d, J = 8.2 Hz, 1H), 6.42 (d, J = 2.2 Hz, 1H), 6.22 (d, J = 2.2
Hz, 1H), 5.68 – 5.56 (m, 2H), 5.26 (m, 2H), 5.13 (d, J = 1.2 Hz, 1H), 3.32 (d, J = 7.2 Hz,
2H), 3.06 (t, J = 3.2 Hz, 2H), 2.30 (s, 3H), 1.81 – 1.72 (m, 6H); 13C NMR (125 MHz,
CDCl3) δ 170.0, 165.8, 158.9, 156.0, 154.9, 150.0, 137.7, 135.9, 132.2, 130.0 (2), 128.5 (2),
128.3 (2), 126.9, 126.6, 122.2, 121.1, 115.7, 104.7, 103.0, 101.9, 78.0, 67.9, 29.6, 26.1 (2),
21.4, 18.1; IR (KBr)νmax 3432, 2922, 1701, 1562, 1471, 1101, 1271, 1093 cm−1; HRMS
(ESI−) m/z [M−H−] calcd for C29H27O7, 487.1757, found 487.1755.
5,7-Dihydroxy-2-(3,4,5-trimethoxyphenyl)chroman-3-yl benzoate (11f)
10p (15 mg, 0.023 mmol) and palladium/carbon (10%) were suspended in tetrahydrofuran
(2 mL) and stirred for 18 h under a hydrogen atmosphere. The suspension was filtered
through plug of SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue
purified by flash chromatography (SiO2, Acetone/Dichloromethane 1:8) to give the desired
product 11f (9.5 mg, 88.5 %) as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.99 – 7.86
(m, 2H), 7.53 (ddt, J = 8.7, 7.2, 1.3 Hz, 1H), 7.45 – 7.33 (m, 2H), 6.70 (s, 2H), 6.19 (d, J =
2.3 Hz, 1H), 5.98 (d, J = 2.3 Hz, 1H), 5.70 (ddd, J = 4.3, 2.8, 1.3 Hz, 1H), 3.80 (s, 3H), 3.70
(s, 6H), 3.15 – 3.00 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 165.6, 156.1, 155.3 (2), 155.1
(2), 153.1, 137.7, 133.3, 129.8(2), 129.7 (3), 128.4, 103.8 (2), 98.9, 96.5, 96.1, 77.9, 68.3,
60.9, 55.9 (2), 25.8 cm−1; IR (KBr)νmax 3421, 2931, 2850, 1717, 1596, 1465, 1276, 1126,
756 cm−1; HRMS (ESI−) m/z [M−H−] calcd for C25H23O8, 451.1393, found 451.1412.
5,7-Dihydroxy-2-(3,4,5-trimethoxyphenyl)chroman-3-yl 3-methoxybenzoate (11g)
10q (14 mg, 0.021 mmol) and palladium/carbon (10%) were suspended in tetrahydrofuran
(2 mL) and stirred for 18 h under a hydrogen atmosphere. The suspension was filtered
through plug of SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue
purified by flash chromatography (SiO2, Acetone/Dichloromethane 1:8) to afford 11g (9 mg,
89%) as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.55 (dt, J = 7.7, 1.2 Hz, 1H), 7.45
(dd, J = 2.7, 1.5 Hz, 1H), 7.06 (ddd, J = 8.3, 2.7, 1.0 Hz, 1H), 6.18 (d, J = 2.3 Hz, 1H), 5.94
(d, J = 2.3 Hz, 1H), 5.68 (ddd, J = 4.2, 2.8, 1.3 Hz, 1H), 5.43 (s, 1H), 5.29 (s, 1H), 5.15 –
5.05 (m, 1H), 3.15 – 3.03 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 165.6, 159.5, 156.0,
155.4, 155.2, 153.1 (2), 137.6, 133.4, 131.1, 129.4, 122.0, 119.4, 114.6, 103.8 (2), 98.8,
96.3, 96.1, 77.9, 68.6, 60.8, 55.9, 55.4 (2), 25.7; IR (KBr)νmax 3419, 3404, 3010, 2927,
2852, 1716, 1596, 1463, 1274, 1128,1105, 754 cm−1; HRMS (ESI+) m/z [M-H−] calcd for
C26H25O9, 481.1499, found 481.1509.
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10r (14 mg, 0.021 mmol) and palladium/carbon (10%) were suspended in tetrahydrofuran (2
mL) and stirred for 18 h under a hydrogen atmosphere. The suspension was filtered through
plug of SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue purified
by flash chromatography (SiO2, Acetone/Dichloromethane 1:8) to give 11h (9 mg, 89 %) as
a colorless oil: 1H NMR (500 MHz, CD3OD) δ 7.93 – 7.76 (m, 2H), 6.98 – 6.90 (m, 2H),
6.79 (s, 2H), 6.00 (q, J = 2.3 Hz, 2H), 5.63 (ddd, J = 4.7, 2.3, 1.2 Hz, 1H), 5.14 (s, 1H), 3.83
(s, 3H), 3.70 (s, 3H), 3.67 (s, 6H), 3.07 (dd, J = 17.4, 4.6 Hz, 1H), 2.95 – 2.86 (m, 1H); 13C
NMR (125 MHz, CDCl3) δ 165.2, 163.8, 156.2, 155.5, 155.3, 153.3, 137.3, 133.5, 132.0 (3),
122.4, 113.8 (2), 104.0 (2), 99.2, 96.6, 96.2, 78.2, 68.1, 63.0, 56.1, 55.7 (2), 26.0; IR
(KBr)νmax 3419, 2931, 2842, 1701, 1604, 1506, 1458, 1361, 1257, 1166, 1126, 1101, 1018
cm−1; HRMS (ESI−) m/z [M−H−] calcd for C26H25O9, 481.1499, found 481.1518.
5,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)chroman-3-yl 3′,6-dimethoxy-[1,1′-biphenyl]-3-
carboxylate (11i)
10r (25 mg, 0.032 mmol) and palladium/carbon (10%) were suspended in tetrahydrofuran (2
mL) and stirred for 18 h under a hydrogen atmosphere. The suspension was filtered through
plug of SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue purified
by flash chromatography (SiO2, Acetone/Dichloromethane 1:8) to give the 11g (17.4 mg, 91
%) as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.83 – 7.78 (m, 2H), 7.45 – 7.39 (m,
2H), 7.31 – 7.22 (m, 3H), 7.23 – 7.20 (m, 1H), 6.98 (ddd, J = 7.6, 1.6, 1.0 Hz, 1H), 6.93 (dd,
J = 2.6, 1.6 Hz, 1H), 6.88 – 6.80 (m, 2H), 6.08 (d, J = 2.2 Hz, 1H), 5.91 (d, J = 2.4 Hz, 1H),
5.57 (tt, J = 3.3, 1.5 Hz, 1H), 5.13 (s, 1H), 5.01 (s, 1H), 4.91 (s, 1H), 3.76 (d, J = 1.4 Hz,
6H), 3.08 – 2.95 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 165.7, 160.6, 159.4, 156.2, 155.6,
155.4, 153.3 (2), 138.8, 133.6, 132.6, 131.2, 130.6, 129.3 (2), 122.5, 122.1, 115.3, 113.2,
110.7, 103.9 (2), 99.2, 96.6, 96.3, 78.1, 68.5, 61.0, 56.1, 56.0, 55.5, 53.6, 29; IR (KBr)νmax
3429, 2931, 2851, 1699, 1604, 1508, 1476, 1248, 1166, 1145, 1098, cm−1; HRMS (ESI+)
m/z [M+H+] calcd for C33H33O10, 589.2074 found 589.2057.
5,7-Dihydroxy-2-(3,4,5-trimethoxyphenyl)chroman-3-yl 4-acetoxy-3-(3-methylbut-2-en-1-
yl)benzoate (11j)
A solution of palladium acetate (1 mg, 0.004 mmol), triethylamine (7 μL, 0.047 mmol),
triethylsilane (34 μL, 0.208 in dichloromethane (0.5 mL) was stirred for 15 minutes before
the addition of 10t (20 mg, 0.026 mmol) in dichloromethane (0.4 mL). The resulting mixture
was stirred for 15 h, quenched with saturated ammonium chloride (2 mL) and extracted with
diethyl ether (3 × 4 mL). The combined organic layers were washed with saturated sodium
chloride solution and dried over anhydrous Na2SO4. Solvent was removed and residue was
purified via flash chromatography (SiO2, 5:95 MeOH/DCM) to give 11j (4 mg, 18.9 %) as a
colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.71 (dd, J = 6.4, 2.4 Hz, 2H), 6.67 (s, 3H),
6.43 (d, J = 2.2 Hz, 1H), 6.23 (d, J = 2.2 Hz, 1H), 5.74 (s, 1H), 5.66 – 5.59 (m, 1H), 5.36
(brs, 1H), 5.22 (dddt, J = 7.3, 5.8, 2.9, 1.5 Hz, 1H), 4.97 (s, 1H), 3.32 (d, J = 7.4 Hz, 2H),
3.07 – 2.99 (m, 2H), 2.30 (d, J = 5.3 Hz, 3H), 1.80 – 1.64 (m, 6H); 13C NMR (125 MHz,
CDCl3) δ 170.1, 165.6, 159.2, 156.0, 155.0, 153.3 (2), 150.0, 137.9, 136.0, 133.2, 132.2,
130.0, 127.1 (2), 122.2, 121.0, 115.7, 104.8, 103.9 (2), 103.1, 102.1, 78.2, 67.7, 61.0, 56.2,
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29.7, 26.0 (2), 21.4, 18.1; IR (KBr)νmax 3412, 2937, 2843, 1715, 1693, 1562, 1473, 1126
cm−1; HRMS (ESI−) m/z [M−H−] calcd for C32H33O10, 577.2074, found 577.2079.
(((5-(Allyloxy)-1,3-phenylene)bis(oxy))bis(methylene))dibenzene (18a)
A solution of 4b (1.2 g, 3.9 mmol), potassium carbonate (2.17g, 15.7 mmol) and ally
bromide (0.44 mL, 5.1 mmol) in dimethyl formamide (40 mL) was heated at 90 °C for 12 h.
The reaction mixture was cooled to rt, diluted with ethyl acetate (200 mL), washed with
water (3 × 100 mL) and then saturated sodium chloride solution (100 mL). The organic
phase was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified
by flash chromatography (SiO2 1:9 EtOAc/Hexanes) to give 18a (1.62 g, 89%) as a light
yellow oil: 1H NMR (400 MHz, CDCl3) δ 7.51 – 7.29 (m, 10H), 6.27 (t, J = 2.2 Hz, 1H),
6.21 (d, J = 2.1 Hz, 2H), 6.04 (ddt, J = 17.2, 10.6, 5.4 Hz, 1H), 5.40 (dq, J = 17.3, 1.6 Hz,
1H), 5.29 (dq, J = 10.5, 1.4 Hz, 1H), 5.01 (s, 4H), 4.49 (dt, J = 5.4, 1.5 Hz, 2 H); 13C NMR
(125 MHz, CDCl3) δ 160.8 (2), 160.6, 137.0 (2), 133.3, 128.8 (4), 128.2 (2), 127.8 (4),
118.0, 95.0, 94.9 (2), 70.3 (2), 69.1; IR (KBr)νmax 3390, 2975, 2908, 2864, 1622, 1591,
1506, 1434, 1213, 1159, 1110, 1066, 1043, 933, 810, 703 cm−1; HRMS (ESI+) m/z [M+H+]
calcd for C23H23O3, 347.1647, found 347.1647.
1-(Allyloxy)-3-(benzyloxy)benzene (18b)
A solution of 17 (2.45g, 12.3 mmol), potassium carbonate (6.62g, 49.2 mmol) and ally
bromide (1.34 mL, 16 mmol)) dimethylformamide (60 mL) was stirred for 12 h at 90 °C.
The reaction mixture was cooled to rt, diluted with EtOAc (200 mL), washed with water (3
× 100 mL times) and saturated sodium chloride solution (100 mL). The organic phase was
dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by flash
chromatography (SiO2, 1:9 EtOAc/Hexanes) to give 18b (2.8g, 95.2 %) as light yellow
oil: 1H NMR (500 MHz, CDCl3) δ 7.47 – 7.43 (m, 2H), 7.42 – 7.38 (m, 2H), 7.37 – 7.32 (m,
1H), 7.19 (t, J = 8.1 Hz, 1H), 6.06 (ddt, J = 17.2, 10.6, 5.3 Hz, 1H), 5.42 (dq, J = 17.2, 1.6
Hz, 1H), 5.29 (dq, J = 10.5, 1.4 Hz, 1H), 5.06 (s, 2H), 4.53 (dt, J = 5.3, 1.5 Hz, 2H); 13C
NMR (125 MHz, CDCl3) δ 160.2, 160.0, 137.3, 133.4, 130.1, 128.8 (2), 128.2 (2), 127.7,
117.9, 107.5, 107.4, 102.3, 70.2, 69.0; IR (KBr)νmax 3031, 2866, 1591, 1490, 1454, 1379,
1288, 1261, 1178, 1149, 1039, 1027, 927, 835, 734, 696 cm−1; HRMS (ESI+) m/z [M+Na+]
calcd for C16H16NaO2, 263.1048, found 263.1053.
2-Allyl-3,5-bis(benzyloxy)phenol (19a)
18a (1.62 g, 4.66 mmol) was dissolved in N,N-diethylaniline (23 mL) and heated at 210 °C
for 12 h. Reaction mixture was cooled to rt, diluted with ethyl acetate (200 mL), washed
with 1N HCl (3 × 100mL), and then saturated sodium chloride solution. The organic layer
was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by
flash chromatography (SiO2, 1:8 EtOAc/Hexanes) to afford 19a (1.215g, 75%) as a pale
yellow oil: 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.32 (m, 11H), 6.27 (d, J = 2.3 Hz, 1H),
6.19 (d, J = 2.3 Hz, 1H), 5.98 (ddt, J = 16.3, 10.0, 6.1 Hz, 1H), 5.18 (q, J = 1.8 Hz, 1H),
5.13 (dq, J = 5.0, 1.7 Hz, 1H), 5.07 (s, 1H), 5.02 (s, 2H), 5.01 (s, 2H), 3.46 (dt, J = 6.2, 1.7
Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 161.9, 160.5, 158.3, 137.0 (2), 136.9, 128.8 (4),
128.2 (2), 127.8 (4), 116.0, 106.3, 95.0, 92.9, 70.3, 69.1, 26.3; IR (KBr)νmax 2925, 2867,
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1596, 1456, 1375, 1213, 1153, 1058, 927, 817, 736 cm−1; HRMS (ESI−) m/z [M−H−] calcd
for C23H21O3, 345.1491, found 345.1503.
3-(2,4-Bis(benzyloxy)-6-hydroxyphenyl)propane-1,2-diol (20a)
A mixture of 19a (1.062g, 3.1 mmol) in tetrahydrofuran-water (13mL-9mL), 4% aqueous
solution of osmium tetraoxide in water (0.03 mmol) and N-methyl morphline-N-oxide (575
mg, 4.9 mmol) was stirred for 12 h before quenching with 10 % aqueous sodium
metabisulfite. The aqueous layer was extracted with ethyl acetate (3 × 50 mL) and the
combined organic layers washed with saturated sodium chloride solution (100 mL). The
solvent was removed and the residue purified by flash chromatography (SiO2, 2:5 EtOAc/
Hexanes) to afford 20a (744 mg, 64 %) as a colorless oil: 1H NMR (500 MHz, (CD3)2CO) δ
8.77 (s, 1H), 7.50 (dd, J = 8.1, 1.4 Hz, 2H), 7.48 – 7.44 (m, 2H), 7.39 (td, J = 7.9, 7.5, 1.5
Hz, 4H), 7.36 – 7.30 (m, 2H), 6.32 (d, J = 2.3 Hz, 1H), 6.20 (d, J = 2.3 Hz, 1H), 5.10 (s,
2H), 5.05 (s, 2H), 4.65 (d, J = 5.2 Hz, 1H), 3.91 (brs, 1H), 3.81 (d, J = 6.1 Hz, 1H), 3.53
(brs, 1H), 3.41 (dd, J = 11.3, 6.4 Hz, 1H), 2.96 (dd, J = 14.1, 5.0 Hz, 1H), 2.79 (dd, J = 14.1,
6.8 Hz, 1H); 13C NMR (125 MHz, (CD3)2CO) δ 159.9, 159.1 (2), 138.7 (2), 129.4 (2), 129.3
(2), 128.9, 128.7, 128.6, 128.5, 128.2, 107.6, 96.8, 96.8, 93.6, 74.1, 70.9, 70.5, 66.6, 27.8; IR
(KBr)νmax 3298, 1616, 1598, 1452, 1436, 1375, 1217, 1147, 1105, 1045, 1027, 908, 813,
736, 696, 649 cm−1; HRMS (ESI−) m/z [M+H+] calcd for C23H25O5, 381.1702, found
381.1709.
3-(4-(Benzyloxy)-2-hydroxyphenyl)propane-1,2-diol (20b)
18b (2.7g, 11.23 mmol) was dissolved in N,N-diethylaniline (70 mL) and heated at 210 °C
for 12 h. The reaction mixture was cooled to rt, diluted with ethyl acetate (200 mL), washed
with 1N HCl (3 × 100mL), and then with saturated sodium chloride solution. The organic
layer was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified
by flash chromatography (SiO2, 1:8 EtOAc/Hexanes) to give a mixture of 19b and 19c. The
mixture of 19b & 19c (2.02g, 8.41 mmol) in tetrahydrofuran-water (18mL-12mL), 4%
aqueous solution osmium tetraoxide in water (0.168mmol) and N-methyl morphline-N-
oxide (1.67g, 14.29 mmol) was stirred 12 h before quenching with 10 % aqueous sodium
metabisulfite. The aqueous phase was extracted with ethyl acetate (3 × 200 mL), the
combined organic layers were washed with saturated sodium chloride solution and solvent
was removed. The residue was purified by flash chromatography (1:5 Acetone-DCM) to
afford 20b (1.24g) as a colorless oil: 1H NMR (500 MHz, (CD3)2CO) δ 7.49 – 7.43 (m, 2H),
7.427.35 (m, 2H), 7.34 – 7.27 (m, 1H), 6.99 (d, J = 8.3 Hz, 1H), 6.49 (d, J = 2.6 Hz, 1H),
6.45 (dd, J = 8.2, 2.5 Hz, 1H), 3.90 (tt, J = 6.9, 4.4 Hz, 1H), 3.54 – 3.49 (m, 1H), 3.47 – 3.40
(m, 1H), 2.83 – 2.75 (m, 1H), 2.74 – 2.66 (m, 1H); 13C NMR (125 MHz, (CD3)2CO) δ
159.6, 157.7, 138.6, 132.6, 129.2, 129.1, 128.4 (2), 128.2, 118.8, 106.7, 103.8, 74.2, 70.2,
66.2, 35.3; IR (KBr)νmax 3311, 2931, 1618, 1585, 1506, 1454, 1279, 1286, 1166, 1108,
1024, 842, 736, 696 cm−1; HRMS (ESI−) m/z [M−H−] calcd for C16H17O4, 273.1127, found
273.1129.
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The mixture of 19b & 19c (2.02g, 8.41 mmol) in tetrahydrofuran-water (18mL-12mL), 4%
aqueous solution osmium tetraoxide in water (0.168mmol) and N-methyl morphline-N-
oxide ( (1.67g, 14.29 mmol) was stirred 12 h before quenching with 10 % aqueous sodium
metabisulfite. The aqueous phase was extracted with ethyl acetate (3 × 200 mL, and the
combined organic layers washed with saturated sodium chloride solution. The solvent was
removed and the residue purified by flash chromatography (1:5 Acetone-DCM) to afford
20c (0.8 g) as a colorless oil was used as is in the next step: 1H NMR (500 MHz, (CD3)2CO)
δ 8.70 (s, 1H), 7.53 – 7.48 (m, 2H), 7.42 – 7.35 (m, 2H), 7.35 – 7.29 (m, 1H), 7.02 (t, J = 8.2
Hz, 1H), 6.59 (dd, J = 8.3, 1.0 Hz, 1H), 6.52 (dd, J = 8.1, 1.0 Hz, 1H), 5.10 (s, 2H), 4.86 –
4.48 (m, 1H), 3.97 (tdd, J = 6.7, 5.3, 4.0 Hz, 1H), 3.83 (brs, 1H), 3.55 (dd, J = 11.2, 4.0 Hz,
1H), 3.43 (dd, J = 11.2, 6.6 Hz, 1H), 3.04 (dd, J = 13.8, 5.3 Hz, 1H), 2.89 (dd, J = 13.8, 6.7
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 157.47, 156.58, 136.82, 128.69 (2), 128.10 (2),
127.40 (2), 112.99, 110.56, 104.13, 72.83, 70.54, 65.24, 26.59; IR (KBr)νmax 3334, 2929,
1618, 1583, 1506, 1454, 1279, 1286, 1217, 1166, 1045, 1025, 849 cm−1; HRMS (ESI−) m/z
[M−H−] calcd for C16H17O4, 273.1127, found 273.1127.
3-(2,4-Bis(benzyloxy)-6-hydroxyphenyl)-2-hydroxypropyl 4-methylbenzenesulfonate (21a)
Pyridine (0.46mL, 5.8 mmol) was added to a solution of 19a (500 mg, 1.37 mmol) and p-
toluenesulfonyl chloride (282 mg, 1.5 mmol) in dichloromethane (14 mL) at 0 °C. The
resulting mixture was stirred for 12 h at rt before quenching with 2N HCl (20mL). The
aqueous layer was extracted with dichloromethane (2 × 30mL). The combined organic
layers were washed with saturated sodium chloride solution, dried over anhydrous Na2SO4,
filtered and concentrated. The residue was purified by flash chromatography (SiO2, 2:5
EtOAc/Hexanes) to give 21a (427 mg, 58%) as a pale yellow oil: 1H NMR (500 MHz,
(CD3)2CO) δ 8.51 (s, 1H), 7.72 – 7.67 (m, 2H), 7.50 – 7.44 (m, 4H), 7.43 – 7.37 (m, 6H),
7.37 – 7.30 (m, 2H), 6.31 (d, J = 2.4 Hz, 1H), 6.19 (d, J = 2.3 Hz, 1H), 5.07 (s, 2H), 5.04 (s,
2H), 4.84 (d, J = 4.5 Hz, 1H), 4.11 – 3.94 (m, 2H), 3.95 – 3.70 (m, 1H), 2.42 (s, 3H); 13C
NMR (125 MHz, (CD3)2CO) δ 160.0, 159.1, 158.0, 145.7, 138.4 (2), 130.8 (2), 129.4 (2),
129.3 (2), 128.6 (5), 128.5 (2), 128.1 (2), 106.1, 96.2, 93.3, 75.2, 70.6, 70.4, 70.2, 28.0, 21.5;
IR (KBr)νmax 3334, 2925, 1625, 1506, 1361, 1174, 1108, 1095, 975 cm−1; HRMS (ESI+)
m/z [M+H+] calcd for C30H31O7S, 535.1790, found 535.1773.
3-(4-(Benzyloxy)-2-hydroxyphenyl)-2-hydroxypropyl 4-methylbenzenesulfonate (21b)
Pyridine (0.46mL, 5.8 mmol) was added to a solution of 19b (500 mg, 1.37 mmol) and p-
toluenesulfonyl chloride (282 mg, 1.5 mmol) in dichloromethane (14 mL) at 0 °C. The
resulting mixture was stirred for 12 h at rt before quenching with 2N HCl (20mL). The
aqueous layer was extracted with dichloromethane (2 × 30 mL). The combined organic
layers were washed with saturated sodium chloride solution (40 mL), dried over anhydrous
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (SiO2,
2:5 EtOAc/Hexanes) to give 21b (.97g, 58.6 %) as a pale yellow oil: 1H NMR (500 MHz,
(CD3)2CO) δ 7.82 – 7.74 (m, 3H), 7.50 – 7.43 (m, 5H), 7.43 – 7.28 (m, 4H), 6.92 (d, J = 8.2
Hz, 1H), 6.48 (d, J = 2.5 Hz, 1H), 6.42 (dd, J = 8.3, 2.5 Hz, 1H), 4.17 – 3.97 (m, 3H), 3.89
(dd, J = 9.9, 6.7 Hz, 1H), 2.76 – 2.67 (m, 2H), 2.45 (s, 3H); 13C NMR (125 MHz,
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(CD3)2CO) δ 159.8 (2), 145.8, 138.6, 134.1, 132.8, 130.9, 130.8, 129.3 (2), 128.8, 128.7,
128.6 (2), 128.4, 106.8, 103.5, 74.3, 70.4, 70.3, 34.9, 21.5; IR (KBr)νmax 3348, 2928, 1627,
1361, 1174, 1108, 1096 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C23H25O6S, 429.1372,
found 429.1383.
3-(2-(Benzyloxy)-6-hydroxyphenyl)-2-hydroxypropyl 4-methylbenzenesulfonate (21c)
Pyridine (0.47 mL, 15.4 mmol) was added to a solution of 20c (410 mg, 1.5 mmol) and p-
toluenesulfonyl chloride (310 mg, 1.7 mmol) in dichloromethane (14 mL) at 0 °C. The
resulting mixture was stirred for 12 h at rt before quenching with 2N HCl (20mL). The
aqueous layer was extracted with dichloromethane (2 × 30mL). The combined organic
layers were washed with saturated sodium chloride solution (40 mL), dried over anhydrous
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (SiO2,
2:5 EtOAc/Hexanes) to give 21c (367 mg, 57 %) as a pale yellow oil and was used as is in
the next step.
5,7-Bis(benzyloxy)chroman-3-ol (22a)
Potassium carbonate (115 mg, 0.83 mmol) was added to a solution of 21a (277 mg, 0.58
mmol) in methanol (2.6 mL) and the resulting mixture was stirred for 6 h at rt. Methanol
was removed, the residue was partitioned between water (5 mL) and dichloromethane (5
mL) The aqueous layer was extracted with dichloromethane (2 × 5 mL). The combined
organic layers were washed with saturated sodium chloride solution, dried over anhydrous
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (SiO2,
1:5 EtOAc/Hexanes) to give 22a (86 mg, 46%) as a colorless oil: 1H NMR (500 MHz,
CDCl3) δ 7.45 – 7.37 (m, 8H), 7.34 (ddt, J = 7.4, 4.0, 1.7 Hz, 2H), 6.26 (d, J = 2.3 Hz, 1H),
6.18 (d, J = 2.3 Hz, 1H), 5.02 (s, 2H), 5.01 (s, 2H), 4.33 – 4.15 (m, 1H), 4.15 – 3.97 (m, 2H),
2.93 (dd, J = 17.0, 5.0 Hz, 1H), 2.75 (dd, J = 17.0, 4.5 Hz, 1H), 1.89 (brs, 1H); 13C NMR
(125 MHz, CDCl3) δ 158.9, 158.4, 155.2, 137.1, 137.1, 128.8 (2), 128.7, 128.7, 128.2,
128.1, 127.8, 127.7, 127.4 (2), 101.6, 94.8, 94.0, 70.3, 70.1, 69.8, 63.2, 28.4; IR (KBr)νmax
3392, 2925, 2871, 1616, 1591, 1496, 1456, 1145, 1122, 1062, 1027, 811, 696 cm−1; HRMS
(ESI+) m/z [M+H+] calcd for C23H23O4, 363.1596, found 363.1596.
7-(Benzyloxy)chroman-3-ol (22b)
Potassium carbonate (440 mg, 3.18 mmol) was added to a solution of 21a (830 mg, 1.98
mmol) in methanol (5 mL) and the resulting solution was stirred for 6 h at rt. Methanol was
removed, the residue was partitioned between water 105 mL) and dichloromethane (10 mL)
The aqueous layer was extracted with dichloromethane (2 × 10 mL). The combined organic
layers were washed with saturated sodium chloride solution, dried over anhydrous Na2SO4,
filtered and concentrated. The residue was purified by flash chromatography (SiO2, 1:5
EtOAc/Hexanes) to give desire product 22b (200 mg, 40 %) as a colorless oil: 1H NMR
(500 MHz, CDCl3) δ 7.51 – 7.30 (m, 5H), 7.04 (d, J = 8.0 Hz, 1H), 6.52 – 6.45 (m, 2H),
5.03 (s, 2H), 4.98 – 4.80 (m, 1H), 3.84 (dd, J = 12.0, 3.3 Hz, 1H), 3.74 (dd, J = 12.0, 6.4 Hz,
1H), 3.19 (dd, J = 15.1, 9.4 Hz, 1H), 2.94 (ddd, J = 15.1, 7.2, 1.2 Hz, 1H), 2.07 (brs,
1H); 13C NMR (125 MHz, CDCl3) δ 159.7, 137.2, 128.8 (2), 128.1 (2), 127.6, 125.2, 118.9,
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107.3, 97.5, 84.3, 70.5, 65.2, 30.8; IR (KBr)νmax 3382, 2927, 1614, 1494, 1145, 1029 cm−1;
HRMS (ESI+) m/z [M+Na+] calcd for C16H16NaO3, 279.0097, found 279.1002.
5-(Benzyloxy)chroman-3-ol (22c)
Potassium carbonate 21c (262 mg, 0.61 mmol), potassium carbonate (135 mg, 0.98 mmol)
in methanol (2 mL) and the resulting solution was stirred for 6 h at rt. Methanol was
removed, the residue was partitioned between water (5 mL) and dichloromethane (5 mL)
The aqueous layer was extracted with dichloromethane (2 × 5 mL). The combined organic
layers were washed with saturated sodium chloride solution, dried over anhydrous Na2SO4,
filtered and concentrated. The residue was purified by flash chromatography (SiO2, 1:5
EtOAc/Hexanes) to give desire product 22c (70 mg, 45 %) as a colorless oil: 1H NMR (500
MHz, CD3OD) δ 7.49 – 7.43 (m, 2H), 7.37 (ddd, J = 7.7, 6.4, 1.2 Hz, 2H), 7.30 (td, J = 7.1,
1.4 Hz, 1H), 7.01 (t, J = 8.2 Hz, 1H), 6.55 (dd, J = 8.3, 1.1 Hz, 1H), 6.43 (dd, J = 8.1, 1.1
Hz, 1H), 5.07 (s, 2H), 3.88 (ddd, J = 10.7, 6.4, 1.5 Hz, 1H), 2.99 (ddd, J = 17.3, 5.3, 1.6 Hz,
1H), 2.66 (dd, J = 17.1, 5.9 Hz, 1H); 13C NMR (125 MHz, CD3OD) δ 158.8, 156.3, 139.0,
129.5, 128.8, 128.3, 128.1 (2), 110.5, 110.3, 104.8 (2), 71.0, 70.3, 63.7, 29.3; IR (KBr)νmax
3388, 2928, 1616, 1591, 1496, 1146, 1061, 1027 cm−1; HRMS (ESI+) m/z [M+Na+] calcd
for C16H16NaO3, 279.0997, found 279.0993.
5,7-Dihydroxychroman-3-yl benzoate (23a)45
A solution of alcohol (14 mg, 0.04 mmol) in dichloromethane (0.5 mL) was added to a
stirred solution of benzoic acid (10 mg, 0.08 mmol), N,N′-dicyclohexylcarbodiimide (17
mg, 0.08 mmol) and 4-dimethylaminopyridine (4.8 mg, 0.04 mmol) in dichloromethane (1
mL) at 0 °C. The resulting solution was stirred for 6 h at rt and then filtered. The eluent was
diluted with dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL) and then saturated
sodium bicarbonate (2 × 4 mL) solution. The combined organic layers were washed with
saturated sodium chloride solution (4 mL), dried over anhydrous Na2SO4, filtered
concentrate. The residue was purified by flash chromatography (SiO2, 1:4 EtOAc/Hexanes)
to afford give 5,7-bis(benzyloxy)chroman-3-yl benzoate (16.2 mg, 90%) as a colorless oil,
which was used as for hydrogenolysis. 5,7-Bis(benzyloxy)chroman-3-yl benzoate (16.2 mg,
0.034 mmol) and palladium/carbon (10%) were suspended in tetrahydrofuran (2 mL) and
stirred for 18 h under a hydrogen atmosphere. The suspension was filtered through a small
plug of SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue purified
by flash chromatography (SiO2, 1:1 EtOAc/Hexanes) to give 23a (8 mg, 81.6 %) as a
colorless oil: 1H NMR (500 MHz, (CD3)2CO) δ 8.32 (s, 1H), 8.05 (s, 1H), 8.02 – 7.91 (m,
2H), 7.71 – 7.59 (m, 1H), 7.57 – 7.44 (m, 2H), 6.05 (d, J = 2.3 Hz, 1H), 5.91 (d, J = 2.3 Hz,
1H), 5.60 – 5.41 (m, 1H), 3.02 (ddd, J = 17.1, 5.3, 1.2 Hz, 1H), 2.90 – 2.83 (m, 1H); 13C
NMR (125 MHz, (CD3)2CO) δ 166.4, 157.9, 157.5, 156.5, 134.1, 131.3 (2), 130.3 (2),
129.5, 99.2, 96.5, 95.8, 67.4, 67.3, 25.6; IR (KBr)νmax 3385, 2933, 2840, 1716, 1622, 1593,
1496, 1452, 1272, 1201, 1145, 1056, 813, 711 cm−1; HRMS (ESI+) m/z [M+H+] calcd for
C16H14O5, 287.0919, found 287.0912.
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A solution of alcohol (14 mg, 0.04 mmol), in dichloromethane (0.5 mL) was added to a
stirred solution of 3-methoxybenzoic acid (12 mg, 0.08 mmol), N,N′-
dicyclohexylcarbodiimide (17 mg, 0.08 mmol) and 4-dimethylaminopyridine (4.8 mg, 0.04
mmol) in dichloromethane (1 mL) at 0 °C. The resulting solution was stirred for 6 h at rt and
then filtered The eluent was diluted with dichloromethane (5 mL), washed with 0.5N HCl (2
× 4 mL) and then with saturated sodium bicarbonate (2 × 4 mL) solution. The combined
organic layers were washed with saturated sodium chloride solution (4 mL), dried over
anhydrous Na2SO4, filtered and concentrated. The residue was purified by flash
chromatography (SiO2, 1:4 EtOAc/Hexanes) to afford give 5,7-bis(benzyloxy)chroman-3-yl
3-methoxybenzoate (18 mg, 89%) as a colorless oil, which was used as for hydrogenolysis.
5,7-bis(benzyloxy)chroman-3-yl 3-methoxybenzoate (18 mg) and palladium/carbon (10%)
were suspended in tetrahydrofuran (2 mL) and stirred for 18 h under hydrogen atmosphere.
The suspension was filtered through a small plug of SiO2 (40 – 63 μm particle size). The
eluent was concentrated and the residue purified by flash chromatography (SiO2, 1:1 EtOAc/
Hexanes) to give 23b (11 mg, 96 %) as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.60
(ddd, J = 7.7, 1.5, 1.0 Hz, 1H), 7.53 (dd, J = 2.7, 1.5 Hz, 1H), 7.32 (t, J = 8.0 Hz, 1H), 7.09
(ddd, J = 8.3, 2.7, 1.0 Hz, 1H), 6.03 (d, J = 2.3 Hz, 1H), 5.99 (d, J = 2.4 Hz, 1H), 5.54 – 5.45
(m, 1H), 5.43 – 5.33 (m, 1H), 5.24 (s, 1H), 4.29 (ddd, J = 11.4, 5.0, 1.8 Hz, 1H), 4.20 (ddd, J
= 11.4, 2.3, 1.0 Hz, 1H), 3.04 (ddd, J = 16.9, 5.4, 1.2 Hz, 1H), 2.88 (ddd, J = 16.9, 4.5, 1.7
Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 166.3, 159.7, 155.7, 155.4, 155.3, 131.3, 129.7,
122.4, 119.8, 114.6, 99.5, 96.3, 96.1, 66.9, 66.2, 55.7, 24.9; IR (KBr)νmax 3404, 2960, 1716,
1596, 1469, 1278, 1224, 1099, 933, 752 cm−1; HRMS (ESI−) m/z [M−H−] calcd for
C17H15O6, 315.0869, found 315.0830.
5,7-Dihydroxychroman-3-yl 4-methoxybenzoate (23c)
A solution of 22a (13 mg, 0.036 mmol) in dichloromethane (0.5 mL) was added to a stirred
solution of 4-methoxybenzoic acid (11 mg, 0.072 mmol), N,N′-dicyclohexylcarbodiimide
(17 mg, 0.08 mmol) and 4-dimethylaminopyridine (4.8 mg, 0.04 mmol) in dichloromethane
(1 mL) at 0 °C. The resulting solution was stirred for 6 h at rt and then filtered. The eluent
was diluted with dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL) and then with
saturated sodium bicarbonate (2 × 4 mL) solution. The combined organic layers were
washed with saturated sodium chloride solution (4 mL), dried over anhydrous Na2SO4,
filtered and concentrated. The residue was purified by flash chromatography (SiO2, 1:4
EtOAc/Hexanes) to afford 5,7-bis(benzyloxy)chroman-3-yl 4-methoxybenzoate (16.7 mg,
93.8%) as a colorless oil, which was used as for hydrogenolysis. 5,7-
bis(benzyloxy)chroman-3-yl 4-methoxybenzoate (16.2 mg, 0.033 mmol) and palladium/
carbon (10%) were suspended in tetrahydrofuran (2 mL) and stirred for 18 h under a
hydrogen atmosphere. The suspension was filtered through a small plug of SiO2 (40 – 63 μm
particle size). The eluent was concentrated and the residue purified by flash chromatography
(SiO2, 1:1 EtOAc/Hexanes) to give 23c (10 mg, 98 %) as colorless oil: 1H NMR (500 MHz,
(CD3)2CO) δ 8.30 (s, 1H), 8.04 (s, 1H), 7.99 – 7.88 (m, 2H), 7.03 – 6.94 (m, 2H), 6.05 (d, J
= 2.3 Hz, 1H), 5.90 (d, J = 2.3 Hz, 1H), 5.42 (dtd, J = 5.4, 4.5, 2.2 Hz, 1H), 4.24 (ddd, J =
11.4, 4.7, 1.9 Hz, 1H), 4.19 (ddt, J = 11.5, 1.9, 0.9 Hz, 1H), 3.86 (s, 3H), 3.00 (ddd, J = 17.2,
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5.3, 1.2 Hz, 1H), 2.83 (ddd, J = 17.2, 4.4, 1.9 Hz, 1H); 13C NMR (125 MHz, (CD3)2CO) δ
166.1 (2), 164.6, 157.8, 157.5, 156.5, 132.4 (2), 123.5, 114.7, 99.2, 96.5, 95.7, 67.3, 66.9,
56.0, 25.6; IR (KBr)νmax 3404, 2958, 1716, 1596, 14266, 1284 1224, 1098 cm−1; HRMS
(ESI+) m/z [M+H+] calcd for C17H17O6, 317.1025, found 317.1029.
5,7-Dihydroxychroman-3-yl 3,4-dimethoxybenzoate (23d)
A solution of 22a (12 mg, 0.033 mmol) in dichloromethane (0.5 mL) was added to a stirred
solution of 4-methoxybenzoic acid 3,4-methoxybenzoic acid (14 mg, 0.066 mmol), N,N′-
dicyclohexylcarbodiimide (14 mg, 0.066 mmol) and 4-dimethylaminopyridine (4.8 mg, 0.04
mmol) in dichloromethane (1 mL) at 0 °C. The resulting solution was stirred for 6 h at rt and
then filtered. The eluent was diluted with dichloromethane (5 mL), washed with 0.5N HCl
(2 × 4 mL) and then with saturated sodium bicarbonate (2 × 4 mL) solution. The combined
organic layers were washed with saturated sodium chloride solution (4 mL), dried over
anhydrous Na2SO4, filtered and the solvent removed. The residue was purified by flash
chromatography (SiO2, 1:4 EtOAc/Hexanes) to afford 5,7-bis(benzyloxy)chroman-3-yl 3,4-
methoxybenzoate (17 mg, 95%) as colorless oil which was used as for hydrogenolysis. 5,7-
bis(benzyloxy)chroman-3-yl 3,4-methoxybenzoate (17 mg, 0.032 mmol) and palladium/
carbon (10%) were suspended in tetrahydrofuran (2 mL) and stirred for 18 h under a
hydrogen atmosphere. The suspension was filtered through a small plug of SiO2 (40 – 63 μm
particle size). The eluent was concentrated and the residue purified by flash chromatography
(SiO2, 1:1 EtOAc/Hexanes) to give 23d (9.5 mg, 86 %) as colorless oil: 1H NMR (500
MHz, (CD3)2CO) δ 8.30 (s, 1H), 8.04 (s, 1H), 7.58 (dd, J = 8.5, 2.0 Hz, 1H), 7.50 (d, J = 2.0
Hz, 1H), 7.02 (d, J = 8.5 Hz, 1H), 6.05 (d, J = 2.3 Hz, 1H), 5.90 (d, J = 2.3 Hz, 1H), 5.41
(qd, J = 4.7, 2.5 Hz, 1H), 4.21 (td, J = 4.2, 3.5, 1.4 Hz, 2H), 3.87 (s, 4H), 3.83 (s, 3H), 3.01
(ddd, J = 17.1, 5.3, 1.1 Hz, 1H), 2.88 – 2.73 (m, 1H); 13C NMR (125 MHz (CD3)2CO) δ
166.2, 157.9, 157.5, 156.6, 154.7, 150.0, 124.4, 123.5, 113.2, 111.8, 99.3, 96.5, 95.7, 78.1,
67.1, 56.3, 56.2, 25.7; IR (KBr)νmax 3404, 2921, 1699, 1515, 1271, 1145, 1022, 761, 667
cm−1; HRMS (ESI+) m/z [M+H+] calcd for C18H19O7, 347.1131, found 347.1128.
5,7-Dihydroxychroman-3-yl 3,5-dimethoxybenzoate (23e)
A solution of 22a (13 mg, 0.036 mmol), in dichloromethane (0.5 mL) was added to a stirred
solution of 4-methoxybenzoic acid 3,5-dimethoxybenzoic acid (13 mg, 0.072 mmol), N,N′-
dicyclohexylcarbodiimide (17 mg, 0.08 mmol)and 4-dimethylaminopyridine (4.8 mg, 0.04
mmol) in dichloromethane (1 mL) at 0 °C. The resulting solution was stirred for 6 h at rt and
then filtered. The eluent was diluted with dichloromethane (5 mL), washed with 0.5N HCl
(2 × 4 mL) and then with saturated sodium bicarbonate (2 × 4 mL) solution. The combined
organic layers were washed with saturated sodium chloride solution (4 mL), dried over
anhydrous Na2SO4, filtered and concentrated. The residue was purified by flash
chromatography (SiO2, 1:4 EtOAc/Hexanes) to afford 5,7-bis(benzyloxy)chroman-3-yl 3,5-
dimethoxybenzoate (17.8 mg, 94.6%) as a colorless oil, which was used as for
hydrogenolysis. 5,7-bis(benzyloxy)chroman-3-yl 3,5-methoxybenzoate (17 mg, 0.032
mmol) and palladium/carbon (10%) were suspended in tetrahydrofuran (2 mL) and stirred
for 18 h under a hydrogen atmosphere. The suspension was filtered through a small plug of
SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue purified by
flash chromatography (SiO2, 1:1 EtOAc/Hexanes) to give 23e (9.5 mg, 86 %) as colorless
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oil: 1H NMR (500 MHz, (CD3)2CO) δ 8.31 (s, 1H), 8.04 (s, 1H), 7.10 (d, J = 2.4 Hz, 2H),
6.72 (t, J = 2.4 Hz, 1H), 6.05 (d, J = 2.3 Hz, 1H), 5.90 (d, J = 2.3 Hz, 1H), 5.53 – 5.35 (m,
1H), 4.32 – 4.16 (m, 2H), 3.15 – 2.95 (m, 1H), 2.86 – 2.82 (m, 1H); 13C NMR (125 MHz,
(CD3)2CO) δ 166.1, 161.8 (2), 157.8, 157.4, 156.4, 133.2, 108.1 (2), 105.6, 99.1, 96.4, 95.6,
77.1, 67.5, 67.2, 55.9, 25.5; IR (KBr)νmax 1916, 2848, 1702, 1683, 1558, 1244, 1145, 1103,
cm−1; HRMS (ESI+) m/z [M+Na+] calcd for C18H18NaO7, 369.0950, found 369.0962.
5,7-Dihydroxychroman-3-yl 3-hydroxybenzoate (23f)45
A solution of 22a (14 mg, 0.039 mmol) in dichloromethane (0.5 mL) was added to a stirred
solution of 4-(benzyloxy)benzoic acid (13 mg, 0.072 mmol), N,N′-
dicyclohexylcarbodiimide (16 mg, 0.077 mmol)and 4-dimethylaminopyridine (4.8 mg, 0.04
mmol) in dichloromethane (1 mL) at 0 °C. The resulting solution was stirred for 6 h at rt
then filtered. The eluent was diluted with dichloromethane (5 mL), washed with 0.5N HCl
(2 × 4 mL) and saturated sodium bicarbonate (2 × 4 mL) solution. The combined organic
layers were washed with saturated sodium chloride solution (4 mL), dried over anhydrous
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (SiO2,
1:4 EtOAc/Hexanes) to afford 5,7-bis(benzyloxy)chroman-3-yl 3-(benzyloxy)benzoate (19
mg, 86.3 %), which was used further as obtained. 5,7-bis(benzyloxy)chroman-3-yl 3-
(benzyloxy)benzoate (18 mg, 0.031 mmol) and palladium/carbon (10%) were suspended in
tetrahydrofuran (2 mL) and stirred for 18 h under a hydrogen atmosphere. The suspension
was filtered through a small plug of SiO2 (40 – 63 μm particle size). The eluent was
concentrated and the residue purified by flash chromatography (SiO2, 1:9 Acetone/
Dichloromethane) to give 23f (8.6 mg, 92.6 %) as a colorless oil: 1H NMR (500 MHz,
MeOD) δ 7.83 (d, J = 8.8 Hz, 1H), 6.79 (d, J = 8.8 Hz, 1H), 5.94 (d, J = 2.3 Hz, 1H), 5.84
(d, J = 2.3 Hz, 1H), 5.37 (ddd, J = 5.3, 4.5, 2.7 Hz, 1H), 4.19 (ddd, J = 11.4, 4.9, 1.8 Hz,
1H), 4.14 (dd, J = 11.4, 2.1 Hz, 1H), 2.95 (ddd, J = 17.1, 5.4, 1.1 Hz, 1H), 2.77 (ddd, J =
17.1, 4.5, 1.7 Hz, 1H); 13C NMR (125 MHz, (CD3)2CO) δ 166.2, 158.3, 157.7, 157.4, 156.4,
132.6, 130.5, 121.5, 121.0, 116.7, 99.1, 96.3, 95.6, 67.6, 67.2, 25.5; IR (KBr)νmax 3384,
2910, 1848, 1699, 1436, 1290, 1145 cm−1; HRMS (ESI−) m/z [M−H−] calcd for C16H13O6,
301.0712, found 301.0717.
5,7-Bis(benzyloxy)chroman-3-yl 4-(benzyloxy)benzoate (23g)36
A solution of 22a (14 mg, 0.039 mmol) in dichloromethane (0.5 mL) was added to a stirred
solution of 4-(benzyloxy)benzoic acid (13 mg, 0.072 mmol), N,N′-
dicyclohexylcarbodiimide (16 mg, 0.077 mmol)and 4-dimethylaminopyridine (4.8 mg, 0.04
mmol) in dichloromethane (1 mL) at 0 °C. The resulting solution was stirred for 6 h at rt and
filtered. The eluent was diluted with dichloromethane (5 mL), washed with 0.5N HCl (2 × 4
mL) and then with saturated sodium bicarbonate (2 × 4 mL) solution. The combined organic
layers were washed with saturated sodium chloride solution (4 mL), dried over anhydrous
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (SiO2,
1:4 EtOAc/Hexanes) to afford 5,7-bis(benzyloxy)chroman-3-yl 4-(benzyloxy)benzoate (20
mg, 90.4 %) as a colorless oil, which was used as for hydrogenolysis. 5,7-
bis(benzyloxy)chroman-3-yl 3-(benzyloxy)benzoate (18 mg, 0.031 mmol) and palladium/
carbon (10%) were suspended in tetrahydrofuran (2 mL) and stirred for 18 h under a
hydrogen atmosphere. The suspension was filtered through a small plug of SiO2 (40 – 63 μm
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particle size). The eluent was concentrated and the residue purified by flash chromatography
(SiO2, 1:1 EtOAc/Hexanes) to give 23g (9.8 mg, 97%) as a colorless oil: 1H NMR (500
MHz, (CD3)2CO) δ 9.15 (s, 1H), 8.29 (s, 1H), 8.03 (s, 1H), 7.85 (d, J = 8.7 Hz, 2H), 6.97 –
6.83 (m, 2H), 6.05 (d, J = 2.3 Hz, 1H), 5.90 (d, J = 2.3 Hz, 1H), 5.57 – 5.28 (m, 1H), 4.23
(ddd, J = 11.4, 4.7, 1.8 Hz, 1H), 4.18 (ddt, J = 11.4, 2.1, 0.9 Hz, 1H), 2.99 (ddd, J = 17.0,
5.4, 1.1 Hz, 1H), 2.82 (ddd, J = 17.0, 4.4, 1.7 Hz, 1H); 13C NMR (125 MHz, (CD3)2CO) δ
166.2, 160.7, 159.8, 159.4, 156.1, 133.1, 108.7, 108.1, 101.1, 94.2, 92.2, 67.3, 66.8, 55.8,
55.5, 25.3; IR (KBr)νmax 3363, 2962, 2927, 1683, 1608, 1355, 1272, 1166, 1143, 1099,
1014, 769 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C16H15O6, 303.0869, found
303.0878.
5,7-Dihydroxychroman-3-yl 3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxylate (23h)
A solution of 22a (11 mg, 0.03 mmol) in dichloromethane (0.5 mL) was added to a stirred
solution of 3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxylic acid (16 mg, 0.06 mmol), N,N′-
dicyclohexylcarbodiimide (13 mg, 0.06 mmol) and 4-dimethylaminopyridine (4.8 mg, 0.04
mmol) in dichloromethane (1 mL) 0 °C. The resulting solution was stirred for 6 h at rt and
filtered. The eluent was diluted with dichloromethane (5 mL), washed with 0.5N HCl (2 × 4
mL) and then with saturated sodium bicarbonate (2 × 4 mL) solution. The combined organic
layers were washed with saturated sodium chloride solution (4 mL), dried over anhydrous
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (SiO2,
EtOAc/Hexanes) to afford 5,7-bis(benzyloxy)chroman-3-yl 3′,6-dimethoxy-[1,1′-
biphenyl]-3-carboxylate (17.5 mg, 96.1%) as a colorless oil, which was used as for
hydrogenolysis. 5,7-bis(benzyloxy)chroman-3-yl 3′,6-dimethoxy-[1,1′-biphenyl]-3-
carboxylate (17 mg, 0.028 mmol) and palladium/carbon (10%) were suspended in
tetrahydrofuran (2 mL) and stirred for 18 h under a hydrogen atmosphere. The suspension
was filtered through a small plug of SiO2 (40 – 63 μm particle size). The eluent was
concentrated and the residue purified by flash chromatography (SiO2, 1:1 EtOAc/Hexanes)
to give 23h (11.1 mg, 93.2 %) as a colorless oil: 1H NMR (500 MHz, (CD3)2CO) δ 7.97 (dd,
J = 8.7, 2.2 Hz, 1H), 7.92 (d, J = 2.2 Hz, 1H), 7.37 – 7.29 (m, 1H), 7.19 (d, J = 8.7 Hz, 1H),
7.10 – 7.00 (m, 2H), 6.91 (ddd, J = 8.3, 2.6, 1.1 Hz, 1H), 6.04 (d, J = 2.3 Hz, 1H), 5.89 (d, J
= 2.3 Hz, 1H), 5.50 – 5.35 (m, 1H), 4.33 – 4.23 (m, 1H), 4.22 – 4.18 (m, 1H), 3.89 (s, 4H),
3.81 (s, 3H), 3.01 (ddd, J = 17.1, 5.3, 1.2 Hz, 1H), 2.92 – 2.80 (m, 1H); 13C NMR (125
MHz, (CD3)2CO) δ 166.0, 161.4, 160.4, 157.8, 157.4, 156.5, 139.9, 132.7, 131.7, 131.3,
129.9, 123.5, 122.5, 116.0, 113.6, 112.1, 99.2, 96.4, 95.7, 67.3, 67.0, 55.5 (2), 25.6; IR
(KBr)νmax 3355, 2923, 1701, 1606,1458, 1251, 1145, 1031, 752, 667 cm−1; HRMS (ESI+)
m/z [M+H+] calcd for C24H23O7, 423.1444, found 423.1454.
5,7-Dihydroxychroman-3-yl 4-acetoxy-3-(3-methylbut-2-en-1-yl)benzoate (23i)
4-Acetoxy-3-(3-methylbut-2-en-1-yl)benzoic acid (34 mg, 0.137 mmol) and thionyl chloride
(33 μL, 0.27 mmol) in tetrahydrofuran (5 mL) was heated at reflux for 3 h, cooled to rt and
concentrated. The residue was dissolved in dichloromethane (0.5 mL) and added to a stirred
solution of 22a (25 mg, 0.069 mmol) in dichloromethane (0.7 mL) with triethylamine (0.3
mL) under at 0°C. The resulting mixture was stirred for 6 h, concentrated and the residue
was purified by flash chromatography (SiO2, 1:4 EtOAc/Hexanes) to give 5,7-
bis(benzyloxy)chroman-3-yl 4-acetoxy-3-(3-methylbut-2-en-1-yl)benzoate (34 mg, 85 %) as
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colorless a oil, which was used as for hydrogenolysis. A solution of palladium acetate (5 mg,
0.023 mg), triethylamine (15μL, 0.108 mmol), triethylsilane (82μL, 0.108) in
dichloromethane (0.8 mL) was stirred for 15 minutes before the slow addition of a solution
of bis(benzyloxy)chroman-3-yl 4-acetoxy-3-(3-methylbut-2-en-1-yl)benzoate (34 mg, 0.057
mmol) in dichloromethane (0.4 mL). The resulting mixture was stirred for 15 h, quenched
with saturated ammonium chloride (2 mL) and extracted with ether (3 × 4 mL). The
combined organic layers were washed with saturated sodium chloride solution, dried over
anhydrous Na2SO4, filtered and concentrated. The residue was purified by flash
chromatography (silica, 5:95 MeOH/DCM) to afford 23i as a colorless oil: 1H NMR (500
MHz, CDCl3): δ 7.92 (dd, J = 13.7, 2.2 Hz, 1H), 7.86 (dd, J = 8.4, 2.2 Hz, 1H), 7.06 (d, J =
8.4 Hz, 1H), 6.03 – 5.99 (m, 1H), 5.96 (d, J = 2.4 Hz, 1H), 5.50 (ddt, J = 7.2, 4.8, 2.4 Hz,
1H), 5.18 (dddd, J = 7.3, 5.8, 2.9, 1.5 Hz, 1H), 4.29 (ddd, J = 11.5, 4.9, 1.9 Hz, 1H), 4.24 –
4.14 (m, 1H), 3.25 (d, J = 7.2 Hz, 2H), 3.07 – 2.98 (m, 1H), 2.87 (ddd, J = 16.9, 4.4, 1.8 Hz,
1H), 2.32 (s, 3H), 1.72 (q, J = 1.3 Hz, 2H), 1.68 (d, J = 1.4 Hz, 3H); 13C NMR (125 MHz,
CDCl3) δ 169.1, 165.7, 155.4, 155.3 (2), 152.9, 134.2, 134.1, 132.2, 129.0, 127.9, 122.6,
121.0, 99.4, 96.3, 96.0, 66.9, 65.9, 28.9, 25.9, 24.9, 21.1, 18.1; IR (KBr)νmax 3363, 2921,
1703, 1606, 1252, 1146 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C23H25O7, 413.1600,
found 413.1617.
7-Hydroxychroman-3-yl 4-methoxybenzoate (23j)
A solution of 22b (15 mg, 0.06 mmol) in dichloromethane (0.5 mL) was added to a stirred
solution benzoic acid (14 mg, 0.12 mmol), N,N′-dicyclohexylcarbodiimide (24 mg, 0.12
mmol) and 4-dimethylaminopyridine (7.2 mg, 0.06 mmol) at 0 °C. The resulting solution
was stirred for 6 h at rt and then filtered. The eluent was diluted with dichloromethane (5
mL), washed with 0.5N HCl (2 × 4 mL) and then with saturated sodium bicarbonate (2 × 4
mL) solution. The combined organic layers were washed with saturated sodium chloride
solution (4 mL), dried over anhydrous Na2SO4, filtered and concentrated. The residue was
purified by flash chromatography (SiO2, 1:8 EtOAc/Hexanes) to afford 7-
(benzyloxy)chroman-3-yl benzoate as a colorless oil (21 mg, 90%), which was used as for
hydrogenolysis. 7-(benzyloxy)chroman-3-yl benzoate (14 mg, 0.04 mmol) and palladium/
carbon (10%) were suspended in tetrahydrofuran (2 mL) and stirred for 18 h under a
hydrogen atmosphere. The suspension was filtered through a small plug of SiO2 (40 – 63 μm
particle size). The eluent was concentrated and the residue purified by flash chromatography
(SiO2, 1:1 EtOAc/Hexanes) to give 23j (11.1 mg, 90.4 %) as a colorless oil: 1H NMR (500
MHz, CDCl3) δ 8.04 – 7.93 (m, 2H), 7.54 (ddt, J = 8.7, 7.7, 1.3 Hz, 1H), 7.40 (ddt, J = 7.3,
6.3, 1.0 Hz, 2H), 6.92 (dt, J = 8.1, 0.9 Hz, 1H), 6.42 (dd, J = 8.2, 2.6 Hz, 1H), 6.38 (d, J =
2.5 Hz, 1H), 5.49 (qd, J = 4.8, 2.2 Hz, 1H), 4.71 (s, 1H), 4.32 (ddd, J = 11.5, 4.8, 1.9 Hz,
1H), 4.23 (dtd, J = 11.5, 1.5, 0.8 Hz, 1H), 3.18 (ddt, J = 16.6, 5.1, 1.1 Hz, 1H), 3.02 – 2.89
(m, 1H); 13C NMR (125 MHz, CDCl3) δ 166.3, 155.3, 154.8, 133.4, 130.8 (2), 130.1, 130.0,
128.6 (2), 111.4, 108.9, 103.5, 67.1, 66.4, 29.8; IR (KBr)νmax 3392, 2925, 1716, 1699,
1519, 1456, 1272, 1145, 1027, 1016, 821, 711cm−1; HRMS (ESI−) m/z [M+H+] calcd for
C16H15O4, 271.0970, found 271.0966.
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A solution of 22b (11 mg, 0.04 mmol) in dichloromethane (0.5 mL) was added to a stirred
solution 3-methoxybenzoic acid (12 mg, 0.08 mmol), N,N′-dicyclohexylcarbodiimide (17
mg, 0.08 mmol)and 4-dimethylaminopyridine (5 mg, 0.04 mmol) under argon at 0 °C. The
resulting solution was stirred for 6 h at rt and then filtered. The eluent was diluted with
dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL) and saturated sodium
bicarbonate (2 × 4 mL) solution. The combined organic layers were washed with saturated
sodium chloride solution (4 mL), dried over anhydrous Na2SO4, filtered and concentrated.
The residue was purified by flash chromatography (SiO2, 1:8 EtOAc/Hexanes) to afford 7-
(benzyloxy)chroman-3-yl 3-methoxybenzoate (15 mg, 89.5) as a colorless oil, which was
used as for hydrogenolysis. 7-(benzyloxy)chroman-3-yl 3-methoxybenzoate (11 mg, 0.028
mmol) and palladium/carbon (10%) were suspended in tetrahydrofuran (2 mL) and stirred
for 18 h under a hydrogen atmosphere. The suspension was filtered through a small plug of
SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue purified by
flash chromatography (SiO2, 1:1 EtOAc/Hexanes) to give 23k (7.5 mg, 89.4 %) as a
colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.58 (dt, J = 7.7, 1.2 Hz, 1H), 7.52 (dd, J = 2.7,
1.5 Hz, 1H), 7.31 (t, J = 8.0 Hz, 1H), 7.09 (ddd, J = 8.2, 2.7, 1.0 Hz, 1H), 6.92 (dt, J = 8.2,
1.0 Hz, 1H), 6.43 (dd, J = 8.2, 2.5 Hz, 1H), 6.39 (d, J = 2.5 Hz, 1H), 5.49 (qd, J = 4.9, 2.3
Hz, 1H), 4.81 (brs, 1H), 4.32 (ddd, J = 11.5, 4.9, 1.9 Hz, 1H), 4.24 (ddt, J = 11.4, 1.8, 1.0
Hz, 1H), 3.19 (ddt, J = 16.7, 5.2, 1.2 Hz, 1H), 3.03 – 2.84 (m, 1H); 13C NMR (125 MHz,
CDCl3) δ 166.2, 159.7, 155.3, 154.8, 131.4, 130.9, 129.6, 122.4, 119.8, 114.5, 111.3, 108.9,
103.5, 67.1, 66.5, 55.7, 29.9; IR (KBr)νmax 3384, 2910, 2848, 1701, 1635, 1508, 1259,
1164, 1116, 667 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C17H17O5, 301.1076, found
301.1076.
7-Hydroxychroman-3-yl 4-methoxybenzoate (23l)
A solution of 22b (11 mg, 0.04 mmol) in dichloromethane (0.5 mL) was added to a stirred
solution 4-methoxybenzoic acid (12 mg, 0.08 mmol), N,N′-dicyclohexylcarbodiimide (17
mg, 0.08 mmol) and 4-dimethylaminopyridine (4.8 mg, 0.04 mmol) under argon at 0 °C.
The resulting solution was stirred for 6 h at rt and then filtered. The eluent was diluted with
dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL) and then with saturated sodium
bicarbonate (2 × 4 mL) solution. The combined organic layers were washed with saturated
sodium chloride solution (4 mL), dried over anhydrous Na2SO4, filtered and concentrated.
The residue was purified by flash chromatography (SiO2, 1:8 EtOAc/Hexanes) to afford 7-
(benzyloxy)chroman-3-yl 4-methoxybenzoate (15.5 mg, 79.2 %) as a colorless oil, which
was used as for hydrogenolysis. 7-(Benzyloxy)chroman-3-yl 4-methoxybenzoate (11 mg,
0.028 mmol) and palladium/carbon (10%) were suspended in tetrahydrofuran (2 mL) and
stirred for 18 h under a hydrogen atmosphere. The suspension was filtered through a small
plug of SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue purified
by flash chromatography (SiO2, 1:1 EtOAc/Hexanes) to give 23l (8 mg, 94.3 %) as a
colorless oil: 1H NMR (500 MHz, CDCl3) δ 8.00 – 7.88 (m, 2H), 6.93 (dt, J = 8.3, 0.9 Hz,
1H), 6.91 – 6.87 (m, 2H), 6.43 (dd, J = 8.2, 2.5 Hz, 1H), 6.39 (d, J = 2.5 Hz, 1H), 5.48 (qd, J
= 4.8, 2.2 Hz, 1H), 4.78 (brs, 1H), 4.32 (ddd, J = 11.5, 4.9, 1.9 Hz, 1H), 4.23 (dtd, J = 11.5,
1.5, 0.8 Hz, 1H), 3.85 (s, 3H), 3.18 (ddt, J = 16.5, 5.0, 1.2 Hz, 1H), 2.95 (dtd, J = 16.7, 2.4,
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1.3 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 166.0, 163.7, 155.3, 154.8, 132.0, 130.9 (2),
122.5 (2), 113.8, 111.5, 108.8, 103.5, 67.2, 66.0, 55.7, 29.9; IR (KBr)νmax 3392, 2918,
2848, 1701, 1606, 1510, 1458, 1259, 1164, 1108, 1022 cm−1; HRMS (ESI+) m/z [M+H+]
calcd for C17H17O5, 301.1076, found 301.1071.
7-Hydroxychroman-3-yl 3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxylate (23m)
A solution of 22b (10 mg, 0.039 mmol)in dichloromethane (0.5 mL) was added to a stirred
solution 4-methoxybenzoic acid (12 mg, 0.08 mmol), N,N′-dicyclohexylcarbodiimide (17
mg, 0.08 mmol)a nd 4-dimethylaminopyridine (4.8 mg, 0.04 mmol) under argon at 0 °C.
The resulting solution was stirred for 6 h at rt and then filtered. The filtrate was diluted with
dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL) and then with saturated sodium
bicarbonate (2 × 4 mL) solution. The combined organic layers were washed with saturated
sodium chloride solution (4 mL) dried over anhydrous Na2SO4, filtered and concentrated.
The residue was purified by flash chromatography (SiO2, 1:8 EtOAc/Hexanes) to afford 7-
(benzyloxy)chroman-3-yl 3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxylate (17 mg, 87.4 %) as
a colorless oil, which was used further as for hydrogenolysis. 7-(benzyloxy)chroman-3-yl 3′,
6-dimethoxy-[1,1′-biphenyl]-3-carboxylate (12 mg, 0.024 mmol) and palladium/carbon
(10%) were suspended in tetrahydrofuran (2 mL) and stirred for 18 h under a hydrogen
atmosphere. The suspension was filtered through a small plug of SiO2 (40 – 63 μm particle
size). The eluent was concentrated and the residue purified by flash chromatography (SiO2,
1:1 EtOAc/Hexanes) to give 23m (9 mg, 91.4 %) as colorless oil: 1H NMR (500 MHz,
CDCl3) δ 8.01 – 7.94 (m, 2H), 7.34 (t, J = 7.9 Hz, 1H), 7.10 – 7.05 (m, 1H), 7.03 (dd, J =
2.6, 1.6 Hz, 1H), 6.97 (d, J = 8.6 Hz, 1H), 6.95 – 6.88 (m, 2H), 6.42 (dd, J = 8.2, 2.6 Hz,
1H), 6.38 (d, J = 2.5 Hz, 1H), 4.73 (brs, 1H), 4.31 (ddd, J = 11.4, 5.1, 1.8 Hz, 1H), 4.24
(ddd, J = 11.5, 2.4, 1.1 Hz, 1H), 3.87 (s, 3H), 3.84 (s, 3H), 3.19 (ddt, J = 16.6, 5.0, 1.2 Hz,
1H), 3.03 – 2.90 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 166.0, 160.6, 159.5, 155.3, 154.8,
138.9, 132.7, 131.3, 130.9, 130.6, 129.3, 122.5, 122.2, 115.5, 113.1, 111.5, 110.8, 108.9,
103.5, 67.2, 66.2, 56.0, 55.5, 30.0; IR (KBr)νmax 3411, 2921, 1701, 1598, 1510, 1278, 1224,
1155, 1116, 1043, 754 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C24H23O6, 407.1495,
found 407.1475.
7-Hydroxychroman-3-yl 4-acetoxy-3-(3-methylbut-2-en-1-yl)benzoate (23n)
4-acetoxy-3-(3-methylbut-2-en-1-yl)benzoic acid (39 mg, 0.156 mmol) and thionyl chloride
(38 μL, 0.312 mmol) in THF (5 mL) were heated at reflux for 3 h under argon, cooled to rt
and concentrated. The residue was dissolved in dichloromethane (0.5 mL) and added drop
wise to a stirred solution of 22b (20 mg, 0.078) in dichloromethane (0.7 mL) with
triethylamine (0.3 mL) under argon at 0 °C. The resulting mixture was stirred for and stirred
for 6 h at rt before solvent was removed. The residue was purified by flash chromatography
(SiO2 1:4 EtOAc/Hexanes) to give 7-benzyloxychroman-3-yl 4-acetoxy-3-(3-methylbut-2-
en-1-yl)benzoate (26 mg, 84 %) as q colorless oil, which was used as for hydrogenolysis. A
solution of palladium acetate (1.3 mg, 0.006 mg), triethylamine (4μL, 0.03 mmol),
triethylsilane (24 μL, 0.15) in dichloromethane (0.8 mL) was stirred for 15 minutes under
argon before the addition of a solution of 7-benzyloxychroman-3-yl 4-acetoxy-3-(3-
methylbut-2-en-1-yl)benzoate (15 mg, 0.03 mmol) in dichloromethane (0.4 mL). The
resulting mixture was stirred for 15 h, quenched with saturated ammonium chloride (2 mL)
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and extracted with ether (3 × 4 mL). The combined organic layers were washed with
saturated sodium chloride solution, dried over anhydrous Na2SO4, filtered and concentrated
solvent. The residue was purified by flash chromatography (SiO2, 1:2 EtOAc/Hexanes) to
give 23n as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.88 (d, J = 2.1 Hz, 1H), 7.84 (dd,
J = 8.4, 2.2 Hz, 1H), 7.06 (d, J = 8.4 Hz, 1H), 6.92 (dt, J = 8.3, 0.9 Hz, 1H), 6.46 – 6.40 (m,
1H), 6.38 (d, J = 2.5 Hz, 1H), 5.49 (qd, J = 4.7, 2.2 Hz, 1H), 5.17 (dddt, J = 7.3, 5.9, 2.9, 1.4
Hz, 1H), 4.63 (s, 1H), 4.32 (ddd, J = 11.5, 4.8, 1.9 Hz, 1H), 4.22 (dt, J = 11.4, 1.6 Hz, 1H),
3.24 (d, J = 7.2 Hz, 2H), 3.18 (ddt, J = 16.7, 5.1, 1.2 Hz, 1H), 2.94 (ddd, J = 16.5, 4.7, 1.8
Hz, 1H), 2.32 (s, 3H), 1.72 (q, J = 1.3 Hz, 3H), 1.67 (d, J = 1.3 Hz, 3H); 13C NMR (125
MHz, CDCl3) δ 167.8, 164.4, 154.0, 153.6, 151.7, 132.9, 130.9, 129.6 (2), 127.7, 126.7 (2),
121.4, 119.7, 110.1, 107.6, 102.2, 65.8, 65.1, 28.7, 27.7, 24.6, 19.8, 16.8; IR (KBr)νmax
3419, 2823, 2854, 1716, 1596, 1456, 1286, 1201, 1163, 1054, 796 cm−1; HRMS (ESI−) m/z
[M+H+] calcd for C23H25O6, 397.1651, found 397.1642.
5-Hydroxychroman-3-yl benzoate (23o)
A solution of 22c (9 mg, 0.035 mmol), in dichloromethane (0.5 mL) was added to a stirred
solution of benzoic acid (8.6 mg, 0.07 mmol), N,N′-dicyclohexylcarbodiimide (23 mg, 0.11
mmol) and 4-dimethylaminopyridine (4.2 mg, 0.035 mmol) under argon at 0 °C. The
resulting solution was stirred for 6 h at rt and then filtered. The filtrate was diluted with
dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL) and saturated sodium
bicarbonate (2 × 4 mL) solution. The combined organic layers were washed with saturated
sodium chloride solution (4 mL), dried over anhydrous Na2SO4, filtered and concentrated.
The residue was purified by flash chromatography (SiO2, 1:9 EtOAc/Hexanes) to afford
give 5-(benzyloxy)chroman-3-yl benzoate (21 mg, 90%) as a colorless oil, which was used
as for hydrogenolysis. obtained. 5-(benzyloxy)chroman-3-yl benzoate (5 mg, 0.014 mmol)
and palladium/carbon (10%) were suspended in tetrahydrofuran (2 mL) and stirred for 18 h
under a hydrogen atmosphere The suspension was filtered through a small plug of SiO2 (40
– 63 μm particle size). The eluent was concentrated and the residue purified by flash
chromatography (SiO2, 1:1 EtOAc/Hexanes) to give 23o (3 mg, 93 %) as a colorless oil: 1H
NMR (500 MHz, CDCl3) δ 8.10 – 7.92 (m, 2H), 7.62 – 7.47 (m, 1H), 7.47 – 7.35 (m, 2H),
7.01 (t, J = 8.1 Hz, 1H), 6.52 (dd, J = 8.2, 1.0 Hz, 1H), 6.38 (dd, J = 8.0, 1.0 Hz, 1H), 5.55
(tdd, J = 5.2, 4.4, 2.2 Hz, 1H), 4.84 (brs, 1H), 4.33 (ddd, J = 11.4, 4.9, 1.9 Hz, 1H), 4.22 (dt,
J = 11.6, 1.5 Hz, 1H), 3.12 (dd, J = 17.4, 5.5 Hz, 1H), 2.97 (ddd, J = 17.5, 4.3, 1.8 Hz,
1H); 13C NMR (125 MHz, CDCl3) δ 166.3, 155.3, 154.5, 133.4, 130.1, 130.0, 128.6 (2),
127.7 (2), 109.4, 107.4, 107.2, 66.8, 65.9, 25.3. IR (KBr)νmax 3374, 2921, 1703, 1681,1476,
1098, 770 cm−1; HRMS (ESI−) m/z [M−H−] calcd for C16H13O4, 269.0814, found
269.0804.
5-Hydroxychroman-3-yl 3-methoxybenzoate (23p)
A solution of 22c (14 mg, 0.055 mmol) in dichloromethane (0.5 mL) was added to a stirred
solution of 3-methoxybenzoic acid (17 mg, 0.11 mmol), N,N′-dicyclohexylcarbodiimide (23
mg, 0.11 mmol) and 4-dimethylaminopyridine (8 mg, 0.11mmol) under argon at 0 °C. The
resulting solution was stirred for 6 h at rt and then filtered. The eluent was diluted with
dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL) and then with saturated sodium
bicarbonate (2 × 4 mL) solution. The combined organic layers were washed with saturated
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sodium chloride solution (4 mL), dried over anhydrous Na2SO4, filtered and the solvent
removed. The residue was purified by flash chromatography (SiO2, 1:9 EtOAc/Hexanes) to
afford give give 5-(benzyloxy)chroman-3-yl 3-methoxybenzoate (19 mg, 90%) as a
colorless oil, which was used as for hydrogenolysis. 5-(benzyloxy)chroman-3-yl 3-
methoxybenzoate (18 mg, 0.044 mmol) and palladium/carbon (10%) were suspended in
tetrahydrofuran (2 mL) and stirred for 18 h under a hydrogen atmosphere. The suspension
was filtered through a small plug of SiO2 (40 – 63 μm particle size). The eluent was
concentrated and the residue purified by flash chromatography (SiO2, 1:1 EtOAc/Hexanes)
to give 23p (12.9 mg, 92.4 %) as colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.53 (dt, J =
7.7, 1.3 Hz, 1H), 7.46 (dd, J = 2.7, 1.5 Hz, 1H), 7.24 (t, J = 8.0 Hz, 1H), 7.02 (ddd, J = 8.2,
2.7, 1.0 Hz, 1H), 6.93 (t, J = 8.1 Hz, 1H), 6.44 (dd, J = 8.3, 1.0 Hz, 1H), 6.31 (dd, J = 8.0,
1.0 Hz, 1H), 5.54 – 5.43 (m, 1H), 4.87 (s, 1H), 4.27 – 4.21 (m, 1H), 4.15 (dt, J = 11.4, 1.6
Hz, 1H), 3.75 (s, 3H), 3.06 (dd, J = 17.4, 5.5 Hz, 1H), 2.90 (ddd, J = 17.4, 4.6, 1.7 Hz,
1H); 13C NMR (125 MHz, CDCl3) δ 166.2, 159.7, 155.3, 154.5, 131.4, 129.6, 127.7, 122.4,
119.8, 114.5, 109.4, 107.4, 107.2, 66.8, 66.1, 55.7, 25.3. IR (KBr)νmax cm−1; HRMS (ESI−)
m/z [M−H−] calcd for C17H15O5, 299.0920, found 299.0934.
5-Hydroxychroman-3-yl 4-methoxybenzoate (23q)
A solution of 22c (11 mg, 0.042 mmol) in dichloromethane (0.5 mL) was added to a stirred
solution of 4-methoxybenzoic acid (13 mg, 0.09 mmol), N,N′-dicyclohexylcarbodiimide (18
mg, 0.085 mmol) and 4-dimethylaminopyridine (5 mg, 0.05mmol) under argon at 0 °C. The
resulting solution was stirred for 6 h at rt and then filtered. The filtrate was diluted with
dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL) and then with saturated sodium
bicarbonate (2 × 4 mL) solution. The combined organic layers were washed with saturated
sodium chloride solution (4 mL), dried over anhydrous Na2SO4, filtered and concentrated.
The residue was purified by flash chromatography (SiO2, 1:9 EtOAc/Hexanes) to give 5-
(benzyloxy)chroman-4-yl 3-methoxybenzoate (15 mg, 91.5%) as a colorless oil, which was
used as for hydrogenolysis. 5-(Benzyloxy)chroman-3-yl 4-methoxybenzoate (5 mg, 0.014
mmol) and palladium/carbon (10%) were suspended in tetrahydrofuran (2 mL) and stirred
for 18 h under a hydrogen atmosphere. The suspension was filtered through a small plug of
SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue purified by
flash chromatography (SiO2, 1:1 EtOAc/Hexanes) to give 23q (3.5 mg, 93 %) as a colorless
oil: 1H NMR (500 MHz, CDCl3) δ 8.10 – 7.92 (m, 2H), 7.64 – 7.49 (m, 1H), 7.49 – 7.38 (m,
2H), 7.02 (t, J = 8.1 Hz, 1H), 6.53 (dd, J = 8.2, 1.0 Hz, 1H), 6.40 (dd, J = 8.0, 1.0 Hz, 1H),
5.56 (tdd, J = 5.2, 4.4, 2.2 Hz, 1H), 4.86 (s, 1H), 4.35 (ddd, J = 11.4, 4.9, 1.9 Hz, 1H), 4.23
(dt, J = 11.6, 1.6 Hz, 1H), 3.14 (dd, J = 17.4, 5.5 Hz, 1H), 2.99 (ddd, J = 17.5, 4.3, 1.8 Hz,
1H); 13C NMR (125 MHz, CDCl3) δ 166.3, 155.3, 154.5 (2), 133.4 (2), 130.1, 130.0, 128.6,
127.7, 109.4 (2), 107.4, 107.2, 66.8, 65.9, 25.3; IR (KBr)νmax 3384, 2921, 1701, 1683,
1606, 1471, 1259, 1168, 1099, 771 cm−1; HRMS (ESI−) m/z [M−H−] calcd for C17H15O5,
299.0920, found 299.0928.
5-hydroxychroman-3-yl 3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxylate (23r)
A solution of 22c (11 mg, 0.042 mmol), in dichloromethane (0.5 mL) was added to a stirred
solution of 3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxylic acid (22 mg, 0.085 mmol),, N,N′-
dicyclohexylcarbodiimide (18 mg, 0.085 mmol) and 4-dimethylaminopyridine (5 mg,
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0.0042mmol) under argon at 0 °C. The resulting solution was stirred for 6 h at rt and then
filtered. The filtrate was diluted with dichloromethane (5 mL), washed with 0.5N HCl (2 × 4
mL) and saturated sodium bicarbonate (2 × 4 mL) solution. The combined organic layers
were washed with saturated sodium chloride solution (4 mL), dried over anhydrous Na2SO4,
filtered and concentrated. The residue was purified by flash chromatography (SiO2, 1:8
EtOAc/Hexanes) to afford 7-(benzyloxy)chroman-3-yl 3′,6-dimethoxy-[1,1′-biphenyl]-3-
carboxylate (18 mg, 85 %) as a colorless oil, which was used further as obtained. 7-
(benzyloxy)chroman-3-yl 3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxylate (18 mg, 0.036
mmol) and palladium/carbon (10%) were suspended in tetrahydrofuran (2 mL) and stirred
for 18 h under a hydrogen atmosphere. The suspension was filtered through a small plug of
SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue purified by
flash chromatography (SiO2, 1:1 EtOAc/Hexanes) to give 23r (13 mg, 88.2 %) as colorless
oil: 1H NMR (500 MHz, CDCl3) δ 7.96 – 7.88 (m, 2H), 7.25 (t, J = 7.9 Hz, 1H), 7.00 (dt, J
= 7.6, 1.2 Hz, 1H), 6.96 (dd, J = 2.6, 1.5 Hz, 1H), 6.94 – 6.87 (m, 2H), 6.83 (ddd, J = 8.3,
2.6, 1.0 Hz, 1H), 6.44 (dd, J = 8.3, 1.0 Hz, 1H), 6.31 (dd, J = 8.0, 1.1 Hz, 1H), 5.55 – 5.34
(m, 1H), 4.86 (brs, 1H), 4.22 (ddd, J = 11.3, 5.2, 1.7 Hz, 1H), 4.16 (ddd, J = 11.4, 2.4, 1.2
Hz, 1H), 3.78 (s, 3H), 3.76 (s, 3H), 3.06 (dd, J = 17.3, 5.6 Hz, 1H), 2.92 – 2.83 (m, 1H); 13C
NMR (125 MHz, CDCl3) δ 166.0, 160.6, 159.4, 155.3, 154.5, 138.9, 132.7, 131.3, 130.7,
129.3, 127.6, 122.5, 122.2, 115.4, 113.2, 110.7, 109.4, 107.4, 107.3, 66.9, 65.7, 56.0, 55.5,
25.4; IR (KBr)νmax 3396, 2933, 2837, 1712, 1598, 1469, 1440, 1249, 1031, 771, 711 cm−1;
HRMS (ESI−) m/z [M+H+] calcd for C24H23O6, 407.1495, found 407.1482.
5-Hydroxychroman-3-yl 4-acetoxy-3-(3-methylbut-2-en-1-yl)benzoate (23s)
A solution of 22c (10 mg, 0.04 mmol), in dichloromethane (0.5 mL) was added to a stirred
solution of 4-acetoxy-3-(3-methylbut-2-en-1-yl)benzoic acid (20 mg, 0.08 mmol), N,N′-
dicyclohexylcarbodiimide (16 mg, 0.08 mmol) and 4-dimethylaminopyridine (5 mg, 0.042
mmol) under argon at 0 °C. The resulting solution was stirred for 6 h at rt and filtered. The
filtrate was diluted with dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL) and
then with saturated sodium bicarbonate (2 × 4 mL) solution. The combined organic layers
were washed with saturated sodium chloride solution (4 mL), dried over anhydrous Na2SO4,
filtered and solvent was removed. The residue was purified by flash chromatography (SiO2,
1:8 EtOAc/Hexanes) to give 5-(benzyloxy)chroman-3-yl 4-acetoxy-3-(3-methylbut-2-en-1-
yl)benzoate (13 mg, 72.2 %) as a colorless oil, which was used as in the next step. For
benzyl group removal, a solution of palladium acetate (1 mg, 0.004 mmol), triethylamine
(4μL, .025 mmol), triethylsilane (19μL, 0.0112) in DCM (0.8 mL) was stirred for 15 minutes
under argon before the addition of a solution of 5-(benzyloxy)chroman-3-yl 4-acetoxy-3-(3-
methylbut-2-en-1-yl)benzoate (12 mg, 0.025mmol) in dichloromethane (0.2 mL) was added
and reaction was stirred for 15 hours. Then reaction was quenched with saturated
ammonium chloride (2 mL) and extracted with ether (3 × 4 mL). The combined organic
layers were washed with saturated sodium chloride solution, dried over Na2SO4, filtered and
concentrated. The residue was purified by flash chromatography (SiO2, 1:2 EtOAc/Hexanes)
to afford 23s as colorless oil: 1H NMR (500 MHz, CDCl3) δ 8.02 – 7.67 (m, 2H), 7.05 (d, J
= 8.3 Hz, 1H), 7.03 – 6.98 (m, 1H), 6.53 (dd, J = 8.3, 1.1 Hz, 1H), 6.43 (dd, J = 8.1, 1.0 Hz,
1H), 5.52 (tdd, J = 5.1, 4.2, 2.1 Hz, 1H), 5.17 (dddt, J = 7.3, 5.8, 2.9, 1.4 Hz, 1H), 4.31 (ddd,
J = 11.5, 4.8, 2.0 Hz, 1H), 4.24 – 4.12 (m, 1H), 3.24 (d, J = 7.2 Hz, 2H), 3.05 (dd, J = 17.6,
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5.3 Hz, 1H), 2.94 (ddd, J = 17.5, 4.4, 1.8 Hz, 1H), 2.32 (s, 3H), 1.71 (q, J = 1.3 Hz, 3H),
1.69 – 1.65 (m, 3H); 13C NMR (125 MHz, CDCl3) δ 168.8, 165.4, 155.0, 154.6, 152.7,
133.9, 131.9, 128.8, 127.8 (2), 127.1, 122.4, 120.8, 110.8, 110.5, 109.5, 66.4, 66.0, 28.7,
25.8, 25.7, 20.9, 17.8; IR (KBr)νmax 3429, 2854, 1716, 1595, 1458, 1286, 1161, 1054 cm−1;
HRMS (ESI−) m/z [M+H+] calcd for C23H25O6, 397.1651, found 397.1662.
5,7-Dimethoxychroman-3-yl benzoate (27a)
A solution of 26 (10 mg, 0.04 mmol), in dichloromethane (0.5 mL) was added to a stirred
solution of benzoic acid (12 mg, 0.1 mmol), N,N′-dicyclohexylcarbodiimide (20.6 mg, 0.1
mmol) and 4-dimethylaminopyridine (5 mg, 0.042 mmol) under argon at 0 °C. The resulting
solution was stirred for 6 h at rt and then filtered. The filtrate was diluted with
dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL) and then with saturated sodium
bicarbonate (2 × 4 mL) solution. The combined organic layers were washed with saturated
sodium chloride solution (4 mL), dried over anhydrous Na2SO4, filtered and concentrated.
The residue was purified by flash chromatography (SiO2, 1:7 EtOAc/Hexanes) to afford 27a
(13 mg, 90 %) as a colorless oil 1H NMR (500 MHz, CDCl3) δ 8.14 – 7.91 (m, 2H), 7.55
(ddt, J = 7.6, 6.8, 1.1 Hz, 1H), 7.47 – 7.37 (m, 2H), 6.11 (s, 2H), 5.52 (tdt, J = 5.5, 4.5, 1.9
Hz, 1H), 4.32 (dddd, J = 11.4, 4.9, 1.9, 0.9 Hz, 1H), 4.21 (ddd, J = 11.5, 2.2, 1.2 Hz, 1H),
3.79 (dd, J = 2.9, 0.9 Hz, 6H), 3.09 – 2.94 (m, 1H), 2.88 (ddd, J = 17.4, 4.3, 1.8 Hz,
1H); 13C NMR (125 MHz, CDCl3) δ 166.3, 159.8, 159.1, 155.3, 133.4, 130.3, 130.1 (2),
128.6 (2), 100.8, 93.4, 92.0, 67.1, 66.2, 55.7, 55.6, 25.1; IR (KBr)νmax 2931, 1716, 1620,
1591, 1499, 1456, 1145, 1045, 754 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C18H19O5,
315.1232, found 315.1239.
5,7-Dimethoxychroman-3-yl 3-methoxybenzoate (27b)
A solution of 26 (10 mg, 0.04 mmol), in dichloromethane (0.5 mL) was added to a stirred
solution of 3-methoxybenzoic acid (15 mg, 0.1 mmol), N,N′-dicyclohexylcarbodiimide
(20.6 mg, 0.1 mmol) and 4-dimethylaminopyridine (5 mg, 0.042 mmol) under argon at 0 °C.
The resulting solution was stirred for 6 h at rt and then filtered. The filtrate was diluted with
dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL) and then with saturated sodium
bicarbonate (2 × 4 mL) solution. The combined organic layers were washed with saturated
sodium chloride solution (4 mL), dried over anhydrous Na2SO4, filtered and concentrated.
The residue was purified by flash chromatography (SiO2, 1:6 EtOAc/Hexanes) to afford 27b
(13 mg, 80 %) as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.61 (dt, J = 7.7, 1.2 Hz,
1H), 7.54 (dd, J = 2.7, 1.5 Hz, 1H), 7.31 (t, J = 7.9 Hz, 1H), 7.09 (ddd, J = 8.3, 2.7, 1.1 Hz,
1H), 6.10 (d, J = 1.2 Hz, 2H), 5.69 – 5.42 (m, 1H), 4.30 (ddd, J = 11.4, 5.1, 1.8 Hz, 1H),
4.24 – 4.16 (m, 1H), 3.83 (s, 3H), 3.79 (s, 3H), 3.78 (s, 3H), 3.02 (ddd, J = 17.5, 5.6, 1.3 Hz,
1H), 2.86 (ddd, J = 17.4, 4.5, 1.7 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 166.2, 159.8,
159.7, 159.0, 155.3, 131.5, 129.6, 122.4, 119.6, 114.5, 100.7, 93.4, 92.0, 67.0, 66.3, 55.7,
55.6, 55.6, 25.1; IR (KBr)νmax 2935, 2839, 1716, 1622, 1593, 1498, 1456, 1276, 1145,
1045, 754 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C19H21O6, 345.1338, found
345.1347.
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A solution of 26 (10 mg, 0.04 mmol), in dichloromethane (0.5 mL) was added to a stirred
solution of 4-methoxybenzoic acid (15 mg, 0.1 mmol), N,N′-dicyclohexylcarbodiimide
(20.6 mg, 0.1 mmol) and 4-dimethylaminopyridine (5 mg, 0.042 mmol) under argon at 0 °C.
The resulting solution was stirred for 6 h at rt and then filtered. The filtrate was diluted with
dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL) and then with saturated sodium
bicarbonate (2 × 4 mL) solution. The combined organic layers were washed with saturated
sodium chloride solution (4 mL), dried over anhydrous Na2SO4, filtered and concentrated.
The residue was purified by flash chromatography (SiO2, 1:6 EtOAc/Hexanes) to afford 27c
(14 mg, 86 %) as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.98 (ddd, J = 10.7, 5.1, 2.6
Hz, 2H), 7.27 (td, J = 4.5, 1.5 Hz, 1H), 6.89 (ddd, J = 8.5, 5.7, 2.6 Hz, 2H), 6.10 (m, 2H),
5.56 – 5.37 (m, 1H), 4.29 (m, 1H), 4.26 – 4.12 (m, 1H), 3.88 – 3.81 (s, 3H), 3.78 (s, 6H),
3.10 – 2.93 (m, 1H), 2.85 (dddd, J = 17.5, 5.7, 4.3, 2.3 Hz, 1H); 13C NMR (125 MHz,
CDCl3) δ 166.0, 163.7, 159.8, 159.0, 155.3, 132.1 (2), 122.7, 113.8 (2), 100.9, 93.3, 91.9,
67.1, 65.8, 55.6, 55.6 (2), 25.1; IR (KBr)νmax 2935, 1716, 1620, 1593, 1499, 1456, 1145,
1043 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C19H21O6, 345.1338, found 345.1347.
5,7-Dimethoxychroman-3-yl 3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxylate (27d)
A solution of 26 (10 mg, 0.04 mmol), in dichloromethane (0.5 mL) was added to a stirred
solution of 3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxylic acid (15 mg, 0.1 mmol), N,N′-
dicyclohexylcarbodiimide (20.6 mg, 0.1 mmol) and 4-dimethylaminopyridine (5 mg, 0.042
mmol) under argon at 0 °C. The resulting solution was stirred for 6 h at rt and then filtered.
The filtrate was diluted with dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL)
and then with saturated sodium bicarbonate (2 × 4 mL) solution. The combined organic
layers were washed with saturated sodium chloride solution (4 mL), dried over anhydrous
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (SiO2,
1:6 EtOAc/Hexanes) to afford 27d (18.4 mg, 82 %) as a colorless oil: 1H NMR (500 MHz,
CDCl3) δ 8.06 – 7.97 (m, 2H), 7.34 (t, J = 7.9 Hz, 1H), 7.08 (dt, J = 7.7, 1.2 Hz, 1H), 7.04
(dd, J = 2.6, 1.5 Hz, 1H), 6.97 (d, J = 8.6 Hz, 1H), 6.91 (ddd, J = 8.2, 2.6, 0.9 Hz, 1H), 6.10
(s, 2H), 5.54 – 5.42 (m, 1H), 4.28 (ddd, J = 11.3, 5.2, 1.7 Hz, 1H), 4.21 (ddd, J = 11.2, 2.3,
1.1 Hz, 1H), 3.87 (s, 3H), 3.84 (s, 3H), 3.79 (s, 3H), 3.78 (s, 3H), 3.02 (ddd, J = 17.4, 5.6,
1.2 Hz, 1H), 2.85 (ddd, J = 17.2, 4.6, 1.6 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 166.0,
160.5, 159.7, 159.4, 159.0, 155.3, 139.0, 132.6, 131.3, 130.6, 129.2, 122.7, 122.2, 115.4,
113.1, 110.7, 100.9, 93.3, 91.9, 67.1, 66.0, 56.0, 55.62, 55.6, 55.5, 25.2. IR (KBr)νmax 2954,
2931, 1712, 1595, 1498, 1456, 1436, 1247, 1215, 1052, 813, 756 cm−1; HRMS (ESI+) m/z
[M+Na+] calcd for C26H26NaO7, 473.1576, found 473.1566.
5,7-Dimethoxychroman-3-yl 4-acetoxy-3-(3-methylbut-2-en-1-yl)benzoate (27e)
A solution of 26 (20 mg, 0.08 mmol), in dichloromethane (1 mL) was added to a stirred
solution of 4-acetoxy-3-(3-methylbut-2-en-1-yl)benzoic acid (48 mg, 0.19 mmol), N,N′-
dicyclohexylcarbodiimide (40 mg, 0.19 mmol) and 4-dimethylaminopyridine (12 mg, 0.084
mmol) under argon at 0 °C. The resulting solution was stirred for 6 h at rt and then filtered.
The filtrate was diluted with dichloromethane (10 mL), washed with 0.5N HCl (2 × 8 mL)
and then with saturated sodium bicarbonate (2 × 8 mL) solution. The combined organic
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layers were washed with saturated sodium chloride solution (8 mL), dried over anhydrous
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (SiO2,
1:7 EtOAc/Hexanes) to afford 27e (17 mg, 53%) as a colorless oil: 1H NMR (500 MHz,
CDCl3) δ 7.90 (d, J = 2.1 Hz, 1H), 7.86 (dd, J = 8.4, 2.2 Hz, 1H), 7.06 (d, J = 8.4 Hz, 1H),
6.18 (s, 2H), 5.57 – 5.44 (m, 1H), 5.18 (dddd, J = 7.2, 5.8, 2.8, 1.4 Hz, 1H), 3.79 (s, 3H),
3.78 (s, 3H), 3.25 (d, J = 7.2 Hz, 2H), 2.99 (ddd, J = 17.3, 5.4, 1.2 Hz, 1H), 2.86 (ddd, J =
17.4, 4.4, 1.8 Hz, 1H), 2.32 (s, 3H), 1.72 (q, J = 1.2 Hz, 3H), 1.69 – 1.63 (m, 3H); 13C NMR
(126 MHz, CDCl3) δ 169.1, 165.7, 159.8, 159.0, 155.2, 152.9, 134.1 (2), 132.1, 129.0,
128.1, 122.6, 121.1, 100.7, 93.3, 91.9, 66.9, 66.2, 55.6, 55.6, 28.9, 25.9, 25.1, 21.1, 18.1; IR
(KBr)νmax 2937, 2844, 1737, 1622, 2595, 1242, 1218, 1201, 1145, 1128, 1058, 811 cm−1;
HRMS (ESI+) m/z [M+H+] calcd for C25H29O7, 441.1913, found 441.1894.
5,7-Dimethoxychroman-3-yl 3,4-dimethoxybenzoate (27f)
A solution of 26 (5 mg, 0.025mmol) in dichloromethane (0.5 mL) was added to a stirred
solution of 3,4-dimethoxybenzoic acid (9mg, 0.05 mmol), N,N′-dicyclohexylcarbodiimide
(10mg, 0.05 mmol) and 4-dimethylaminopyridine (3mg, 0.025 mmol) under argon at 0 °C.
The resulting solution was stirred for 6 h at rt and then filtered. The filtrate was diluted with
dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL) and then with saturated sodium
bicarbonate (2 × 4 mL) solution. The combined organic layers were washed with saturated
sodium chloride solution (4 mL), dried over anhydrous Na2SO4, filtered and concentrated.
The residue was purified by flash chromatography (SiO2, 1:6 EtOAc/Hexanes) to afford 27f
(10 mg, 71.4 %) as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.65 (dd, J = 8.4, 2.0 Hz,
1H), 7.52 (d, J = 2.0 Hz, 1H), 6.85 (d, J = 8.5 Hz, 1H), 6.10 (s, 2H), 5.57 – 5.41 (m, 1H),
4.28 (ddd, J = 11.3, 5.1, 1.8 Hz, 1H), 4.21 (ddd, J = 11.3, 2.2, 1.1 Hz, 1H), 3.92 (d, J = 8.3
Hz, 6H), 3.79 (d, J = 4.1 Hz, 6H), 3.02 (ddd, J = 17.2, 5.5, 1.2 Hz, 1H), 2.86 (ddd, J = 17.3,
4.5, 1.6 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 159.9 (2), 159.5 (2), 155.4 (2), 138.5,
128.8, 128.3, 126.5, 100.5, 93.5, 92.4, 78.9, 66.6, 55.7 (2), 55.6 (2), 28.4; IR (KBr)νmax
2931, 1701, 1558, 1458, 1419, 1271, 732 cm−1; HRMS (ESI+) m/z [M+Na+] calcd for
C20H22NaO7, 397.1263, found 397.1269.
5,7-Dimethoxychroman-3-yl 3,5-dimethoxybenzoate (27g)
A solution of 26 (5 mg, 0.025mmol) in dichloromethane (0.5 mL) was added to a stirred
solution of 3,4-dimethoxybenzoic acid (9mg, 0.05 mmol), N,N′-dicyclohexylcarbodiimide
(10mg, 0.05 mmol) and 4-dimethylaminopyridine (3mg, 0.025 mmol) under argon at 0 °C.
The resulting solution was stirred for 6 h at rt and then filtered. The filtrate was diluted with
dichloromethane (5 mL), washed with 0.5N HCl (2 ×4 mL) and then with saturated sodium
bicarbonate (2 × 4 mL) solution. The combined organic layers were washed with saturated
sodium chloride solution (4 mL), dried over anhydrous Na2SO4, filtered and concentrated.
The residue was purified by flash chromatography (SiO2, 1:6 EtOAc/Hexanes) to afford 27g
(11.9mg, 85 %) as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.16 (d, J = 2.4 Hz, 2H),
6.64 (t, J = 2.4 Hz, 1H), 6.10 (s, 2H), 5.57 – 5.43 (m, 1H), 4.28 (ddd, J = 11.3, 5.2, 1.7 Hz,
1H), 4.21 (ddd, J = 11.3, 2.4, 1.1 Hz, 1H), 3.85 – 3.73 (m, 13H), 3.02 (ddd, J = 17.3, 5.5, 1.2
Hz, 1H), 2.85 (ddd, J = 17.4, 4.7, 1.7 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 159.9 (2),
159.5 (2), 155.4 (2), 138.5, 128.8, 128.3, 126.5, 100.5 (2), 93.5, 92.4, 78.9, 66.6, 55.7, 55.6
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(2), 28.4. IR (KBr)νmax 2931, 1701, 1558, 1458, 1419, 1271, 732 cm−1; HRMS (ESI+) m/z
[M+Na+] calcd for C20H22NaO7, 397.1263, found 397.1269.
5,7-Dimethoxychroman-3-yl 3-ethoxybenzoate (27h)
A solution of 26 (10 mg, 0.04 mmol), in dichloromethane (0.5 mL) was added to a stirred
solution of 3-ethoxybenzoic acid (17 mg, 0.1 mmol), N,N′-dicyclohexylcarbodiimide (20.6
mg, 0.1 mmol) and 4-dimethylaminopyridine (5 mg, 0.042 mmol) under argon at 0 °C. The
resulting solution was stirred for 6 h and filtered. The filtrate was diluted with
dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL) and then with saturated sodium
bicarbonate (2 × 4 mL) solution. The combined organic layers were washed with saturated
sodium chloride solution (4 mL), dried over anhydrous Na2SO4, filtered and concentrated.
The residue was purified by flash chromatography (SiO2, 1:6 EtOAc/Hexanes) to afford 27h
(14 mg, 82.3 %) as a colorless oil: 1H NMR (500 MHz, (CD3)2CO) δ 7.52 (ddd, J = 7.7, 1.5,
1.0 Hz, 1H), 7.46 (dd, J = 2.6, 1.5 Hz, 1H), 7.38 (t, J = 7.9 Hz, 1H), 7.16 (ddd, J = 8.2, 2.7,
1.0 Hz, 1H), 6.14 (d, J = 2.4 Hz, 1H), 6.06 (d, J = 2.4 Hz, 1H), 5.50 – 5.41 (m, 1H), 4.32
(ddd, J = 11.5, 4.5, 2.0 Hz, 1H), 4.22 (ddt, J = 11.5, 1.9, 0.9 Hz, 1H), 4.07 (q, J = 7.0 Hz,
2H), 3.79 (s, 3H), 3.76 (s, 3H), 2.99 (ddd, J = 17.3, 5.2, 1.1 Hz, 1H), 2.89 – 2.78 (m, 1H),
1.36 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, (CD3)2CO) δ 166.2, 160.7, 160.0, 159.8,
156.1, 132.5, 130.5, 122.3, 120.1, 115.9, 101.1, 94.2, 92.2, 67.3, 67.1, 64.3, 55.8, 55.5, 25.4,
15.0; IR (KBr)νmax 2910, 1718, 1622, 1593, 1498, 1423, 1274, 1217, 1145, 1051, 754 cm−1;
HRMS (ESI+) m/z [M+H+] calcd for C20H23O6, 359.1495, found 359.1483.
5,7-Dimethoxychroman-3-yl 3-(benzyloxy)benzoate (27i)
A solution of 26 (10 mg, 0.04 mmol), in dichloromethane (0.5 mL) was added to a stirred
solution of 3-(benzyloxy)benzoic acid (23 mg, 0.1 mmol) (17 mg, 0.1 mmol), N,N′-
dicyclohexylcarbodiimide (20.6 mg, 0.1 mmol) and 4-dimethylaminopyridine (5 mg, 0.042
mmol) under argon at 0 °C. The resulting solution was stirred for 6 h at rt then filterd. The
filtrate was diluted with dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL) and
then with saturated sodium bicarbonate (2 × 4 mL) solution. The combined organic layers
were washed with saturated sodium chloride solution (4 mL), dried over anhydrous Na2SO4,
filtered and concentrated. The residue was purified by flash chromatography (SiO2, 1:5
EtOAc/Hexanes) to afford 27i (18 mg, 90 %) as a pale yellow amorphous solid: 1H NMR
(500 MHz, CDCl3) δ 7.62 (dd, J = 7.2, 1.5 Hz, 2H), 7.48 – 7.36 (m, 4H), 7.37 – 7.27 (m,
3H), 7.19 – 7.12 (m, 1H), 6.11 (s, 2H), 5.50 (ddt, J = 5.3, 4.2, 2.5 Hz, 1H), 5.09 (s, 2H), 4.31
(ddd, J = 11.3, 4.9, 1.9 Hz, 1H), 4.20 (ddd, J = 11.4, 2.2, 1.2 Hz, 1H), 3.02 (ddd, J = 17.4,
5.5, 1.2 Hz, 1H), 2.87 (ddd, J = 17.4, 4.3, 1.8 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ
166.1, 159.8, 159.0, 158.8, 155.3, 136.7, 131.6, 129.6 (2), 128.9 (2), 128.3 (2), 127.8, 122.7,
120.4, 115.6, 100.7, 93.4, 92.0, 70.4, 67.0, 66.3, 55.6, 55.6, 25.1; IR (KBr)νmax 2918, 1701,
1683, 1558, 15036, 1458, 1203, 1145, cm−1; HRMS (ESI+) m/z [M+H+] calcd for
C25H25O6, 421.1651, found 421.1637.
5,7-Dimethoxychroman-3-yl 4-(benzyloxy)benzoate (27j)
A solution of 26 (10 mg, 0.04 mmol), in dichloromethane (0.5 mL) was added to a stirred
solution of 4-(benzyloxy)benzoic acid (23 mg, 0.1 mmol) (23 mg, 0.1 mmol) (17 mg, 0.1
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mmol), N,N′-dicyclohexylcarbodiimide (20.6 mg, 0.1 mmol) and 4-dimethylaminopyridine
(5 mg, 0.042 mmol) under argon at 0 °C. The resulting solution was stirred for 6 h at rt and
then filtered. The filtrate was diluted with dichloromethane (5 mL), washed with 0.5N HCl
(2 × 4 mL) and then with saturated sodium bicarbonate (2 × 4 mL) solution. The combined
organic layers were washed with saturated sodium chloride solution (4 mL), dried over
anhydrous Na2SO4, filtered and concentrated. The residue was purified by flash
chromatography (SiO2, 1:5 EtOAc/Hexanes) to afford 27j (17 mg, 85%) as a colorless
oil: 1H NMR (500 MHz, CDCl3) δ 7.62 (dd, J = 7.2, 1.5 Hz, 2H), 7.46 – 7.37 (m, 4H), 7.36
– 7.29 (m, 2H), 7.21 – 7.04 (m, 1H), 6.11 (s, 2H), 5.50 (ddt, J = 5.3, 4.2, 2.5 Hz, 1H), 5.09
(s, 2H), 4.31 (ddd, J = 11.3, 4.9, 1.9 Hz, 1H), 4.20 (ddd, J = 11.4, 2.2, 1.2 Hz, 1H), 3.81 –
3.78 (m, 6H), 3.02 (ddd, J = 17.4, 5.5, 1.2 Hz, 1H), 2.87 (ddd, J = 17.4, 4.3, 1.8 Hz,
1H); 13C NMR (125 MHz, CDCl3) δ 165.9, 162.8, 159.7, 159.0, 155.3, 136.4, 132.1 (2),
128.9 (2), 128.4, 127.7, 122.9, 114.6 (2), 100.8, 93.3, 91.9, 70.3, 67.1, 65.8, 55.6, 55.6, 25.1.
IR (KBr)νmax, 2918, 2817, 1701, 1683, 1558, 1503, 1458, 1203, 1145, 729 cm−1; HRMS
(ESI+) m/z [M+H+] calcd for C25H25O6, 421.1651, found 421.1666.
5,7-Dimethoxychroman-3-yl 3,5-bis(benzyloxy)benzoate (27k)
A solution of 26 (10 mg, 0.04 mmol), in dichloromethane (0.5 mL) was added to a stirred
solution of 3,5-bis(benzyloxy)benzoic acid (33.4 mg, 0.1 mmol) N,N′-
dicyclohexylcarbodiimide (20.6 mg, 0.1 mmol) and 4-dimethylaminopyridine (5 mg, 0.042
mmol) under argon at 0 °C. The resulting solution was stirred for 6 h at rt and then filtered.
The filtrate was diluted with dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL)
and then with saturated sodium bicarbonate (2 × 4 mL) solution. The combined organic
layers were washed with saturated sodium chloride solution (4 mL), dried over anhydrous
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (SiO2,
1:5 EtOAc/Hexanes) to afford 27k (22 mg, 88%) as an amorphous pale yellow solid: 1H
NMR (500 MHz, CDCl3) δ 7.51 – 7.27 (m, 12H), 6.79 (t, J = 2.3 Hz, 1H), 6.11 (s, 2H), 5.47
(qd, J = 5.0, 2.2 Hz, 1H), 5.04 (s, 4H), 4.29 (ddd, J = 11.4, 5.0, 1.8 Hz, 1H), 4.25 – 4.12 (m,
1H), 3.79 (s, 3H), 3.77 (s, 3H), 3.01 (ddd, J = 17.4, 5.5, 1.1 Hz, 1H), 2.85 (ddd, J = 17.4,
4.5, 1.7 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 166.0, 159.9 (2), 159.8, 159.0, 155.3,
136.6 (2), 132.1, 128.9 (4), 128.4 (4), 127.9 (2), 108.8 (2), 107.3, 100.7, 93.4, 92.0, 70.5 (2),
66.9, 66.5, 55.6, 55.6, 25.1; IR (KBr)νmax 2955, 2852, 1697, 1596, 1456, 1145, 1251, 1009,
769, cm−1. HRMS (ESI+) m/z [M+H+] calcd for C32H31O7, 527.2070, found 527.2087.
5,7-Dimethoxychroman-3-yl 3,4-bis(benzyloxy)benzoate (27l)
A solution of 26 (9mg, 0.04 mmol), in dichloromethane (0.5 mL) was added to a stirred
solution of 3,4-bis(benzyloxy)benzoic acid (33.4 mg, 0.1 mmol) N,N′-
dicyclohexylcarbodiimide (20.6 mg, 0.1 mmol) and 4-dimethylaminopyridine (5 mg, 0.042
mmol) under argon at 0 °C. The resulting solution was stirred for 6 h at rt and then filtered.
The filtrate was diluted with dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL)
and then with saturated sodium bicarbonate (2 × 4 mL) solution. The combined organic
layers were washed with saturated sodium chloride solution (4 mL), dried over anhydrous
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (SiO2,
1:5 EtOAc/Hexanes) to afford 27l (20.8 mg, 92%) as an amorphous pale yellow solid: 1H
NMR (500 MHz, CDCl3) δ 7.61 (d, J = 2.0 Hz, 1H), 7.58 (dd, J = 8.4, 2.0 Hz, 1H), 7.48 –
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7.40 (m, 4H), 7.40 – 7.29 (m, 6H), 6.88 (d, J = 8.4 Hz, 1H), 6.11 (s, 2H), 5.56 – 5.39 (m,
1H), 5.22 (s, 2H), 5.17 (s, 2H), 4.27 (ddd, J = 11.3, 4.9, 1.8 Hz, 1H), 4.22 – 4.14 (m, 1H),
3.79 (s, 3H), 3.78 (s, 3H), 2.98 (ddd, J = 17.3, 5.5, 1.2 Hz, 1H), 2.83 (ddd, J = 17.4, 4.3, 1.7
Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 165.9, 159.8, 159.0, 155.3, 153.1, 148.4, 137.0,
136.7, 128.8 (3), 128.7, 128.2, 128.1, 127.7 (2), 127.3 (2), 124.4, 123.1, 115.8, 113.3, 100.8,
93.3, 91.9, 71.3, 71.0, 67.0, 65.9, 55.6, 55.6, 25.1. IR (KBr)νmax 2921, 2848, 1699, 1618,
1510, 1454, 1290, 1203, 1058 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C32H31O7,
527.2070, found 527.2081.
5,7-Dimethoxychroman-3-yl 4-(benzyloxy)-3-methoxybenzoate (27m)
A solution of 26 (20 mg, 0.1 mmol), in dichloromethane (0.5 mL) was added to a stirred
solution of 4-(benzyloxy)-3-methoxybenzoic acid (49 mg, 0.19 mmol) N,N′-
dicyclohexylcarbodiimide (39 mg, 0.19 mmol) and 4-dimethylaminopyridine (12 mg, 0.1
mmol) under argon at 0 °C. The resulting solution was stirred for 6 h at rt and then filtered.
The filtrate was diluted with dichloromethane (5 mL), washed with 0.5N HCl (2 × 4 mL)
and then with saturated sodium bicarbonate (2 × 4 mL) solution. The combined organic
layers were washed with saturated sodium chloride solution (4 mL), dried over anhydrous
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (SiO2,
1:5 EtOAc/Hexanes) to afford 27m (34 mg, 81%) as an amorphous pale yellow solid. IR
(KBr)νmax 2921, 2848, 1699, 1618, 1510, 1454, 1290, 1203, 1058 cm−1. HRMS (ESI+) m/z
[M+H+] calcd for C26H27O7, 451.1757, found 451.1668.
5,7-Dimethoxychroman-3-yl 3-hydroxybenzoate (28a)
Palladium/carbon (10%) and 27i (18 mg, 0.03 mmol) were suspended in tetrahydrofuran (2
mL) and stirred for 18 h under a hydrogen atmosphere. The suspension was filtered through
a small plug of SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue
purified by flash chromatography (SiO2, 1:1 EtOAc/Hexanes) to give flash chromatography
(SiO2, 1:3 EtOAc/Hexanes) to give 28a (8.8 mg, 92.6%) as a colorless oil: 1H NMR (500
MHz, CD3CN) δ 7.41 (ddd, J = 7.7, 1.6, 1.0 Hz, 1H), 7.33 (dd, J = 2.6, 1.6 Hz, 1H), 7.29 (t,
J = 7.9 Hz, 1H), 7.24 – 7.16 (m, 1H), 7.03 (ddd, J = 8.1, 2.6, 1.1 Hz, 1H), 6.14 (d, J = 2.3
Hz, 1H), 6.07 (d, J = 2.3 Hz, 1H), 5.52 – 5.36 (m, 1H), 4.30 (ddd, J = 11.7, 4.2, 2.1 Hz, 1H),
4.15 (ddt, J = 11.6, 1.9, 1.0 Hz, 1H), 3.77 (s, 3H), 3.74 (s, 3H), 2.92 (ddd, J = 17.4, 5.2, 1.1
Hz, 1H), 2.86 – 2.71 (m, 1H). 13C NMR (125 MHz, CD3CN) δ 166.5, 160.7, 159.9, 157.9,
156.1, 132.6, 130.8, 122.5, 121.9, 118.3, 117.0, 94.2, 92.4, 67.4, 67.0, 56.2, 55.9, 25.1. IR
(KBr)νmax 3335, 2918, 1701, 1683, 1558, 15036, 1458, 1203, 1145, cm−1. HRMS (ESI+)
m/z [M+H+] calcd for C18H19O6, 331.1182, found 331.1188.
5,7-Dimethoxychroman-3-yl 4-hydroxybenzoate (27b)
Palladium/carbon (10%) and 27j (12 mg, 0.028 mmol) were suspended in tetrahydrofuran (2
mL) and stirred for 18 h under a hydrogen atmosphere. The suspension was filtered through
a small plug of SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue
purified by flash chromatography (SiO2, 1:3 EtOAc/Hexanes) to give the 28b (9 mg, 90 %)
as a colorless oil: 1H NMR (500 MHz, (CD3)2CO) δ 9.16 (s, 1H), 7.88 – 7.80 (m, 2H), 6.94
– 6.86 (m, 2H), 6.14 (d, J = 2.3 Hz, 1H), 6.05 (d, J = 2.3 Hz, 1H), 5.49 – 5.36 (m, 1H), 4.29
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(ddd, J = 11.5, 4.6, 2.0 Hz, 1H), 4.24 – 4.14 (m, 1H), 3.79 (s, 3H), 3.75 (s, 3H), 2.97 (ddd, J
= 17.3, 5.3, 1.1 Hz, 1H), 2.80 (ddd, J = 17.3, 4.0, 1.9 Hz, 1H); 13C NMR (125 MHz,
(CD3)2CO) δ 166.1, 162.7, 160.7, 159.8, 156.1, 132.5 (2), 122.4, 116.0 (2), 101.2, 94.2,
92.2, 67.4, 66.4, 55.8, 55.5, 25.5. IR (KBr)νmax 3365, 2956, 2852, 1701, 1596, 1456, 1214,
1145, 1051, 767cm−1; HRMS (ESI+) m/z [M+Na+] calcd for C18H18 NaO6, 353.1001, found
353.0991.
5,7-Dimethoxychroman-3-yl 3,5-dihydroxybenzoate (28c)
Palladium/carbon (10%) and 27k (12 mg, 0.028 mmol) were suspended in tetrahydrofuran
(2 mL) and stirred for 18 h under a hydrogen atmosphere. The suspension was filtered
through a small plug of SiO2 (40 – 63 μm particle size). The eluent was concentrated and the
residue purified by flash chromatography (SiO2, 1:1 EtOAc/Hexanes) to give 28c (12 mg,
91 %) as a colorless oil: 1H NMR (500 MHz, (CD3)2CO) δ 8.58 (s, 2H), 6.96 (d, J = 2.3 Hz,
2H), 6.56 (t, J = 2.3 Hz, 1H), 6.15 (d, J = 2.3 Hz, 1H), 6.05 (d, J = 2.3 Hz, 1H), 5.43 (dtd, J
= 5.5, 4.1, 1.9 Hz, 1H), 4.31 (ddd, J = 11.6, 4.3, 2.1 Hz, 1H), 4.19 (ddt, J = 11.7, 1.9, 1.0 Hz,
1H), 3.79 (s, 3H), 3.75 (s, 3H), 2.97 (ddd, J = 17.6, 5.4, 1.2 Hz, 1H), 2.82 – 2.74 (m,
1H); 13C NMR (125 MHz, (CD3)2CO) δ 166.2, 160.7, 159.8 (2), 159.4, 156.1, 133.1, 108.7,
108.1, 101.1, 94.2, 92.2, 67.3, 66.8, 55.8, 55.5 (2), 25.3. IR (KBr)νmax 3365, 3330, 2956,
2850, 1697, 1596, 1456, 1361, 1145, 1054, 1004, 769, cm−1; HRMS (ESI+) m/z [M+H+]
calcd for C18H19O7, 347.1131, found 347.1134.
5,7-Dimethoxychroman-3-yl 3,4-dihydroxybenzoate (28d)
Palladium/carbon (10%) and 27l (18 mg, 0.034 mmol) were suspended in tetrahydrofuran (2
mL) and stirred for 18 h under a hydrogen atmosphere. The suspension was filtered through
a small plug of SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue
purified by flash chromatography (SiO2, 1:3 EtOAc/Hexanes) to give the desired product
28d (11 mg, 92 %) as a colorless oil: 1H NMR (500 MHz, (CD3)2 CO) δ 7.45 (d, J = 2.1 Hz,
1H), 7.41 (dd, J = 8.3, 2.0 Hz, 1H), 6.88 (d, J = 8.3 Hz, 1H), 6.15 (d, J = 2.3 Hz, 1H), 6.10 –
6.04 (m, 1H), 5.49 – 5.38 (m, 1H), 4.29 (ddd, J = 11.5, 4.4, 2.0 Hz, 1H), 4.22 – 4.14 (m,
1H), 3.80 (s, 3H), 3.76 (s, 3H), 2.97 (ddd, J = 17.4, 5.5, 1.2 Hz, 1H). 13C NMR (125 MHz,
(CD3)2 CO)) δ 159.9, 160.2 (2), 158.1 (2), 123.6 (2), 122.85, 117.21, 115.9, 101.3, 94.3,
92.3, 67.47, 66.4, 55.9, 55.6, 25.5; IR (KBr)νmax 3381, 3321, 2924, 2839, 1698, 16120,
1510, 1456, 1203, 1056, 728 cm−1; HRMS (ESI+) m/z [M+H+] calcd for C18H19O7,
347.1131, found 347.1125:
5,7-Dimethoxychroman-3-yl 4-hydroxy-3-methoxybenzoate (28e)
Palladium/carbon (10%) and 27l (24 mg, 0.053 mmol) were suspended in tetrahydrofuran (2
mL) and stirred for 18 h under a hydrogen atmosphere. The suspension was filtered through
a small plug of SiO2 (40 – 63 μm particle size). The eluent was concentrated and the residue
purified by flash chromatography (SiO2, 1:3 EtOAc/Hexanes) to give the desired product
28e (17 mg, 91 %) as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.60 (dd, J = 8.4, 1.9
Hz, 1H), 7.52 (d, J = 1.9 Hz, 1H), 6.90 (d, J = 8.3 Hz, 1H), 6.10 (s, 2H), 6.07 (s, 1H), 5.47
(dq, J = 7.5, 2.6 Hz, 1H), 4.28 (ddd, J = 11.3, 5.1, 1.8 Hz, 1H), 4.24 – 4.16 (m, 1H), 3.92 (s,
3H), 3.78 (d, J = 3.5 Hz, 6H), 3.01 (ddd, J = 17.5, 5.6, 1.2 Hz, 1H), 2.85 (ddd, J = 17.3, 4.6,
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1.7 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 165.8, 159.6, 158.2, 155.2, 150.2, 146.1, 124.5,
122.1, 114, 111.8, 100.6, 93.1, 91.7, 66.9, 65.8, 56.1, 55.4, 55.3, 24.9; IR (KBr)νmax 3385,
2939, 2841, 1699, 1612, 1508, 1214, 1145, 729 cm−1; HRMS (ESI+) m/z [M+H+] calcd for
C19H21O7, 361.1287, found 361.1278.
3-Azido-5,7-dimethoxychroman (29)
A solution of 26 (75, 0.36 mmol) and triphenylphosphine (161 mg, 0.61) in tetrahydrofuran
(2.5 ml) at 0 °C was treated with diisopropyl azodicarboxylate (120 μl, 0.61 mmol) and
diphenylphosphoryl azide (130 μl, 0.61 mmol). The resulting mixture was stirred for 15 h at
25°C before the solvent was removed. The residue was purified by flash chromatography
(SiO2, 1:20 EtOAc/Hexanes) to give 29 (75 mg, 83.9 %) as a light yellow oil: 1H NMR (500
MHz, CDCl3) δ 6.09 (d, J = 2.4 Hz, 1H), 6.06 (d, J = 2.4 Hz, 1H), 4.15 (ddd, J = 10.8, 2.6,
1.3 Hz, 1H), 4.02 (ddd, J = 10.9, 6.4, 1.5 Hz, 1H), 3.96 (qd, J = 6.0, 2.6 Hz, 1H), 3.80 (s,
3H), 3.76 (s, 3H), 2.95 (ddd, J = 16.7, 5.5, 1.4 Hz, 1H), 2.71 (ddd, J = 16.7, 6.0, 1.5 Hz,
1H). 13C NMR (125 MHz, CDCl3) δ 159.0, 157.9, 154.1, 99.3, 92.3, 91.2, 66.3, 54.7, 54.6,
52.4, 23.8; IR (KBr)νmax 2931, 2847, 2113, 1558, 1456, 1276,811 cm−1;HRMS (ESI+) m/z
[M+H+] calcd for C11H14N3O3, 236.1035, found 236.1028.
5,7-Dimethoxychroman-3-amine (30)
To a solution of 29 and triphenylphosphine in water in THF (3 mL), water (22 μl, 0.93
mmol) was added and stirred for 30 h at rt. The solvent was removed and the residue
purified via flash chromatography (silica gel 3:97 MeOH/CHCl3) to give 30 (55 mg, 83%)
as yellow oil. 1H NMR (500 MHz, CDCl3) δ 6.23 – 5.87 (m, 2H), 4.09 (ddd, J = 10.5, 2.8,
1.5 Hz, 1H), 3.84 – 3.79 (m, 1H), 3.78 (s, 3H), 3.76 (s, 3H), 3.34 (tdd, J = 6.8, 5.5, 2.9 Hz,
1H), 2.88 (ddd, J = 16.5, 5.5, 1.5 Hz, 1H), 2.36 (ddd, J = 16.4, 6.6, 1.2 Hz, 1H), 2.04 (d, J =
5.5 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 159.7, 159.1, 155.3, 101.7, 93.2, 91.8, 71.3,
55.6, 55.5, 44.0, 28.9; HRMS (ESI+) m/z [M+H+] calcd for C11H16NO3, 210.1130, found
210.1133.
N-(5,7-Dimethoxychroman-3-yl)benzamide (31a)
Benzoic acid (15 mg, 0.12 mmol) and N-(3-dimethylamino-propyl)-N′-ethylcarbodiimide
hydrochloride (19 mg, 0.14 mmol) were added to a solution of alcohol 30 (12 mg, 0.057
mmol) in dichloromethane (0.7 mL) with pyridine (0.3 mL). The resulting mixture was
stirred for 16 h and then the reaction mixture was diluted with dichloromethane (2 mL). The
organic phase was washed with saturated NaHCO3 (2 × 2 mL) and saturated sodium
chloride solution (3 mL). The organic layer was dried over anhydrous Na2SO4, filtered and
concentrated. The residue was purified by flash chromatography (SiO2, 1:2 Hexanes/EtOAc)
to give 31a (12 mg, 81%) as a pale yellow oil: 1H NMR (500 MHz, CDCl3) δ 7.78 – 7.66
(m, 2H), 7.54 – 7.46 (m, 1H), 7.41 (tt, J = 6.6, 1.4 Hz, 2H), 6.39 (d, J = 8.0 Hz, 1H), 6.17 –
5.90 (m, 2H), 4.70 (ddtd, J = 7.5, 5.5, 3.5, 1.8 Hz, 1H), 4.26 (ddd, J = 10.9, 3.8, 2.1 Hz, 1H),
4.15 (dd, J = 10.9, 1.8 Hz, 1H), 3.78 (d, J = 1.1 Hz, 6H), 2.91 (dd, J = 17.2, 5.7 Hz, 1H),
2.78 (ddd, J = 17.1, 3.2, 2.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 167.4, 159.9, 159.4,
155.3, 134.5, 131.8, 128.7 (2), 127.2 (2), 101.0, 93.5, 92.2, 68.3, 55.6, 55.6, 42.6, 25.6; IR
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(KBr)νmax 3307, 2925, 2850, 1645, 1635, 1622, 1539, 1521, 1145, 1122, 813, 756cm−1;
HRMS (ESI+) m/z [M+H+] calcd for C18H20NO4, 314.1392, found 314.1391.
N-(5,7-Dimethoxychroman-3-yl)-3-methoxybenzamide (31b)
3-Methoxybenzoic acid (15 mg, 0.12 mmol) and N-(3-dimethylamino-propyl)-N′-
ethylcarbodiimide hydrochloride (19 mg, 0.14 mmol) were added to a solution of alcohol 30
(12 mg, 0.057 mmol) in dichloromethane (0.7 mL) with pyridine (0.3 mL). The resulting
mixture was stirred for 16 h and then the reaction mixture was diluted with dichloromethane
(2 mL). The organic phase was washed with saturated sodium bicarbonate (2 × 2 mL) and
saturated sodium chloride solution (3 mL). The organic layer was dried over anhydrous
Na2SO4, filtered and concentrated. The residue was purified by flash chromatography (SiO2,
1:2 Hexanes/EtOAc) to give 31b (12 mg, 70%) as pale yellow oil: 1H NMR (500 MHz,
CDCl3) δ 7.26 (dd, J = 2.6, 1.6 Hz, 1H), 7.22 (t, J = 7.9 Hz, 1H), 7.14 (dt, J = 7.7, 1.3 Hz,
1H), 6.94 (ddd, J = 8.2, 2.7, 1.0 Hz, 1H), 6.30 (d, J = 8.0 Hz, 1H), 6.02 (d, J = 2.4 Hz, 1H),
6.01 (d, J = 2.4 Hz, 1H), 4.60 (dtt, J = 7.7, 3.8, 1.8 Hz, 1H), 4.17 (ddd, J = 10.9, 3.9, 2.1 Hz,
1H), 4.11 – 4.01 (m, 1H), 3.77 (s, 3H), 3.70 (s, 6H), 2.83 (dd, J = 17.1, 5.7 Hz, 1H), 2.69
(ddd, J = 17.2, 3.4, 2.1 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 167.3, 160.0, 159.9, 159.4,
155.3, 136.0, 129.7, 119.0, 117.9, 112.7, 100.9, 93.5, 92.2, 68.2, 55.7, 55.6 (2), 42.6, 25.5;
IR (KBr)νmax 3363, 2921, 2850, 1712, 1681, 1498, 1454, 1272, 1145, 771 cm−1; HRMS
(ESI+) m/z [M+H+] calcd for C19H22NO5, 344.1498, found 344.1498.
N-(5,7-dimethoxychroman-3-yl)-3′,6-dimethoxy-[1,1′-biphenyl]-3-carboxamide (31c)
3-3′,6-Dimethoxy-[1,1′-biphenyl]-3-carboxylic acid (25 mg, 0.1 mmol) and N-(3-
dimethylamino-propyl)-N′-ethylcarbodiimide hydrochloride (19 mg, 0.12 mmol) were
added to a solution of alcohol 30 (10 mg, 0.048 mmol) in dichlormethane (0.7 mL) with
pyridine (0.3 mL). The resulting mixture was stirred for 16 h and then the reaction mixture
was diluted with dichloromethane (2 mL) and organic phase was washed with saturated
NaHCO3 (2 × 2 mL) and saturated sodium chloride solution (2 mL). The organic layer was
dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by flash
chromatography (SiO2, 1:2 Hexanes/EtOAc) to give 31c (19.3 mg, 90%) as an amorphous
light yellow solid: 1H NMR (500 MHz, CDCl3) δ 7.76 (dd, J = 8.6, 2.4 Hz, 1H), 7.67 (d, J =
2.4 Hz, 1H), 7.39 – 7.30 (m, 1H), 7.08 (dt, J = 7.7, 1.1 Hz, 1H), 7.04 (dd, J = 2.6, 1.6 Hz,
1H), 6.98 (d, J = 8.6 Hz, 1H), 6.91 (ddd, J = 8.3, 2.6, 1.0 Hz, 1H), 6.32 (d, J = 7.9 Hz, 1H),
6.09 (d, J = 2.4 Hz, 1H), 6.08 (d, J = 2.4 Hz, 1H), 4.68 (ddt, J = 7.8, 3.9, 1.9 Hz, 1H), 4.24
(ddd, J = 10.8, 4.0, 2.0 Hz, 1H), 4.15 (dd, J = 10.7, 1.9 Hz, 1H), 3.84 (s, 6H), 3.77 (s, 6H),
2.92 (dd, J = 17.1, 5.7 Hz, 1H), 2.76 (ddd, J = 17.2, 3.5, 1.9 Hz, 1H). 13C NMR (126 MHz,
CDCl3) δ 166.9, 159.8, 159.5, 159.3 (2), 155.3, 139.1, 130.7, 129.8, 129.3, 128.4, 126.9,
122.2, 115.4, 113.1, 110.9, 101.1, 93.5, 92.2, 68.3, 56.0, 55.6, 55.6, 55.5, 42.6, 25.6; IR
(KBr)νmax 3315, 2931 1620, 1596, 1531, 1498, 1249, 1201, 1249, 1215, 1145, 1051, 752
cm−1; HRMS (ESI+) m/z [M+Na+] calcd for C26H27NaNO6, 472.1736, found 472.1738.
4-((5,7-dimethoxychroman-3-yl)carbamoyl)-2-(3-methylbut-2-en-1-yl)phenyl acetate (31d)
4-Acetoxy-3-(3-methylbut-2-en-1-yl)benzoic acid (47mg, 0.19 mmol) and N-(3-
dimethylamino-propyl)-N′-ethylcarbodiimide hydrochloride (37 mg, 0.24 mmol) were
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added to a solution of alcohol 30 (20 mg, 0.096 mmol), in dichlormethane (1.4 mL) with
pyridine (0.6 mL). The resulting mixture was stirred for 16 h and then the reaction mixture
was diluted with dichloromethane (4 mL). The organic phase was washed with saturated
NaHCO3 (2 × 4 mL) and saturated sodium chloride solution (4 mL). The organic layer was
dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by flash
chromatography (SiO2, 1:2 Hexanes/EtOAc) to give 31c (33 mg, 77%) as an amorphous
light yellow solid: 1H NMR (500 MHz, CDCl3) δ 7.66 (d, J = 2.2 Hz, 1H), 7.54 (dd, J = 8.3,
2.3 Hz, 1H), 7.06 (d, J = 8.3 Hz, 1H), 6.34 (d, J = 8.0 Hz, 1H), 6.12 (d, J = 2.3 Hz, 1H), 6.10
(d, J = 2.3 Hz, 1H), 5.20 (dddd, J = 7.2, 5.8, 2.9, 1.4 Hz, 1H), 4.68 (dtt, J = 7.6, 3.6, 1.7 Hz,
1H), 4.26 (ddd, J = 10.9, 3.8, 2.1 Hz, 1H), 4.15 (dd, J = 10.8, 1.8 Hz, 1H), 3.80 (s, 6H), 3.27
(d, J = 7.2 Hz, 2H), 2.91 (dd, J = 17.1, 5.6 Hz, 1H), 2.86 – 2.71 (m, 1H), 2.33 (s, 3H), 1.74
(s, 3H), 1.72 – 1.66 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 169.2, 166.9, 159.9, 159.4,
155.3, 151.5, 134.4, 134.0, 132.5, 129.6, 125.7, 122.6, 121.1, 100.9, 93.5, 92.2, 68.2, 55.6,
55.6, 42.6, 29.0, 25.9, 25.5, 21.1, 18.1; IR (KBr)νmax 3325, 2932 1623, 1602, 1596, 1531,
1496, 1249, 1201, 1251, 1215, 1145, 749 cm−1; HRMS (ESI+) m/z [M+Na+] calcd for
C25H29NaNO6, 462.1893, found 462.1872
4. Anti-proliferation Assay
MCF-7 and SKBr3 cells were maintained in a 1:1 mixture of advanced DMEM/F12 (Gibco)
containing non-essential amino acids, L-glutamine (2 mM), streptomycin (500 μg/mL),
penicillin (100 units/mL), and 10% FBS as supplements. Cells were grown to confluence in
a humidified atmosphere (37 °C, 5% CO2) and seeded (2000/well, 100 μL) in 96-well
plates, and allowed to attach for 24 hr. Compounds or geldanamycin at 6 increasing
concentrations in DMSO (1% DMSO final concentration) were added, and cells were
returned to the incubator for 72 h. At 72 h, the number of viable cells was determined using
an MTS/PMS cell proliferation kit (Promega) per the manufacturer’s instructions. Cells
incubated in 1% DMSO were used as 100% proliferation, and values were adjusted
accordingly. IC50 values were calculated from minimum two separate experiments
performed in triplicate using GraphPad Prism program.
5. Western Blot Analysis
MCF-7 cells were cultured as described previously and treated with various concentrations
of the compound to be tested, Geldanamycin in DMSO (1% DMSO final concentration), or
vehicle (DMSO) for 24 h. Cells were harvested in cold PBS and lysed in RIPA lysis buffer
containing 1 mM PMSF, 2 mM sodium orthovanadate, and protease inhibitors on ice for 1 h.
Lysates were clarified at 1400 g for 10 min at 4 °C. Protein concentrations were determined
by using the Pierce BCA assay kit per the manufacturer’s instructions. Equal amounts of
proteins (4 μg) were electrophoresed under reducing conditions, transferred to a
nitrocellulose membrane, and immunoblotted with the corresponding specific antibodies.
Membranes were incubated with an appropriate horseradish peroxidase-labeled secondary
anti-body, developed with chemiluminescent substrate, and visualized.
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Refer to Web version on PubMed Central for supplementary material.
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Hsp 90 C-terminal inhibitors
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Western blot analyses of MCF-7 cell lysates for Hsp90 client protein degradation after 24h
of incubation. (a) Compounds 27b, 27e, 10e and 11e at two different concentrations. “H”
(high) represents a concentration 5 × IC50 value, whereas and “L” (low) represents a
concentration at one half the IC50 value as determined by anti-proliferative studies; (b)
Compound 11e at increasing concentrations.
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Summary of EGCG structure-activity relationships.
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(a) Epimerization of EGCG to GCC, (b) Auto-oxidation products of EGCG.
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(a) Scaffolds derived from EGCG for Hsp90 inhibition, (b) Aryl acids used to replace the
gallic acid moiety.
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Synthesis of EGCG analogues containing modifications to the A-, B- and D-rings
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Synthesis of esters of 3,5-dihydroxychroman-3-ol.
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Synthesis of 3,5-dimethoxychroman-3-ol esters.
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Synthesis of 3,5-dimethoxychroman-3-ol amides.
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Table 4
Anti-proliferative activity produced by analogues containing amide linkers.
Entry R1 R2 MCF-7 (IC50, μM) SKBr3 (IC50, μM)
31a H H >100 >100
31b OMe H >100 >100
31c m-OMePh OMe >100 >100
31d Prenyl OAc 54.5 ± 0.6 55.2 ± 1.2
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